id	sid	tid	token	lemma	pos
cpe-2383	1	1	psychoneuroendocrinology	psychoneuroendocrinology	NOUN
cpe-2383	1	2	and	and	CCONJ
cpe-2383	1	3	clinical	clinical	ADJ
cpe-2383	1	4	psychology	psychology	NOUN
cpe-2383	1	5	scientific	scientific	ADJ
cpe-2383	1	6	update	update	NOUN
cpe-2383	1	7	and	and	CCONJ
cpe-2383	1	8	overview	overview	NOUN
cpe-2383	1	9	psychoneuroendocrinology	psychoneuroendocrinology	NOUN
cpe-2383	1	10	and	and	CCONJ
cpe-2383	1	11	clinical	clinical	ADJ
cpe-2383	1	12	psychology	psychology	NOUN
cpe-2383	1	13	susanne	susanne	PROPN
cpe-2383	1	14	fischer	fischer	PROPN
cpe-2383	2	1	a	a	DET
cpe-2383	2	2	,	,	PUNCT
cpe-2383	2	3	ulrike	ulrike	PROPN
cpe-2383	2	4	ehlert	ehlert	NOUN
cpe-2383	2	5	a	a	DET
cpe-2383	2	6	[	[	X
cpe-2383	2	7	a	a	X
cpe-2383	2	8	]	]	X
cpe-2383	2	9	institute	institute	NOUN
cpe-2383	2	10	of	of	ADP
cpe-2383	2	11	psychology	psychology	NOUN
cpe-2383	2	12	,	,	PUNCT
cpe-2383	2	13	clinical	clinical	ADJ
cpe-2383	2	14	psychology	psychology	NOUN
cpe-2383	2	15	and	and	CCONJ
cpe-2383	2	16	psychotherapy	psychotherapy	NOUN
cpe-2383	2	17	,	,	PUNCT
cpe-2383	2	18	university	university	NOUN
cpe-2383	2	19	of	of	ADP
cpe-2383	2	20	zurich	zurich	PROPN
cpe-2383	2	21	,	,	PUNCT
cpe-2383	2	22	zurich	zurich	PROPN
cpe-2383	2	23	,	,	PUNCT
cpe-2383	2	24	switzerland	switzerland	PROPN
cpe-2383	2	25	.	.	PUNCT
cpe-2383	3	1	clinical	clinical	ADJ
cpe-2383	3	2	psychology	psychology	NOUN
cpe-2383	3	3	in	in	ADP
cpe-2383	3	4	europe	europe	PROPN
cpe-2383	3	5	,	,	PUNCT
cpe-2383	3	6	2019	2019	NUM
cpe-2383	3	7	,	,	PUNCT
cpe-2383	3	8	vol	vol	NOUN
cpe-2383	3	9	.	.	PUNCT
cpe-2383	3	10	1(2	1(2	NUM
cpe-2383	3	11	)	)	PUNCT
cpe-2383	3	12	,	,	PUNCT
cpe-2383	3	13	article	article	NOUN
cpe-2383	3	14	33030	33030	NUM
cpe-2383	3	15	,	,	PUNCT
cpe-2383	3	16	https://doi.org/10.32872/cpe.v1i2.33030	https://doi.org/10.32872/cpe.v1i2.33030	PROPN
cpe-2383	3	17	received	receive	VERB
cpe-2383	3	18	:	:	PUNCT
cpe-2383	3	19	2019	2019	NUM
cpe-2383	3	20	-	-	SYM
cpe-2383	3	21	01	01	NUM
cpe-2383	3	22	-	-	SYM
cpe-2383	3	23	11	11	NUM
cpe-2383	3	24	•	•	NUM
cpe-2383	3	25	accepted	accept	VERB
cpe-2383	3	26	:	:	PUNCT
cpe-2383	3	27	2019	2019	NUM
cpe-2383	3	28	-	-	SYM
cpe-2383	3	29	03	03	NUM
cpe-2383	3	30	-	-	SYM
cpe-2383	3	31	01	01	NUM
cpe-2383	3	32	•	•	NOUN
cpe-2383	3	33	published	publish	VERB
cpe-2383	3	34	(	(	PUNCT
cpe-2383	3	35	vor	vor	NOUN
cpe-2383	3	36	):	):	PUNCT
cpe-2383	3	37	2019	2019	NUM
cpe-2383	3	38	-	-	SYM
cpe-2383	3	39	06	06	NUM
cpe-2383	3	40	-	-	SYM
cpe-2383	3	41	28	28	NUM
cpe-2383	3	42	handling	handling	NOUN
cpe-2383	3	43	editor	editor	NOUN
cpe-2383	3	44	:	:	PUNCT
cpe-2383	3	45	winfried	winfrie	VERB
cpe-2383	3	46	rief	rief	NOUN
cpe-2383	3	47	,	,	PUNCT
cpe-2383	3	48	philipps	philipps	NOUN
cpe-2383	3	49	-	-	PUNCT
cpe-2383	3	50	university	university	PROPN
cpe-2383	3	51	of	of	ADP
cpe-2383	3	52	marburg	marburg	PROPN
cpe-2383	3	53	,	,	PUNCT
cpe-2383	3	54	marburg	marburg	PROPN
cpe-2383	3	55	,	,	PUNCT
cpe-2383	3	56	germany	germany	PROPN
cpe-2383	3	57	corresponding	corresponding	ADJ
cpe-2383	3	58	author	author	NOUN
cpe-2383	3	59	:	:	PUNCT
cpe-2383	3	60	susanne	susanne	PROPN
cpe-2383	3	61	fischer	fischer	PROPN
cpe-2383	3	62	,	,	PUNCT
cpe-2383	3	63	university	university	PROPN
cpe-2383	3	64	of	of	ADP
cpe-2383	3	65	zurich	zurich	PROPN
cpe-2383	3	66	,	,	PUNCT
cpe-2383	3	67	institute	institute	PROPN
cpe-2383	3	68	of	of	ADP
cpe-2383	3	69	psychology	psychology	NOUN
cpe-2383	3	70	,	,	PUNCT
cpe-2383	3	71	clinical	clinical	ADJ
cpe-2383	3	72	psychology	psychology	NOUN
cpe-2383	3	73	and	and	CCONJ
cpe-2383	3	74	psychotherapy	psychotherapy	NOUN
cpe-2383	3	75	,	,	PUNCT
cpe-2383	3	76	binzmuehlestrasse	binzmuehlestrasse	NOUN
cpe-2383	3	77	14	14	NUM
cpe-2383	3	78	/	/	SYM
cpe-2383	3	79	box	box	PROPN
cpe-2383	3	80	26	26	NUM
cpe-2383	3	81	,	,	PUNCT
cpe-2383	3	82	8050	8050	NUM
cpe-2383	3	83	zurich	zurich	PROPN
cpe-2383	3	84	,	,	PUNCT
cpe-2383	3	85	switzerland	switzerland	PROPN
cpe-2383	3	86	.	.	PUNCT
cpe-2383	4	1	e	e	X
cpe-2383	4	2	-	-	NOUN
cpe-2383	4	3	mail	mail	NOUN
cpe-2383	4	4	:	:	PUNCT
cpe-2383	4	5	s.fischer@psychologie.uzh.ch	s.fischer@psychologie.uzh.ch	PROPN
cpe-2383	4	6	abstract	abstract	ADJ
cpe-2383	4	7	background	background	NOUN
cpe-2383	4	8	:	:	PUNCT
cpe-2383	4	9	hormones	hormone	NOUN
cpe-2383	4	10	impact	impact	NOUN
cpe-2383	4	11	on	on	ADP
cpe-2383	4	12	cognition	cognition	NOUN
cpe-2383	4	13	,	,	PUNCT
cpe-2383	4	14	emotions	emotion	NOUN
cpe-2383	4	15	,	,	PUNCT
cpe-2383	4	16	and	and	CCONJ
cpe-2383	4	17	behaviour	behaviour	NOUN
cpe-2383	4	18	.	.	PUNCT
cpe-2383	5	1	given	give	VERB
cpe-2383	5	2	that	that	PRON
cpe-2383	5	3	mental	mental	ADJ
cpe-2383	5	4	disorders	disorder	NOUN
cpe-2383	5	5	are	be	AUX
cpe-2383	5	6	defined	define	VERB
cpe-2383	5	7	by	by	ADP
cpe-2383	5	8	abnormalities	abnormality	NOUN
cpe-2383	5	9	in	in	ADP
cpe-2383	5	10	these	these	DET
cpe-2383	5	11	very	very	ADV
cpe-2383	5	12	same	same	ADJ
cpe-2383	5	13	domains	domain	NOUN
cpe-2383	5	14	,	,	PUNCT
cpe-2383	5	15	clinical	clinical	ADJ
cpe-2383	5	16	psychologists	psychologist	NOUN
cpe-2383	5	17	may	may	AUX
cpe-2383	5	18	benefit	benefit	VERB
cpe-2383	5	19	from	from	ADP
cpe-2383	5	20	learning	learn	VERB
cpe-2383	5	21	more	more	ADJ
cpe-2383	5	22	about	about	ADP
cpe-2383	5	23	alterations	alteration	NOUN
cpe-2383	5	24	in	in	ADP
cpe-2383	5	25	endocrine	endocrine	NOUN
cpe-2383	5	26	systems	system	NOUN
cpe-2383	5	27	,	,	PUNCT
cpe-2383	5	28	how	how	SCONJ
cpe-2383	5	29	they	they	PRON
cpe-2383	5	30	can	can	AUX
cpe-2383	5	31	contribute	contribute	VERB
cpe-2383	5	32	to	to	ADP
cpe-2383	5	33	symptoms	symptom	NOUN
cpe-2383	5	34	commonly	commonly	ADV
cpe-2383	5	35	experienced	experience	VERB
cpe-2383	5	36	by	by	ADP
cpe-2383	5	37	patients	patient	NOUN
cpe-2383	5	38	,	,	PUNCT
cpe-2383	5	39	and	and	CCONJ
cpe-2383	5	40	how	how	SCONJ
cpe-2383	5	41	such	such	ADJ
cpe-2383	5	42	knowledge	knowledge	NOUN
cpe-2383	5	43	may	may	AUX
cpe-2383	5	44	be	be	AUX
cpe-2383	5	45	put	put	VERB
cpe-2383	5	46	to	to	PART
cpe-2383	5	47	use	use	VERB
cpe-2383	5	48	in	in	ADP
cpe-2383	5	49	clinical	clinical	ADJ
cpe-2383	5	50	practice	practice	NOUN
cpe-2383	5	51	.	.	PUNCT
cpe-2383	6	1	method	method	NOUN
cpe-2383	6	2	:	:	PUNCT
cpe-2383	6	3	the	the	DET
cpe-2383	6	4	aim	aim	NOUN
cpe-2383	6	5	of	of	ADP
cpe-2383	6	6	the	the	DET
cpe-2383	6	7	present	present	ADJ
cpe-2383	6	8	scientific	scientific	ADJ
cpe-2383	6	9	update	update	NOUN
cpe-2383	6	10	was	be	AUX
cpe-2383	6	11	to	to	PART
cpe-2383	6	12	provide	provide	VERB
cpe-2383	6	13	a	a	DET
cpe-2383	6	14	brief	brief	ADJ
cpe-2383	6	15	overview	overview	NOUN
cpe-2383	6	16	of	of	ADP
cpe-2383	6	17	endocrine	endocrine	ADJ
cpe-2383	6	18	research	research	NOUN
cpe-2383	6	19	relevant	relevant	ADJ
cpe-2383	6	20	to	to	ADP
cpe-2383	6	21	the	the	DET
cpe-2383	6	22	aetiology	aetiology	NOUN
cpe-2383	6	23	,	,	PUNCT
cpe-2383	6	24	diagnostics	diagnostic	NOUN
cpe-2383	6	25	,	,	PUNCT
cpe-2383	6	26	and	and	CCONJ
cpe-2383	6	27	treatment	treatment	NOUN
cpe-2383	6	28	of	of	ADP
cpe-2383	6	29	mental	mental	ADJ
cpe-2383	6	30	disorders	disorder	NOUN
cpe-2383	6	31	,	,	PUNCT
cpe-2383	6	32	including	include	VERB
cpe-2383	6	33	some	some	PRON
cpe-2383	6	34	of	of	ADP
cpe-2383	6	35	the	the	DET
cpe-2383	6	36	latest	late	ADJ
cpe-2383	6	37	studies	study	NOUN
cpe-2383	6	38	in	in	ADP
cpe-2383	6	39	this	this	DET
cpe-2383	6	40	area	area	NOUN
cpe-2383	6	41	.	.	PUNCT
cpe-2383	7	1	results	result	NOUN
cpe-2383	7	2	:	:	PUNCT
cpe-2383	7	3	hormones	hormone	NOUN
cpe-2383	7	4	appear	appear	VERB
cpe-2383	7	5	to	to	PART
cpe-2383	7	6	be	be	AUX
cpe-2383	7	7	intrinsic	intrinsic	ADJ
cpe-2383	7	8	to	to	ADP
cpe-2383	7	9	the	the	DET
cpe-2383	7	10	development	development	NOUN
cpe-2383	7	11	and	and	CCONJ
cpe-2383	7	12	maintenance	maintenance	NOUN
cpe-2383	7	13	of	of	ADP
cpe-2383	7	14	mental	mental	ADJ
cpe-2383	7	15	disorders	disorder	NOUN
cpe-2383	7	16	.	.	PUNCT
cpe-2383	8	1	oxytocin	oxytocin	PROPN
cpe-2383	8	2	is	be	AUX
cpe-2383	8	3	involved	involve	VERB
cpe-2383	8	4	in	in	ADP
cpe-2383	8	5	social	social	ADJ
cpe-2383	8	6	cognition	cognition	NOUN
cpe-2383	8	7	and	and	CCONJ
cpe-2383	8	8	behaviour	behaviour	NOUN
cpe-2383	8	9	and	and	CCONJ
cpe-2383	8	10	as	as	SCONJ
cpe-2383	8	11	such	such	ADJ
cpe-2383	8	12	may	may	AUX
cpe-2383	8	13	be	be	AUX
cpe-2383	8	14	relevant	relevant	ADJ
cpe-2383	8	15	to	to	ADP
cpe-2383	8	16	mental	mental	ADJ
cpe-2383	8	17	disorders	disorder	NOUN
cpe-2383	8	18	characterised	characterise	VERB
cpe-2383	8	19	by	by	ADP
cpe-2383	8	20	social	social	ADJ
cpe-2383	8	21	deficits	deficit	NOUN
cpe-2383	8	22	(	(	PUNCT
cpe-2383	8	23	e.g.	e.g.	ADV
cpe-2383	8	24	,	,	PUNCT
cpe-2383	8	25	autism	autism	NOUN
cpe-2383	8	26	spectrum	spectrum	NOUN
cpe-2383	8	27	disorder	disorder	NOUN
cpe-2383	8	28	and	and	CCONJ
cpe-2383	8	29	schizophrenia	schizophrenia	NOUN
cpe-2383	8	30	)	)	PUNCT
cpe-2383	8	31	.	.	PUNCT
cpe-2383	9	1	stress	stress	NOUN
cpe-2383	9	2	and	and	CCONJ
cpe-2383	9	3	sex	sex	NOUN
cpe-2383	9	4	steroids	steroid	NOUN
cpe-2383	9	5	exert	exert	VERB
cpe-2383	9	6	demonstrable	demonstrable	ADJ
cpe-2383	9	7	effects	effect	NOUN
cpe-2383	9	8	on	on	ADP
cpe-2383	9	9	mood	mood	NOUN
cpe-2383	9	10	and	and	CCONJ
cpe-2383	9	11	cognition	cognition	NOUN
cpe-2383	9	12	.	.	PUNCT
cpe-2383	10	1	in	in	ADP
cpe-2383	10	2	patients	patient	NOUN
cpe-2383	10	3	with	with	ADP
cpe-2383	10	4	depression	depression	NOUN
cpe-2383	10	5	and	and	CCONJ
cpe-2383	10	6	anxiety	anxiety	NOUN
cpe-2383	10	7	disorders	disorder	NOUN
cpe-2383	10	8	,	,	PUNCT
cpe-2383	10	9	initial	initial	ADJ
cpe-2383	10	10	attempts	attempt	NOUN
cpe-2383	10	11	to	to	PART
cpe-2383	10	12	lower	low	ADJ
cpe-2383	10	13	/	/	SYM
cpe-2383	10	14	enhance	enhance	VERB
cpe-2383	10	15	such	such	ADJ
cpe-2383	10	16	hormones	hormone	NOUN
cpe-2383	10	17	have	have	AUX
cpe-2383	10	18	thus	thus	ADV
cpe-2383	10	19	been	be	AUX
cpe-2383	10	20	undertaken	undertake	VERB
cpe-2383	10	21	within	within	ADP
cpe-2383	10	22	conventional	conventional	ADJ
cpe-2383	10	23	therapies	therapy	NOUN
cpe-2383	10	24	in	in	ADP
cpe-2383	10	25	order	order	NOUN
cpe-2383	10	26	to	to	PART
cpe-2383	10	27	improve	improve	VERB
cpe-2383	10	28	outcomes	outcome	NOUN
cpe-2383	10	29	.	.	PUNCT
cpe-2383	11	1	finally	finally	ADV
cpe-2383	11	2	,	,	PUNCT
cpe-2383	11	3	hunger	hunger	NOUN
cpe-2383	11	4	and	and	CCONJ
cpe-2383	11	5	satiety	satiety	NOUN
cpe-2383	11	6	hormones	hormone	NOUN
cpe-2383	11	7	may	may	AUX
cpe-2383	11	8	be	be	AUX
cpe-2383	11	9	involved	involve	VERB
cpe-2383	11	10	in	in	ADP
cpe-2383	11	11	the	the	DET
cpe-2383	11	12	vicious	vicious	ADJ
cpe-2383	11	13	circle	circle	NOUN
cpe-2383	11	14	of	of	ADP
cpe-2383	11	15	dysfunctional	dysfunctional	ADJ
cpe-2383	11	16	eating	eating	NOUN
cpe-2383	11	17	behaviours	behaviour	NOUN
cpe-2383	11	18	and	and	CCONJ
cpe-2383	11	19	weight	weight	NOUN
cpe-2383	11	20	loss	loss	NOUN
cpe-2383	11	21	/	/	SYM
cpe-2383	11	22	gain	gain	NOUN
cpe-2383	11	23	in	in	ADP
cpe-2383	11	24	anorexia	anorexia	NOUN
cpe-2383	11	25	or	or	CCONJ
cpe-2383	11	26	bulimia	bulimia	NOUN
cpe-2383	11	27	nervosa	nervosa	NOUN
cpe-2383	11	28	.	.	PUNCT
cpe-2383	12	1	conclusion	conclusion	NOUN
cpe-2383	12	2	:	:	PUNCT
cpe-2383	12	3	three	three	NUM
cpe-2383	12	4	conclusions	conclusion	NOUN
cpe-2383	12	5	can	can	AUX
cpe-2383	12	6	be	be	AUX
cpe-2383	12	7	drawn	draw	VERB
cpe-2383	12	8	from	from	ADP
cpe-2383	12	9	this	this	DET
cpe-2383	12	10	review	review	NOUN
cpe-2383	12	11	:	:	PUNCT
cpe-2383	12	12	first	first	ADJ
cpe-2383	12	13	,	,	PUNCT
cpe-2383	12	14	endocrine	endocrine	ADJ
cpe-2383	12	15	research	research	NOUN
cpe-2383	12	16	should	should	AUX
cpe-2383	12	17	be	be	AUX
cpe-2383	12	18	considered	consider	VERB
cpe-2383	12	19	when	when	SCONJ
cpe-2383	12	20	patients	patient	NOUN
cpe-2383	12	21	and	and	CCONJ
cpe-2383	12	22	clinicians	clinician	NOUN
cpe-2383	12	23	are	be	AUX
cpe-2383	12	24	developing	develop	VERB
cpe-2383	12	25	multidimensional	multidimensional	ADJ
cpe-2383	12	26	illness	illness	NOUN
cpe-2383	12	27	models	model	NOUN
cpe-2383	12	28	together	together	ADV
cpe-2383	12	29	.	.	PUNCT
cpe-2383	13	1	second	second	ADV
cpe-2383	13	2	,	,	PUNCT
cpe-2383	13	3	endocrine	endocrine	ADJ
cpe-2383	13	4	markers	marker	NOUN
cpe-2383	13	5	can	can	AUX
cpe-2383	13	6	complement	complement	VERB
cpe-2383	13	7	conventional	conventional	ADJ
cpe-2383	13	8	assessments	assessment	NOUN
cpe-2383	13	9	to	to	PART
cpe-2383	13	10	provide	provide	VERB
cpe-2383	13	11	a	a	DET
cpe-2383	13	12	more	more	ADV
cpe-2383	13	13	comprehensive	comprehensive	ADJ
cpe-2383	13	14	account	account	NOUN
cpe-2383	13	15	of	of	ADP
cpe-2383	13	16	a	a	DET
cpe-2383	13	17	patient	patient	NOUN
cpe-2383	13	18	’s	’s	PART
cpe-2383	13	19	current	current	ADJ
cpe-2383	13	20	state	state	NOUN
cpe-2383	13	21	.	.	PUNCT
cpe-2383	14	1	third	third	ADJ
cpe-2383	14	2	,	,	PUNCT
cpe-2383	14	3	endocrine	endocrine	ADJ
cpe-2383	14	4	testing	testing	NOUN
cpe-2383	14	5	may	may	AUX
cpe-2383	14	6	guide	guide	VERB
cpe-2383	14	7	treatment	treatment	NOUN
cpe-2383	14	8	choices	choice	NOUN
cpe-2383	14	9	and	and	CCONJ
cpe-2383	14	10	inform	inform	VERB
cpe-2383	14	11	the	the	DET
cpe-2383	14	12	development	development	NOUN
cpe-2383	14	13	of	of	ADP
cpe-2383	14	14	novel	novel	ADJ
cpe-2383	14	15	treatments	treatment	NOUN
cpe-2383	14	16	.	.	PUNCT
cpe-2383	15	1	keywords	keyword	VERB
cpe-2383	15	2	anxiety	anxiety	NOUN
cpe-2383	15	3	,	,	PUNCT
cpe-2383	15	4	cognition	cognition	NOUN
cpe-2383	15	5	,	,	PUNCT
cpe-2383	15	6	depression	depression	NOUN
cpe-2383	15	7	,	,	PUNCT
cpe-2383	15	8	hormones	hormone	NOUN
cpe-2383	15	9	,	,	PUNCT
cpe-2383	15	10	mental	mental	ADJ
cpe-2383	15	11	disorders	disorder	NOUN
cpe-2383	15	12	,	,	PUNCT
cpe-2383	15	13	mood	mood	NOUN
cpe-2383	15	14	,	,	PUNCT
cpe-2383	15	15	psychological	psychological	ADJ
cpe-2383	15	16	therapy	therapy	NOUN
cpe-2383	15	17	this	this	PRON
cpe-2383	15	18	is	be	AUX
cpe-2383	15	19	an	an	DET
cpe-2383	15	20	open	open	ADJ
cpe-2383	15	21	access	access	NOUN
cpe-2383	15	22	article	article	NOUN
cpe-2383	15	23	distributed	distribute	VERB
cpe-2383	15	24	under	under	ADP
cpe-2383	15	25	the	the	DET
cpe-2383	15	26	terms	term	NOUN
cpe-2383	15	27	of	of	ADP
cpe-2383	15	28	the	the	DET
cpe-2383	15	29	creative	creative	ADJ
cpe-2383	15	30	commons	common	NOUN
cpe-2383	15	31	attribution	attribution	NOUN
cpe-2383	15	32	4.0	4.0	NUM
cpe-2383	15	33	international	international	ADJ
cpe-2383	15	34	license	license	NOUN
cpe-2383	15	35	,	,	PUNCT
cpe-2383	15	36	cc	cc	VERB
cpe-2383	15	37	by	by	ADP
cpe-2383	15	38	4.0	4.0	NUM
cpe-2383	15	39	,	,	PUNCT
cpe-2383	15	40	which	which	PRON
cpe-2383	15	41	permits	permit	VERB
cpe-2383	15	42	unrestricted	unrestricted	ADJ
cpe-2383	15	43	use	use	NOUN
cpe-2383	15	44	,	,	PUNCT
cpe-2383	15	45	distribution	distribution	NOUN
cpe-2383	15	46	,	,	PUNCT
cpe-2383	15	47	and	and	CCONJ
cpe-2383	15	48	reproduction	reproduction	NOUN
cpe-2383	15	49	,	,	PUNCT
cpe-2383	15	50	provided	provide	VERB
cpe-2383	15	51	the	the	DET
cpe-2383	15	52	original	original	ADJ
cpe-2383	15	53	work	work	NOUN
cpe-2383	15	54	is	be	AUX
cpe-2383	15	55	properly	properly	ADV
cpe-2383	15	56	cited	cite	VERB
cpe-2383	15	57	.	.	PUNCT
cpe-2383	16	1	https://crossmark.crossref.org/dialog/?doi=10.32872/cpe.v1i2.33030&domain=pdf&date_stamp=2019-06-28	https://crossmark.crossref.org/dialog/?doi=10.32872/cpe.v1i2.33030&domain=pdf&date_stamp=2019-06-28	PROPN
cpe-2383	16	2	https://cpe.psychopen.eu/	https://cpe.psychopen.eu/	PROPN
cpe-2383	17	1	https://www.psychopen.eu/	https://www.psychopen.eu/	PROPN
cpe-2383	17	2	https://creativecommons.org/licenses/by/4.0/	https://creativecommons.org/licenses/by/4.0/	PROPN
cpe-2383	17	3	https://creativecommons.org/licenses/by/4.0/	https://creativecommons.org/licenses/by/4.0/	PROPN
cpe-2383	17	4	https://creativecommons.org/licenses/by/4.0/	https://creativecommons.org/licenses/by/4.0/	PROPN
cpe-2383	17	5	highlights	highlight	VERB
cpe-2383	17	6	•	•	NUM
cpe-2383	17	7	hormones	hormone	NOUN
cpe-2383	17	8	are	be	AUX
cpe-2383	17	9	intrinsic	intrinsic	ADJ
cpe-2383	17	10	to	to	ADP
cpe-2383	17	11	the	the	DET
cpe-2383	17	12	development	development	NOUN
cpe-2383	17	13	and	and	CCONJ
cpe-2383	17	14	maintenance	maintenance	NOUN
cpe-2383	17	15	of	of	ADP
cpe-2383	17	16	mental	mental	ADJ
cpe-2383	17	17	disorders	disorder	NOUN
cpe-2383	17	18	•	•	NOUN
cpe-2383	17	19	endocrine	endocrine	NOUN
cpe-2383	17	20	research	research	NOUN
cpe-2383	17	21	should	should	AUX
cpe-2383	17	22	be	be	AUX
cpe-2383	17	23	incorporated	incorporate	VERB
cpe-2383	17	24	into	into	ADP
cpe-2383	17	25	multidimensional	multidimensional	ADJ
cpe-2383	17	26	illness	illness	NOUN
cpe-2383	17	27	models	model	NOUN
cpe-2383	17	28	•	•	ADP
cpe-2383	17	29	endocrine	endocrine	NOUN
cpe-2383	17	30	markers	marker	NOUN
cpe-2383	17	31	can	can	AUX
cpe-2383	17	32	complement	complement	VERB
cpe-2383	17	33	conventional	conventional	ADJ
cpe-2383	17	34	diagnostic	diagnostic	ADJ
cpe-2383	17	35	assessments	assessment	NOUN
cpe-2383	17	36	•	•	NOUN
cpe-2383	17	37	endocrine	endocrine	NOUN
cpe-2383	17	38	testing	testing	NOUN
cpe-2383	17	39	may	may	AUX
cpe-2383	17	40	guide	guide	VERB
cpe-2383	17	41	treatment	treatment	NOUN
cpe-2383	17	42	choices	choice	NOUN
cpe-2383	17	43	and	and	CCONJ
cpe-2383	17	44	inform	inform	VERB
cpe-2383	17	45	the	the	DET
cpe-2383	17	46	development	development	NOUN
cpe-2383	17	47	of	of	ADP
cpe-2383	17	48	new	new	ADJ
cpe-2383	17	49	treatments	treatment	NOUN
cpe-2383	17	50	psychoneuroendocrinology	psychoneuroendocrinology	NOUN
cpe-2383	17	51	is	be	AUX
cpe-2383	17	52	an	an	DET
cpe-2383	17	53	interdisciplinary	interdisciplinary	ADJ
cpe-2383	17	54	research	research	NOUN
cpe-2383	17	55	area	area	NOUN
cpe-2383	17	56	dedicated	dedicate	VERB
cpe-2383	17	57	to	to	ADP
cpe-2383	17	58	the	the	DET
cpe-2383	17	59	interac‐	interac‐	NOUN
cpe-2383	17	60	tion	tion	NOUN
cpe-2383	17	61	between	between	ADP
cpe-2383	17	62	the	the	DET
cpe-2383	17	63	mind	mind	NOUN
cpe-2383	17	64	,	,	PUNCT
cpe-2383	17	65	brain	brain	NOUN
cpe-2383	17	66	,	,	PUNCT
cpe-2383	17	67	and	and	CCONJ
cpe-2383	17	68	hormonal	hormonal	ADJ
cpe-2383	17	69	system	system	NOUN
cpe-2383	17	70	(	(	PUNCT
cpe-2383	17	71	wolf	wolf	PROPN
cpe-2383	17	72	&	&	CCONJ
cpe-2383	17	73	saucier	saucy	ADJ
cpe-2383	17	74	,	,	PUNCT
cpe-2383	17	75	2013	2013	NUM
cpe-2383	17	76	)	)	PUNCT
cpe-2383	17	77	.	.	PUNCT
cpe-2383	18	1	stress	stress	NOUN
cpe-2383	18	2	and	and	CCONJ
cpe-2383	18	3	lifestyle	lifestyle	NOUN
cpe-2383	18	4	behaviours	behaviour	NOUN
cpe-2383	18	5	(	(	PUNCT
cpe-2383	18	6	e.g.	e.g.	ADV
cpe-2383	18	7	,	,	PUNCT
cpe-2383	18	8	diet	diet	NOUN
cpe-2383	18	9	,	,	PUNCT
cpe-2383	18	10	physical	physical	ADJ
cpe-2383	18	11	activity	activity	NOUN
cpe-2383	18	12	)	)	PUNCT
cpe-2383	18	13	are	be	AUX
cpe-2383	18	14	the	the	DET
cpe-2383	18	15	most	most	ADV
cpe-2383	18	16	frequently	frequently	ADV
cpe-2383	18	17	studied	study	VERB
cpe-2383	18	18	psycho‐	psycho‐	VERB
cpe-2383	18	19	logical	logical	ADJ
cpe-2383	18	20	factors	factor	NOUN
cpe-2383	18	21	exerting	exert	VERB
cpe-2383	18	22	shortand	shortand	NOUN
cpe-2383	18	23	long	long	ADJ
cpe-2383	18	24	-	-	PUNCT
cpe-2383	18	25	term	term	NOUN
cpe-2383	18	26	effects	effect	NOUN
cpe-2383	18	27	on	on	ADP
cpe-2383	18	28	hormones	hormone	NOUN
cpe-2383	18	29	.	.	PUNCT
cpe-2383	19	1	conversely	conversely	ADV
cpe-2383	19	2	,	,	PUNCT
cpe-2383	19	3	a	a	DET
cpe-2383	19	4	number	number	NOUN
cpe-2383	19	5	of	of	ADP
cpe-2383	19	6	hormones	hormone	NOUN
cpe-2383	19	7	are	be	AUX
cpe-2383	19	8	known	know	VERB
cpe-2383	19	9	to	to	PART
cpe-2383	19	10	impact	impact	VERB
cpe-2383	19	11	on	on	ADP
cpe-2383	19	12	psychological	psychological	ADJ
cpe-2383	19	13	domains	domain	NOUN
cpe-2383	19	14	,	,	PUNCT
cpe-2383	19	15	such	such	ADJ
cpe-2383	19	16	as	as	ADP
cpe-2383	19	17	cognition	cognition	NOUN
cpe-2383	19	18	,	,	PUNCT
cpe-2383	19	19	emotions	emotion	NOUN
cpe-2383	19	20	,	,	PUNCT
cpe-2383	19	21	and	and	CCONJ
cpe-2383	19	22	behaviour	behaviour	NOUN
cpe-2383	19	23	.	.	PUNCT
cpe-2383	20	1	among	among	ADP
cpe-2383	20	2	these	these	PRON
cpe-2383	20	3	are	be	AUX
cpe-2383	20	4	hormones	hormone	NOUN
cpe-2383	20	5	involved	involve	VERB
cpe-2383	20	6	in	in	ADP
cpe-2383	20	7	social	social	ADJ
cpe-2383	20	8	interaction	interaction	NOUN
cpe-2383	20	9	(	(	PUNCT
cpe-2383	20	10	e.g.	e.g.	ADV
cpe-2383	20	11	,	,	PUNCT
cpe-2383	20	12	oxytocin	oxytocin	PROPN
cpe-2383	20	13	)	)	PUNCT
cpe-2383	20	14	,	,	PUNCT
cpe-2383	20	15	stress	stress	NOUN
cpe-2383	20	16	hormones	hormone	NOUN
cpe-2383	20	17	(	(	PUNCT
cpe-2383	20	18	e.g.	e.g.	ADV
cpe-2383	20	19	,	,	PUNCT
cpe-2383	20	20	noradrenaline	noradrenaline	ADJ
cpe-2383	20	21	and	and	CCONJ
cpe-2383	20	22	cortisol	cortisol	NOUN
cpe-2383	20	23	)	)	PUNCT
cpe-2383	20	24	,	,	PUNCT
cpe-2383	20	25	sex	sex	NOUN
cpe-2383	20	26	hormones	hormone	NOUN
cpe-2383	20	27	(	(	PUNCT
cpe-2383	20	28	e.g.	e.g.	ADV
cpe-2383	20	29	,	,	PUNCT
cpe-2383	20	30	testosterone	testosterone	NOUN
cpe-2383	20	31	,	,	PUNCT
cpe-2383	20	32	oes‐	oes‐	X
cpe-2383	20	33	tradiol	tradiol	NOUN
cpe-2383	20	34	,	,	PUNCT
cpe-2383	20	35	and	and	CCONJ
cpe-2383	20	36	progesterone	progesterone	NOUN
cpe-2383	20	37	)	)	PUNCT
cpe-2383	20	38	,	,	PUNCT
cpe-2383	20	39	and	and	CCONJ
cpe-2383	20	40	hormones	hormone	NOUN
cpe-2383	20	41	involved	involve	VERB
cpe-2383	20	42	in	in	ADP
cpe-2383	20	43	hunger	hunger	NOUN
cpe-2383	20	44	and	and	CCONJ
cpe-2383	20	45	satiety	satiety	NOUN
cpe-2383	20	46	(	(	PUNCT
cpe-2383	20	47	e.g.	e.g.	ADJ
cpe-2383	20	48	,	,	PUNCT
cpe-2383	20	49	ghrelin	ghrelin	NOUN
cpe-2383	20	50	,	,	PUNCT
cpe-2383	20	51	leptin	leptin	NOUN
cpe-2383	20	52	,	,	PUNCT
cpe-2383	20	53	or	or	CCONJ
cpe-2383	20	54	insulin	insulin	NOUN
cpe-2383	20	55	)	)	PUNCT
cpe-2383	20	56	.	.	PUNCT
cpe-2383	21	1	given	give	VERB
cpe-2383	21	2	that	that	SCONJ
cpe-2383	21	3	mental	mental	ADJ
cpe-2383	21	4	disorders	disorder	NOUN
cpe-2383	21	5	are	be	AUX
cpe-2383	21	6	characterised	characterise	VERB
cpe-2383	21	7	by	by	ADP
cpe-2383	21	8	abnormalities	abnormality	NOUN
cpe-2383	21	9	in	in	ADP
cpe-2383	21	10	cog‐	cog‐	PROPN
cpe-2383	21	11	nition	nition	NOUN
cpe-2383	21	12	,	,	PUNCT
cpe-2383	21	13	emotions	emotion	NOUN
cpe-2383	21	14	,	,	PUNCT
cpe-2383	21	15	and	and	CCONJ
cpe-2383	21	16	behaviour	behaviour	NOUN
cpe-2383	21	17	,	,	PUNCT
cpe-2383	21	18	clinical	clinical	ADJ
cpe-2383	21	19	psychologists	psychologist	NOUN
cpe-2383	21	20	may	may	AUX
cpe-2383	21	21	benefit	benefit	VERB
cpe-2383	21	22	from	from	ADP
cpe-2383	21	23	learning	learn	VERB
cpe-2383	21	24	more	more	ADJ
cpe-2383	21	25	about	about	ADP
cpe-2383	21	26	alterations	alteration	NOUN
cpe-2383	21	27	in	in	ADP
cpe-2383	21	28	endocrine	endocrine	NOUN
cpe-2383	21	29	systems	system	NOUN
cpe-2383	21	30	,	,	PUNCT
cpe-2383	21	31	how	how	SCONJ
cpe-2383	21	32	they	they	PRON
cpe-2383	21	33	may	may	AUX
cpe-2383	21	34	contribute	contribute	VERB
cpe-2383	21	35	to	to	ADP
cpe-2383	21	36	symptoms	symptom	NOUN
cpe-2383	21	37	common‐	common‐	ADV
cpe-2383	21	38	ly	ly	ADV
cpe-2383	21	39	experienced	experience	VERB
cpe-2383	21	40	by	by	ADP
cpe-2383	21	41	patients	patient	NOUN
cpe-2383	21	42	,	,	PUNCT
cpe-2383	21	43	and	and	CCONJ
cpe-2383	21	44	how	how	SCONJ
cpe-2383	21	45	such	such	ADJ
cpe-2383	21	46	knowledge	knowledge	NOUN
cpe-2383	21	47	may	may	AUX
cpe-2383	21	48	be	be	AUX
cpe-2383	21	49	put	put	VERB
cpe-2383	21	50	to	to	PART
cpe-2383	21	51	use	use	VERB
cpe-2383	21	52	in	in	ADP
cpe-2383	21	53	clinical	clinical	ADJ
cpe-2383	21	54	prac‐	prac‐	PROPN
cpe-2383	21	55	tice	tice	NOUN
cpe-2383	21	56	.	.	PUNCT
cpe-2383	22	1	the	the	DET
cpe-2383	22	2	aim	aim	NOUN
cpe-2383	22	3	of	of	ADP
cpe-2383	22	4	the	the	DET
cpe-2383	22	5	present	present	ADJ
cpe-2383	22	6	scientific	scientific	ADJ
cpe-2383	22	7	update	update	NOUN
cpe-2383	22	8	was	be	AUX
cpe-2383	22	9	therefore	therefore	ADV
cpe-2383	22	10	to	to	PART
cpe-2383	22	11	provide	provide	VERB
cpe-2383	22	12	a	a	DET
cpe-2383	22	13	brief	brief	ADJ
cpe-2383	22	14	overview	overview	NOUN
cpe-2383	22	15	of	of	ADP
cpe-2383	22	16	endocrine	endocrine	ADJ
cpe-2383	22	17	research	research	NOUN
cpe-2383	22	18	relevant	relevant	ADJ
cpe-2383	22	19	to	to	ADP
cpe-2383	22	20	the	the	DET
cpe-2383	22	21	aetiology	aetiology	NOUN
cpe-2383	22	22	,	,	PUNCT
cpe-2383	22	23	diagnostics	diagnostic	NOUN
cpe-2383	22	24	,	,	PUNCT
cpe-2383	22	25	and	and	CCONJ
cpe-2383	22	26	psychopharmacological	psychopharmacological	ADJ
cpe-2383	22	27	and	and	CCONJ
cpe-2383	22	28	psychotherapeutic	psychotherapeutic	ADJ
cpe-2383	22	29	treatment	treatment	NOUN
cpe-2383	22	30	of	of	ADP
cpe-2383	22	31	mental	mental	ADJ
cpe-2383	22	32	disorders	disorder	NOUN
cpe-2383	22	33	,	,	PUNCT
cpe-2383	22	34	including	include	VERB
cpe-2383	22	35	some	some	PRON
cpe-2383	22	36	of	of	ADP
cpe-2383	22	37	the	the	DET
cpe-2383	22	38	latest	late	ADJ
cpe-2383	22	39	studies	study	NOUN
cpe-2383	22	40	in	in	ADP
cpe-2383	22	41	this	this	DET
cpe-2383	22	42	area	area	NOUN
cpe-2383	22	43	.	.	PUNCT
cpe-2383	23	1	findings	finding	NOUN
cpe-2383	23	2	will	will	AUX
cpe-2383	23	3	be	be	AUX
cpe-2383	23	4	presented	present	VERB
cpe-2383	23	5	separately	separately	ADV
cpe-2383	23	6	for	for	ADP
cpe-2383	23	7	each	each	PRON
cpe-2383	23	8	of	of	ADP
cpe-2383	23	9	the	the	DET
cpe-2383	23	10	aforementioned	aforementione	VERB
cpe-2383	23	11	domains	domain	NOUN
cpe-2383	23	12	and	and	CCONJ
cpe-2383	23	13	summarised	summarise	VERB
cpe-2383	23	14	in	in	ADP
cpe-2383	23	15	the	the	DET
cpe-2383	23	16	final	final	ADJ
cpe-2383	23	17	part	part	NOUN
cpe-2383	23	18	of	of	ADP
cpe-2383	23	19	the	the	DET
cpe-2383	23	20	manuscript	manuscript	NOUN
cpe-2383	23	21	alongside	alongside	ADP
cpe-2383	23	22	recommendations	recommendation	NOUN
cpe-2383	23	23	for	for	ADP
cpe-2383	23	24	clini‐	clini‐	NOUN
cpe-2383	23	25	cal	cal	PROPN
cpe-2383	23	26	applications	application	NOUN
cpe-2383	23	27	.	.	PUNCT
cpe-2383	24	1	how	how	SCONJ
cpe-2383	24	2	hormones	hormone	NOUN
cpe-2383	24	3	affect	affect	VERB
cpe-2383	24	4	social	social	ADJ
cpe-2383	24	5	interaction	interaction	NOUN
cpe-2383	24	6	the	the	DET
cpe-2383	24	7	most	most	ADV
cpe-2383	24	8	prominent	prominent	ADJ
cpe-2383	24	9	hormone	hormone	NOUN
cpe-2383	24	10	regulating	regulate	VERB
cpe-2383	24	11	social	social	ADJ
cpe-2383	24	12	interaction	interaction	NOUN
cpe-2383	24	13	is	be	AUX
cpe-2383	24	14	oxytocin	oxytocin	PROPN
cpe-2383	24	15	(	(	PUNCT
cpe-2383	24	16	meyerlindenberg	meyerlindenberg	PROPN
cpe-2383	24	17	,	,	PUNCT
cpe-2383	24	18	domes	dome	NOUN
cpe-2383	24	19	,	,	PUNCT
cpe-2383	24	20	kirsch	kirsch	PROPN
cpe-2383	24	21	,	,	PUNCT
cpe-2383	24	22	&	&	CCONJ
cpe-2383	24	23	heinrichs	heinrichs	PROPN
cpe-2383	24	24	,	,	PUNCT
cpe-2383	24	25	2011	2011	NUM
cpe-2383	24	26	)	)	PUNCT
cpe-2383	24	27	.	.	PUNCT
cpe-2383	25	1	although	although	SCONJ
cpe-2383	25	2	oxytocin	oxytocin	NOUN
cpe-2383	25	3	is	be	AUX
cpe-2383	25	4	available	available	ADJ
cpe-2383	25	5	in	in	ADP
cpe-2383	25	6	the	the	DET
cpe-2383	25	7	pe‐	pe‐	NOUN
cpe-2383	25	8	riphery	riphery	PROPN
cpe-2383	25	9	(	(	PUNCT
cpe-2383	25	10	e.g.	e.g.	ADV
cpe-2383	25	11	,	,	PUNCT
cpe-2383	25	12	in	in	ADP
cpe-2383	25	13	reproductive	reproductive	ADJ
cpe-2383	25	14	organs	organ	NOUN
cpe-2383	25	15	)	)	PUNCT
cpe-2383	25	16	,	,	PUNCT
cpe-2383	25	17	its	its	PRON
cpe-2383	25	18	central	central	ADJ
cpe-2383	25	19	origin	origin	NOUN
cpe-2383	25	20	is	be	AUX
cpe-2383	25	21	in	in	ADP
cpe-2383	25	22	the	the	DET
cpe-2383	25	23	hypothalamus	hypothalamus	NOUN
cpe-2383	25	24	,	,	PUNCT
cpe-2383	25	25	and	and	CCONJ
cpe-2383	25	26	oxy‐	oxy‐	NOUN
cpe-2383	25	27	tocin	tocin	NOUN
cpe-2383	25	28	receptors	receptor	NOUN
cpe-2383	25	29	are	be	AUX
cpe-2383	25	30	widely	widely	ADV
cpe-2383	25	31	expressed	express	VERB
cpe-2383	25	32	in	in	ADP
cpe-2383	25	33	numerous	numerous	ADJ
cpe-2383	25	34	areas	area	NOUN
cpe-2383	25	35	of	of	ADP
cpe-2383	25	36	the	the	DET
cpe-2383	25	37	brain	brain	NOUN
cpe-2383	25	38	,	,	PUNCT
cpe-2383	25	39	including	include	VERB
cpe-2383	25	40	the	the	DET
cpe-2383	25	41	frontal	frontal	ADJ
cpe-2383	25	42	cortex	cortex	NOUN
cpe-2383	25	43	,	,	PUNCT
cpe-2383	25	44	amygdala	amygdala	NOUN
cpe-2383	25	45	,	,	PUNCT
cpe-2383	25	46	and	and	CCONJ
cpe-2383	25	47	olfactory	olfactory	ADJ
cpe-2383	25	48	nucleus	nucleus	NOUN
cpe-2383	25	49	.	.	PUNCT
cpe-2383	26	1	oxytocin	oxytocin	PROPN
cpe-2383	26	2	has	have	VERB
cpe-2383	26	3	demonstrable	demonstrable	ADJ
cpe-2383	26	4	effects	effect	NOUN
cpe-2383	26	5	on	on	ADP
cpe-2383	26	6	social	social	ADJ
cpe-2383	26	7	cognition	cognition	NOUN
cpe-2383	26	8	and	and	CCONJ
cpe-2383	26	9	behaviour	behaviour	NOUN
cpe-2383	26	10	,	,	PUNCT
cpe-2383	26	11	such	such	ADJ
cpe-2383	26	12	as	as	ADP
cpe-2383	26	13	enhanc‐	enhanc‐	PROPN
cpe-2383	26	14	ing	ing	ADJ
cpe-2383	26	15	theory	theory	NOUN
cpe-2383	26	16	of	of	ADP
cpe-2383	26	17	mind	mind	NOUN
cpe-2383	26	18	,	,	PUNCT
cpe-2383	26	19	emotional	emotional	ADJ
cpe-2383	26	20	recognition	recognition	NOUN
cpe-2383	26	21	,	,	PUNCT
cpe-2383	26	22	empathy	empathy	NOUN
cpe-2383	26	23	,	,	PUNCT
cpe-2383	26	24	social	social	ADJ
cpe-2383	26	25	exploration	exploration	NOUN
cpe-2383	26	26	,	,	PUNCT
cpe-2383	26	27	and	and	CCONJ
cpe-2383	26	28	attachment	attachment	NOUN
cpe-2383	26	29	psychoneuroendocrinology	psychoneuroendocrinology	NOUN
cpe-2383	26	30	and	and	CCONJ
cpe-2383	26	31	clinical	clinical	ADJ
cpe-2383	26	32	psychology	psychology	NOUN
cpe-2383	26	33	2	2	NUM
cpe-2383	26	34	clinical	clinical	ADJ
cpe-2383	26	35	psychology	psychology	NOUN
cpe-2383	26	36	in	in	ADP
cpe-2383	26	37	europe	europe	PROPN
cpe-2383	26	38	2019	2019	NUM
cpe-2383	26	39	,	,	PUNCT
cpe-2383	26	40	vol.1(2	vol.1(2	PROPN
cpe-2383	26	41	)	)	PUNCT
cpe-2383	26	42	,	,	PUNCT
cpe-2383	26	43	article	article	NOUN
cpe-2383	26	44	33030	33030	NUM
cpe-2383	26	45	https://doi.org/10.32872/cpe.v1i2.33030	https://doi.org/10.32872/cpe.v1i2.33030	PROPN
cpe-2383	26	46	https://www.psychopen.eu/	https://www.psychopen.eu/	PUNCT
cpe-2383	26	47	(	(	PUNCT
cpe-2383	26	48	see	see	VERB
cpe-2383	26	49	also	also	ADV
cpe-2383	26	50	ditzen	ditzen	VERB
cpe-2383	26	51	et	et	PROPN
cpe-2383	26	52	al	al	PROPN
cpe-2383	26	53	.	.	PROPN
cpe-2383	26	54	,	,	PUNCT
cpe-2383	26	55	2009	2009	NUM
cpe-2383	26	56	;	;	PUNCT
cpe-2383	26	57	heinrichs	heinrichs	PROPN
cpe-2383	26	58	,	,	PUNCT
cpe-2383	26	59	baumgartner	baumgartner	PROPN
cpe-2383	26	60	,	,	PUNCT
cpe-2383	26	61	kirschbaum	kirschbaum	PROPN
cpe-2383	26	62	,	,	PUNCT
cpe-2383	26	63	&	&	CCONJ
cpe-2383	26	64	ehlert	ehlert	PROPN
cpe-2383	26	65	,	,	PUNCT
cpe-2383	26	66	2003	2003	NUM
cpe-2383	26	67	)	)	PUNCT
cpe-2383	26	68	.	.	PUNCT
cpe-2383	27	1	as	as	ADP
cpe-2383	27	2	such	such	ADJ
cpe-2383	27	3	,	,	PUNCT
cpe-2383	27	4	it	it	PRON
cpe-2383	27	5	has	have	AUX
cpe-2383	27	6	attracted	attract	VERB
cpe-2383	27	7	the	the	DET
cpe-2383	27	8	interest	interest	NOUN
cpe-2383	27	9	of	of	ADP
cpe-2383	27	10	researchers	researcher	NOUN
cpe-2383	27	11	studying	study	VERB
cpe-2383	27	12	mental	mental	ADJ
cpe-2383	27	13	disorders	disorder	NOUN
cpe-2383	27	14	characterised	characterise	VERB
cpe-2383	27	15	by	by	ADP
cpe-2383	27	16	social	social	ADJ
cpe-2383	27	17	deficits	deficit	NOUN
cpe-2383	27	18	,	,	PUNCT
cpe-2383	27	19	including	include	VERB
cpe-2383	27	20	autism	autism	NOUN
cpe-2383	27	21	spectrum	spectrum	NOUN
cpe-2383	27	22	disorders	disorder	NOUN
cpe-2383	27	23	and	and	CCONJ
cpe-2383	27	24	schizophrenia	schizophrenia	NOUN
cpe-2383	27	25	.	.	PUNCT
cpe-2383	28	1	there	there	PRON
cpe-2383	28	2	is	be	VERB
cpe-2383	28	3	now	now	ADV
cpe-2383	28	4	evidence	evidence	NOUN
cpe-2383	28	5	to	to	PART
cpe-2383	28	6	suggest	suggest	VERB
cpe-2383	28	7	that	that	SCONJ
cpe-2383	28	8	oxytocin	oxytocin	PROPN
cpe-2383	28	9	may	may	AUX
cpe-2383	28	10	be	be	AUX
cpe-2383	28	11	an	an	DET
cpe-2383	28	12	aetiological	aetiological	ADJ
cpe-2383	28	13	factor	factor	NOUN
cpe-2383	28	14	in	in	ADP
cpe-2383	28	15	autism	autism	NOUN
cpe-2383	28	16	spectrum	spectrum	NOUN
cpe-2383	28	17	disor‐	disor‐	NOUN
cpe-2383	28	18	der	der	NOUN
cpe-2383	28	19	,	,	PUNCT
cpe-2383	28	20	since	since	SCONJ
cpe-2383	28	21	several	several	ADJ
cpe-2383	28	22	polymorphisms	polymorphism	NOUN
cpe-2383	28	23	within	within	ADP
cpe-2383	28	24	the	the	DET
cpe-2383	28	25	gene	gene	NOUN
cpe-2383	28	26	encoding	encode	VERB
cpe-2383	28	27	its	its	PRON
cpe-2383	28	28	receptor	receptor	NOUN
cpe-2383	28	29	(	(	PUNCT
cpe-2383	28	30	oxtr	oxtr	NOUN
cpe-2383	28	31	)	)	PUNCT
cpe-2383	28	32	have	have	AUX
cpe-2383	28	33	been	be	AUX
cpe-2383	28	34	found	find	VERB
cpe-2383	28	35	to	to	PART
cpe-2383	28	36	be	be	AUX
cpe-2383	28	37	risk	risk	NOUN
cpe-2383	28	38	-	-	PUNCT
cpe-2383	28	39	inducing	induce	VERB
cpe-2383	28	40	(	(	PUNCT
cpe-2383	28	41	kranz	kranz	PROPN
cpe-2383	28	42	et	et	PROPN
cpe-2383	28	43	al	al	PROPN
cpe-2383	28	44	.	.	PROPN
cpe-2383	28	45	,	,	PUNCT
cpe-2383	28	46	2016	2016	NUM
cpe-2383	28	47	;	;	PUNCT
cpe-2383	28	48	loparo	loparo	NOUN
cpe-2383	28	49	&	&	CCONJ
cpe-2383	28	50	waldman	waldman	PROPN
cpe-2383	28	51	,	,	PUNCT
cpe-2383	28	52	2015	2015	NUM
cpe-2383	28	53	)	)	PUNCT
cpe-2383	28	54	.	.	PUNCT
cpe-2383	29	1	on	on	ADP
cpe-2383	29	2	the	the	DET
cpe-2383	29	3	oth‐	oth‐	ADJ
cpe-2383	29	4	er	er	INTJ
cpe-2383	29	5	hand	hand	NOUN
cpe-2383	29	6	,	,	PUNCT
cpe-2383	29	7	peripheral	peripheral	ADJ
cpe-2383	29	8	levels	level	NOUN
cpe-2383	29	9	of	of	ADP
cpe-2383	29	10	oxytocin	oxytocin	NOUN
cpe-2383	29	11	are	be	AUX
cpe-2383	29	12	often	often	ADV
cpe-2383	29	13	found	find	VERB
cpe-2383	29	14	to	to	PART
cpe-2383	29	15	be	be	AUX
cpe-2383	29	16	unaltered	unaltere	VERB
cpe-2383	29	17	in	in	ADP
cpe-2383	29	18	the	the	DET
cpe-2383	29	19	same	same	ADJ
cpe-2383	29	20	patients	patient	NOUN
cpe-2383	29	21	as	as	ADV
cpe-2383	29	22	well	well	ADV
cpe-2383	29	23	as	as	ADP
cpe-2383	29	24	in	in	ADP
cpe-2383	29	25	patients	patient	NOUN
cpe-2383	29	26	with	with	ADP
cpe-2383	29	27	psychotic	psychotic	ADJ
cpe-2383	29	28	disorders	disorder	NOUN
cpe-2383	29	29	(	(	PUNCT
cpe-2383	29	30	rutigliano	rutigliano	NOUN
cpe-2383	29	31	et	et	PROPN
cpe-2383	29	32	al	al	PROPN
cpe-2383	29	33	.	.	PROPN
cpe-2383	29	34	,	,	PUNCT
cpe-2383	29	35	2016	2016	NUM
cpe-2383	29	36	)	)	PUNCT
cpe-2383	29	37	.	.	PUNCT
cpe-2383	30	1	these	these	DET
cpe-2383	30	2	null	null	NOUN
cpe-2383	30	3	-	-	PUNCT
cpe-2383	30	4	find‐	find‐	NOUN
cpe-2383	30	5	ings	ing	NOUN
cpe-2383	30	6	need	need	VERB
cpe-2383	30	7	to	to	PART
cpe-2383	30	8	be	be	AUX
cpe-2383	30	9	interpreted	interpret	VERB
cpe-2383	30	10	with	with	ADP
cpe-2383	30	11	caution	caution	NOUN
cpe-2383	30	12	,	,	PUNCT
cpe-2383	30	13	however	however	ADV
cpe-2383	30	14	,	,	PUNCT
cpe-2383	30	15	since	since	SCONJ
cpe-2383	30	16	the	the	DET
cpe-2383	30	17	bioavailability	bioavailability	NOUN
cpe-2383	30	18	of	of	ADP
cpe-2383	30	19	oxytocin	oxytocin	PROPN
cpe-2383	30	20	in	in	ADP
cpe-2383	30	21	blood	blood	NOUN
cpe-2383	30	22	,	,	PUNCT
cpe-2383	30	23	urine	urine	NOUN
cpe-2383	30	24	,	,	PUNCT
cpe-2383	30	25	or	or	CCONJ
cpe-2383	30	26	saliva	saliva	NOUN
cpe-2383	30	27	does	do	AUX
cpe-2383	30	28	not	not	PART
cpe-2383	30	29	necessarily	necessarily	ADV
cpe-2383	30	30	reflect	reflect	VERB
cpe-2383	30	31	its	its	PRON
cpe-2383	30	32	centrally	centrally	ADV
cpe-2383	30	33	circulating	circulate	VERB
cpe-2383	30	34	levels	level	NOUN
cpe-2383	30	35	(	(	PUNCT
cpe-2383	30	36	valstad	valstad	PROPN
cpe-2383	30	37	et	et	PROPN
cpe-2383	30	38	al	al	PROPN
cpe-2383	30	39	.	.	PROPN
cpe-2383	30	40	,	,	PUNCT
cpe-2383	30	41	2017	2017	NUM
cpe-2383	30	42	)	)	PUNCT
cpe-2383	30	43	,	,	PUNCT
cpe-2383	30	44	which	which	PRON
cpe-2383	30	45	are	be	AUX
cpe-2383	30	46	of	of	ADP
cpe-2383	30	47	greater	great	ADJ
cpe-2383	30	48	importance	importance	NOUN
cpe-2383	30	49	considering	consider	VERB
cpe-2383	30	50	the	the	DET
cpe-2383	30	51	clinical	clinical	ADJ
cpe-2383	30	52	features	feature	NOUN
cpe-2383	30	53	of	of	ADP
cpe-2383	30	54	these	these	DET
cpe-2383	30	55	ill‐	ill‐	PUNCT
cpe-2383	30	56	nesses	ness	NOUN
cpe-2383	30	57	.	.	PUNCT
cpe-2383	31	1	importantly	importantly	ADV
cpe-2383	31	2	,	,	PUNCT
cpe-2383	31	3	central	central	ADJ
cpe-2383	31	4	levels	level	NOUN
cpe-2383	31	5	are	be	AUX
cpe-2383	31	6	only	only	ADV
cpe-2383	31	7	quantifiable	quantifiable	ADJ
cpe-2383	31	8	in	in	ADP
cpe-2383	31	9	humans	human	NOUN
cpe-2383	31	10	via	via	ADP
cpe-2383	31	11	access	access	NOUN
cpe-2383	31	12	to	to	ADP
cpe-2383	31	13	the	the	DET
cpe-2383	31	14	cere‐	cere‐	PROPN
cpe-2383	31	15	brospinal	brospinal	ADJ
cpe-2383	31	16	fluid	fluid	NOUN
cpe-2383	31	17	by	by	ADP
cpe-2383	31	18	means	mean	NOUN
cpe-2383	31	19	of	of	ADP
cpe-2383	31	20	lumbar	lumbar	NOUN
cpe-2383	31	21	puncture	puncture	NOUN
cpe-2383	31	22	.	.	PUNCT
cpe-2383	32	1	thus	thus	ADV
cpe-2383	32	2	,	,	PUNCT
cpe-2383	32	3	although	although	SCONJ
cpe-2383	32	4	it	it	PRON
cpe-2383	32	5	is	be	AUX
cpe-2383	32	6	unlikely	unlikely	ADJ
cpe-2383	32	7	that	that	SCONJ
cpe-2383	32	8	oxytocin	oxytocin	NOUN
cpe-2383	32	9	levels	level	NOUN
cpe-2383	32	10	will	will	AUX
cpe-2383	32	11	be	be	AUX
cpe-2383	32	12	used	use	VERB
cpe-2383	32	13	as	as	ADP
cpe-2383	32	14	a	a	DET
cpe-2383	32	15	diagnostic	diagnostic	ADJ
cpe-2383	32	16	illness	illness	NOUN
cpe-2383	32	17	marker	marker	NOUN
cpe-2383	32	18	in	in	ADP
cpe-2383	32	19	the	the	DET
cpe-2383	32	20	near	near	ADJ
cpe-2383	32	21	future	future	NOUN
cpe-2383	32	22	,	,	PUNCT
cpe-2383	32	23	their	their	PRON
cpe-2383	32	24	potential	potential	ADJ
cpe-2383	32	25	role	role	NOUN
cpe-2383	32	26	in	in	ADP
cpe-2383	32	27	the	the	DET
cpe-2383	32	28	pathophysiology	pathophysiology	NOUN
cpe-2383	32	29	of	of	ADP
cpe-2383	32	30	disorders	disorder	NOUN
cpe-2383	32	31	characterised	characterise	VERB
cpe-2383	32	32	by	by	ADP
cpe-2383	32	33	social	social	ADJ
cpe-2383	32	34	deficits	deficit	NOUN
cpe-2383	32	35	can	can	AUX
cpe-2383	32	36	be	be	AUX
cpe-2383	32	37	incorporated	incorporate	VERB
cpe-2383	32	38	into	into	ADP
cpe-2383	32	39	psychoeducation	psychoeducation	NOUN
cpe-2383	32	40	delivered	deliver	VERB
cpe-2383	32	41	to	to	ADP
cpe-2383	32	42	patients	patient	NOUN
cpe-2383	32	43	and	and	CCONJ
cpe-2383	32	44	their	their	PRON
cpe-2383	32	45	next	next	ADJ
cpe-2383	32	46	of	of	ADP
cpe-2383	32	47	kin	kin	PROPN
cpe-2383	32	48	.	.	PUNCT
cpe-2383	33	1	another	another	DET
cpe-2383	33	2	line	line	NOUN
cpe-2383	33	3	of	of	ADP
cpe-2383	33	4	research	research	NOUN
cpe-2383	33	5	has	have	AUX
cpe-2383	33	6	examined	examine	VERB
cpe-2383	33	7	the	the	DET
cpe-2383	33	8	effects	effect	NOUN
cpe-2383	33	9	of	of	ADP
cpe-2383	33	10	intranasally	intranasally	ADV
cpe-2383	33	11	administered	administer	VERB
cpe-2383	33	12	oxyto‐	oxyto‐	PRON
cpe-2383	33	13	cin	cin	PROPN
cpe-2383	33	14	in	in	ADP
cpe-2383	33	15	patients	patient	NOUN
cpe-2383	33	16	with	with	ADP
cpe-2383	33	17	autism	autism	NOUN
cpe-2383	33	18	spectrum	spectrum	NOUN
cpe-2383	33	19	disorder	disorder	NOUN
cpe-2383	33	20	and	and	CCONJ
cpe-2383	33	21	schizophrenia	schizophrenia	NOUN
cpe-2383	33	22	(	(	PUNCT
cpe-2383	33	23	keech	keech	PROPN
cpe-2383	33	24	,	,	PUNCT
cpe-2383	33	25	crowe	crowe	PROPN
cpe-2383	33	26	,	,	PUNCT
cpe-2383	33	27	&	&	CCONJ
cpe-2383	33	28	hocking	hocking	PROPN
cpe-2383	33	29	,	,	PUNCT
cpe-2383	33	30	2018	2018	NUM
cpe-2383	33	31	)	)	PUNCT
cpe-2383	33	32	,	,	PUNCT
cpe-2383	33	33	with	with	ADP
cpe-2383	33	34	findings	finding	NOUN
cpe-2383	33	35	of	of	ADP
cpe-2383	33	36	small	small	ADJ
cpe-2383	33	37	but	but	CCONJ
cpe-2383	33	38	significant	significant	ADJ
cpe-2383	33	39	improvements	improvement	NOUN
cpe-2383	33	40	in	in	ADP
cpe-2383	33	41	theory	theory	NOUN
cpe-2383	33	42	of	of	ADP
cpe-2383	33	43	mind	mind	NOUN
cpe-2383	33	44	(	(	PUNCT
cpe-2383	33	45	but	but	CCONJ
cpe-2383	33	46	not	not	PART
cpe-2383	33	47	in	in	ADP
cpe-2383	33	48	emotion	emotion	NOUN
cpe-2383	33	49	recognition	recognition	NOUN
cpe-2383	33	50	or	or	CCONJ
cpe-2383	33	51	empathy	empathy	NOUN
cpe-2383	33	52	)	)	PUNCT
cpe-2383	33	53	.	.	PUNCT
cpe-2383	34	1	in	in	ADP
cpe-2383	34	2	other	other	ADJ
cpe-2383	34	3	words	word	NOUN
cpe-2383	34	4	,	,	PUNCT
cpe-2383	34	5	patients	patient	NOUN
cpe-2383	34	6	receiving	receive	VERB
cpe-2383	34	7	exoge‐	exoge‐	DET
cpe-2383	34	8	nous	nous	ADJ
cpe-2383	34	9	oxytocin	oxytocin	PROPN
cpe-2383	34	10	showed	show	VERB
cpe-2383	34	11	an	an	DET
cpe-2383	34	12	increased	increase	VERB
cpe-2383	34	13	ability	ability	NOUN
cpe-2383	34	14	to	to	PART
cpe-2383	34	15	attribute	attribute	VERB
cpe-2383	34	16	mental	mental	ADJ
cpe-2383	34	17	states	state	NOUN
cpe-2383	34	18	to	to	ADP
cpe-2383	34	19	others	other	NOUN
cpe-2383	34	20	,	,	PUNCT
cpe-2383	34	21	thus	thus	ADV
cpe-2383	34	22	pro‐	pro‐	PROPN
cpe-2383	34	23	viding	vide	VERB
cpe-2383	34	24	ex	ex	PRON
cpe-2383	34	25	juvantibus	juvantibus	ADJ
cpe-2383	34	26	evidence	evidence	NOUN
cpe-2383	34	27	for	for	ADP
cpe-2383	34	28	an	an	DET
cpe-2383	34	29	involvement	involvement	NOUN
cpe-2383	34	30	of	of	ADP
cpe-2383	34	31	the	the	DET
cpe-2383	34	32	oxytocin	oxytocin	NOUN
cpe-2383	34	33	system	system	NOUN
cpe-2383	34	34	in	in	ADP
cpe-2383	34	35	the	the	DET
cpe-2383	34	36	patho‐	patho‐	ADJ
cpe-2383	34	37	physiology	physiology	NOUN
cpe-2383	34	38	of	of	ADP
cpe-2383	34	39	these	these	DET
cpe-2383	34	40	disorders	disorder	NOUN
cpe-2383	34	41	.	.	PUNCT
cpe-2383	35	1	importantly	importantly	ADV
cpe-2383	35	2	,	,	PUNCT
cpe-2383	35	3	numerous	numerous	ADJ
cpe-2383	35	4	open	open	ADJ
cpe-2383	35	5	questions	question	NOUN
cpe-2383	35	6	need	need	VERB
cpe-2383	35	7	to	to	PART
cpe-2383	35	8	be	be	AUX
cpe-2383	35	9	an‐	an‐	ADV
cpe-2383	35	10	swered	swere	VERB
cpe-2383	35	11	before	before	SCONJ
cpe-2383	35	12	oxytocin	oxytocin	PROPN
cpe-2383	35	13	can	can	AUX
cpe-2383	35	14	be	be	AUX
cpe-2383	35	15	considered	consider	VERB
cpe-2383	35	16	as	as	ADP
cpe-2383	35	17	an	an	DET
cpe-2383	35	18	adjunct	adjunct	ADJ
cpe-2383	35	19	treatment	treatment	NOUN
cpe-2383	35	20	for	for	ADP
cpe-2383	35	21	autism	autism	NOUN
cpe-2383	35	22	spectrum	spectrum	NOUN
cpe-2383	35	23	disorder	disorder	NOUN
cpe-2383	35	24	or	or	CCONJ
cpe-2383	35	25	schizophrenia	schizophrenia	NOUN
cpe-2383	35	26	,	,	PUNCT
cpe-2383	35	27	including	include	VERB
cpe-2383	35	28	its	its	PRON
cpe-2383	35	29	precise	precise	ADJ
cpe-2383	35	30	mechanisms	mechanism	NOUN
cpe-2383	35	31	of	of	ADP
cpe-2383	35	32	action	action	NOUN
cpe-2383	35	33	in	in	ADP
cpe-2383	35	34	the	the	DET
cpe-2383	35	35	brain	brain	NOUN
cpe-2383	35	36	,	,	PUNCT
cpe-2383	35	37	its	its	PRON
cpe-2383	35	38	long	long	ADJ
cpe-2383	35	39	-	-	PUNCT
cpe-2383	35	40	term	term	NOUN
cpe-2383	35	41	efficacy	efficacy	NOUN
cpe-2383	35	42	,	,	PUNCT
cpe-2383	35	43	and	and	CCONJ
cpe-2383	35	44	potential	potential	ADJ
cpe-2383	35	45	adverse	adverse	ADJ
cpe-2383	35	46	effects	effect	NOUN
cpe-2383	35	47	(	(	PUNCT
cpe-2383	35	48	e.g.	e.g.	ADV
cpe-2383	35	49	,	,	PUNCT
cpe-2383	35	50	increased	increase	VERB
cpe-2383	35	51	irritability	irritability	NOUN
cpe-2383	35	52	)	)	PUNCT
cpe-2383	35	53	.	.	PUNCT
cpe-2383	36	1	interestingly	interestingly	ADV
cpe-2383	36	2	,	,	PUNCT
cpe-2383	36	3	more	more	ADV
cpe-2383	36	4	recent	recent	ADJ
cpe-2383	36	5	research	research	NOUN
cpe-2383	36	6	has	have	AUX
cpe-2383	36	7	explored	explore	VERB
cpe-2383	36	8	the	the	DET
cpe-2383	36	9	role	role	NOUN
cpe-2383	36	10	of	of	ADP
cpe-2383	36	11	endogenous	endogenous	ADJ
cpe-2383	36	12	oxytocin	oxytocin	NOUN
cpe-2383	36	13	as	as	ADP
cpe-2383	36	14	a	a	DET
cpe-2383	36	15	modulator	modulator	NOUN
cpe-2383	36	16	of	of	ADP
cpe-2383	36	17	treatment	treatment	NOUN
cpe-2383	36	18	outcomes	outcome	NOUN
cpe-2383	36	19	.	.	PUNCT
cpe-2383	37	1	a	a	DET
cpe-2383	37	2	pilot	pilot	NOUN
cpe-2383	37	3	study	study	NOUN
cpe-2383	37	4	was	be	AUX
cpe-2383	37	5	able	able	ADJ
cpe-2383	37	6	to	to	PART
cpe-2383	37	7	demonstrate	demonstrate	VERB
cpe-2383	37	8	that	that	SCONJ
cpe-2383	37	9	the	the	DET
cpe-2383	37	10	lower	low	ADJ
cpe-2383	37	11	depressed	depressed	ADJ
cpe-2383	37	12	patients	patient	NOUN
cpe-2383	37	13	’	'	PUNCT
cpe-2383	37	14	pre	pre	ADJ
cpe-2383	37	15	-	-	ADJ
cpe-2383	37	16	treatment	treatment	ADJ
cpe-2383	37	17	oxytocin	oxytocin	NOUN
cpe-2383	37	18	levels	level	NOUN
cpe-2383	37	19	,	,	PUNCT
cpe-2383	37	20	the	the	PRON
cpe-2383	37	21	lower	low	ADJ
cpe-2383	37	22	their	their	PRON
cpe-2383	37	23	degree	degree	NOUN
cpe-2383	37	24	of	of	ADP
cpe-2383	37	25	change	change	NOUN
cpe-2383	37	26	in	in	ADP
cpe-2383	37	27	a	a	DET
cpe-2383	37	28	self	self	NOUN
cpe-2383	37	29	-	-	PUNCT
cpe-2383	37	30	report	report	NOUN
cpe-2383	37	31	measure	measure	NOUN
cpe-2383	37	32	of	of	ADP
cpe-2383	37	33	depression	depression	NOUN
cpe-2383	37	34	over	over	ADP
cpe-2383	37	35	the	the	DET
cpe-2383	37	36	course	course	NOUN
cpe-2383	37	37	of	of	ADP
cpe-2383	37	38	psychological	psychological	ADJ
cpe-2383	37	39	therapy	therapy	NOUN
cpe-2383	37	40	(	(	PUNCT
cpe-2383	37	41	jobst	jobst	PROPN
cpe-2383	37	42	et	et	PROPN
cpe-2383	37	43	al	al	PROPN
cpe-2383	37	44	.	.	PROPN
cpe-2383	37	45	,	,	PUNCT
cpe-2383	37	46	2018	2018	NUM
cpe-2383	37	47	)	)	PUNCT
cpe-2383	37	48	.	.	PUNCT
cpe-2383	38	1	this	this	DET
cpe-2383	38	2	finding	finding	NOUN
cpe-2383	38	3	aligns	align	VERB
cpe-2383	38	4	well	well	ADV
cpe-2383	38	5	with	with	ADP
cpe-2383	38	6	another	another	DET
cpe-2383	38	7	study	study	NOUN
cpe-2383	38	8	in	in	ADP
cpe-2383	38	9	patients	patient	NOUN
cpe-2383	38	10	with	with	ADP
cpe-2383	38	11	depressive	depressive	ADJ
cpe-2383	38	12	disorders	disorder	NOUN
cpe-2383	38	13	,	,	PUNCT
cpe-2383	38	14	which	which	PRON
cpe-2383	38	15	showed	show	VERB
cpe-2383	38	16	that	that	SCONJ
cpe-2383	38	17	oxytocin	oxytocin	NOUN
cpe-2383	38	18	levels	level	NOUN
cpe-2383	38	19	fluctuated	fluctuate	VERB
cpe-2383	38	20	during	during	ADP
cpe-2383	38	21	therapy	therapy	NOUN
cpe-2383	38	22	sessions	session	NOUN
cpe-2383	38	23	,	,	PUNCT
cpe-2383	38	24	and	and	CCONJ
cpe-2383	38	25	in	in	ADP
cpe-2383	38	26	parallel	parallel	NOUN
cpe-2383	38	27	with	with	ADP
cpe-2383	38	28	subtle	subtle	ADJ
cpe-2383	38	29	changes	change	NOUN
cpe-2383	38	30	in	in	ADP
cpe-2383	38	31	the	the	DET
cpe-2383	38	32	therapeutic	therapeutic	ADJ
cpe-2383	38	33	alliance	alliance	NOUN
cpe-2383	38	34	(	(	PUNCT
cpe-2383	38	35	i.e.	i.e.	X
cpe-2383	38	36	,	,	PUNCT
cpe-2383	38	37	ruptures	rupture	NOUN
cpe-2383	38	38	;	;	PUNCT
cpe-2383	38	39	zilcha	zilcha	PROPN
cpe-2383	38	40	-	-	PUNCT
cpe-2383	38	41	mano	mano	PROPN
cpe-2383	38	42	,	,	PUNCT
cpe-2383	38	43	porat	porat	NOUN
cpe-2383	38	44	,	,	PUNCT
cpe-2383	38	45	dolev	dolev	ADV
cpe-2383	38	46	,	,	PUNCT
cpe-2383	38	47	&	&	CCONJ
cpe-2383	38	48	shamay	shamay	NOUN
cpe-2383	38	49	-	-	PUNCT
cpe-2383	38	50	tsoory	tsoory	ADJ
cpe-2383	38	51	,	,	PUNCT
cpe-2383	38	52	2018	2018	NUM
cpe-2383	38	53	)	)	PUNCT
cpe-2383	38	54	.	.	PUNCT
cpe-2383	39	1	together	together	ADV
cpe-2383	39	2	,	,	PUNCT
cpe-2383	39	3	these	these	DET
cpe-2383	39	4	studies	study	NOUN
cpe-2383	39	5	suggest	suggest	VERB
cpe-2383	39	6	that	that	SCONJ
cpe-2383	39	7	oxytocin	oxytocin	NOUN
cpe-2383	39	8	levels	level	NOUN
cpe-2383	39	9	may	may	AUX
cpe-2383	39	10	also	also	ADV
cpe-2383	39	11	be	be	AUX
cpe-2383	39	12	a	a	DET
cpe-2383	39	13	useful	useful	ADJ
cpe-2383	39	14	prognostic	prognostic	ADJ
cpe-2383	39	15	tool	tool	NOUN
cpe-2383	39	16	as	as	ADV
cpe-2383	39	17	well	well	ADV
cpe-2383	39	18	as	as	ADP
cpe-2383	39	19	a	a	DET
cpe-2383	39	20	means	means	NOUN
cpe-2383	39	21	to	to	PART
cpe-2383	39	22	monitor	monitor	VERB
cpe-2383	39	23	treatment	treatment	NOUN
cpe-2383	39	24	progress	progress	NOUN
cpe-2383	39	25	.	.	PUNCT
cpe-2383	40	1	fischer	fischer	PROPN
cpe-2383	40	2	&	&	CCONJ
cpe-2383	40	3	ehlert	ehlert	PROPN
cpe-2383	40	4	3	3	NUM
cpe-2383	40	5	clinical	clinical	ADJ
cpe-2383	40	6	psychology	psychology	NOUN
cpe-2383	40	7	in	in	ADP
cpe-2383	40	8	europe	europe	PROPN
cpe-2383	40	9	2019	2019	NUM
cpe-2383	40	10	,	,	PUNCT
cpe-2383	40	11	vol.1(2	vol.1(2	PROPN
cpe-2383	40	12	)	)	PUNCT
cpe-2383	40	13	,	,	PUNCT
cpe-2383	40	14	article	article	NOUN
cpe-2383	40	15	33030	33030	NUM
cpe-2383	40	16	https://doi.org/10.32872/cpe.v1i2.33030	https://doi.org/10.32872/cpe.v1i2.33030	PROPN
cpe-2383	40	17	https://www.psychopen.eu/	https://www.psychopen.eu/	VERB
cpe-2383	40	18	how	how	SCONJ
cpe-2383	40	19	hormones	hormone	NOUN
cpe-2383	40	20	affect	affect	VERB
cpe-2383	40	21	cognition	cognition	NOUN
cpe-2383	40	22	,	,	PUNCT
cpe-2383	40	23	mood	mood	NOUN
cpe-2383	40	24	,	,	PUNCT
cpe-2383	40	25	and	and	CCONJ
cpe-2383	40	26	sexual	sexual	ADJ
cpe-2383	40	27	function	function	NOUN
cpe-2383	40	28	up	up	ADP
cpe-2383	40	29	to	to	ADP
cpe-2383	40	30	now	now	ADV
cpe-2383	40	31	,	,	PUNCT
cpe-2383	40	32	the	the	DET
cpe-2383	40	33	largest	large	ADJ
cpe-2383	40	34	share	share	NOUN
cpe-2383	40	35	of	of	ADP
cpe-2383	40	36	clinical	clinical	ADJ
cpe-2383	40	37	neuroendocrine	neuroendocrine	NOUN
cpe-2383	40	38	research	research	NOUN
cpe-2383	40	39	has	have	AUX
cpe-2383	40	40	been	be	AUX
cpe-2383	40	41	dedicated	dedicate	VERB
cpe-2383	40	42	to	to	ADP
cpe-2383	40	43	the	the	DET
cpe-2383	40	44	stress	stress	NOUN
cpe-2383	40	45	hormones	hormone	NOUN
cpe-2383	40	46	noradrenaline	noradrenaline	NOUN
cpe-2383	40	47	and	and	CCONJ
cpe-2383	40	48	cortisol	cortisol	NOUN
cpe-2383	40	49	.	.	PUNCT
cpe-2383	41	1	the	the	DET
cpe-2383	41	2	catecholamine	catecholamine	NOUN
cpe-2383	41	3	noradrenaline	noradrenaline	NOUN
cpe-2383	41	4	(	(	PUNCT
cpe-2383	41	5	na	na	NOUN
cpe-2383	41	6	)	)	PUNCT
cpe-2383	41	7	is	be	AUX
cpe-2383	41	8	available	available	ADJ
cpe-2383	41	9	in	in	ADP
cpe-2383	41	10	the	the	DET
cpe-2383	41	11	brain	brain	NOUN
cpe-2383	41	12	and	and	CCONJ
cpe-2383	41	13	in	in	ADP
cpe-2383	41	14	several	several	ADJ
cpe-2383	41	15	other	other	ADJ
cpe-2383	41	16	body	body	NOUN
cpe-2383	41	17	tissues	tissue	NOUN
cpe-2383	41	18	(	(	PUNCT
cpe-2383	41	19	fischer	fischer	PROPN
cpe-2383	41	20	&	&	CCONJ
cpe-2383	41	21	nater	nater	PROPN
cpe-2383	41	22	,	,	PUNCT
cpe-2383	41	23	2015	2015	NUM
cpe-2383	41	24	)	)	PUNCT
cpe-2383	41	25	.	.	PUNCT
cpe-2383	42	1	its	its	PRON
cpe-2383	42	2	central	central	ADJ
cpe-2383	42	3	origin	origin	NOUN
cpe-2383	42	4	is	be	AUX
cpe-2383	42	5	the	the	DET
cpe-2383	42	6	locus	locus	ADJ
cpe-2383	42	7	coeruleus	coeruleus	NOUN
cpe-2383	42	8	,	,	PUNCT
cpe-2383	42	9	with	with	ADP
cpe-2383	42	10	αand	αand	ADV
cpe-2383	42	11	β	β	ADJ
cpe-2383	42	12	-	-	ADJ
cpe-2383	42	13	adrenergic	adrenergic	ADJ
cpe-2383	42	14	receptors	receptor	NOUN
cpe-2383	42	15	expressed	express	VERB
cpe-2383	42	16	in	in	ADP
cpe-2383	42	17	numerous	numerous	ADJ
cpe-2383	42	18	other	other	ADJ
cpe-2383	42	19	brain	brain	NOUN
cpe-2383	42	20	areas	area	NOUN
cpe-2383	42	21	,	,	PUNCT
cpe-2383	42	22	such	such	ADJ
cpe-2383	42	23	as	as	ADP
cpe-2383	42	24	the	the	DET
cpe-2383	42	25	cortex	cortex	NOUN
cpe-2383	42	26	,	,	PUNCT
cpe-2383	42	27	thalamus	thalamus	NOUN
cpe-2383	42	28	,	,	PUNCT
cpe-2383	42	29	hippocampus	hippocampus	NOUN
cpe-2383	42	30	,	,	PUNCT
cpe-2383	42	31	amygdala	amygdala	NOUN
cpe-2383	42	32	,	,	PUNCT
cpe-2383	42	33	and	and	CCONJ
cpe-2383	42	34	hypothala‐	hypothala‐	PROPN
cpe-2383	42	35	mus	mus	PROPN
cpe-2383	42	36	.	.	PROPN
cpe-2383	43	1	in	in	ADP
cpe-2383	43	2	the	the	DET
cpe-2383	43	3	periphery	periphery	NOUN
cpe-2383	43	4	,	,	PUNCT
cpe-2383	43	5	na	na	NOUN
cpe-2383	43	6	,	,	PUNCT
cpe-2383	43	7	together	together	ADV
cpe-2383	43	8	with	with	ADP
cpe-2383	43	9	adrenaline	adrenaline	NOUN
cpe-2383	43	10	,	,	PUNCT
cpe-2383	43	11	is	be	AUX
cpe-2383	43	12	the	the	DET
cpe-2383	43	13	main	main	ADJ
cpe-2383	43	14	end	end	NOUN
cpe-2383	43	15	product	product	NOUN
cpe-2383	43	16	of	of	ADP
cpe-2383	43	17	the	the	DET
cpe-2383	43	18	sym‐	sym‐	PROPN
cpe-2383	43	19	pathetic	pathetic	ADJ
cpe-2383	43	20	nervous	nervous	ADJ
cpe-2383	43	21	system	system	NOUN
cpe-2383	43	22	,	,	PUNCT
cpe-2383	43	23	and	and	CCONJ
cpe-2383	43	24	its	its	PRON
cpe-2383	43	25	receptors	receptor	NOUN
cpe-2383	43	26	are	be	AUX
cpe-2383	43	27	present	present	ADJ
cpe-2383	43	28	in	in	ADP
cpe-2383	43	29	all	all	DET
cpe-2383	43	30	major	major	ADJ
cpe-2383	43	31	organs	organ	NOUN
cpe-2383	43	32	and	and	CCONJ
cpe-2383	43	33	cells	cell	NOUN
cpe-2383	43	34	of	of	ADP
cpe-2383	43	35	the	the	DET
cpe-2383	43	36	immune	immune	ADJ
cpe-2383	43	37	system	system	NOUN
cpe-2383	43	38	.	.	PUNCT
cpe-2383	44	1	noradrenaline	noradrenaline	PROPN
cpe-2383	44	2	has	have	VERB
cpe-2383	44	3	effects	effect	NOUN
cpe-2383	44	4	on	on	ADP
cpe-2383	44	5	multiple	multiple	ADJ
cpe-2383	44	6	domains	domain	NOUN
cpe-2383	44	7	of	of	ADP
cpe-2383	44	8	psychological	psychological	ADJ
cpe-2383	44	9	functioning	functioning	NOUN
cpe-2383	44	10	,	,	PUNCT
cpe-2383	44	11	includ‐	includ‐	VERB
cpe-2383	44	12	ing	ing	ADJ
cpe-2383	44	13	cognition	cognition	NOUN
cpe-2383	44	14	,	,	PUNCT
cpe-2383	44	15	affect	affect	VERB
cpe-2383	44	16	,	,	PUNCT
cpe-2383	44	17	arousal	arousal	NOUN
cpe-2383	44	18	,	,	PUNCT
cpe-2383	44	19	and	and	CCONJ
cpe-2383	44	20	pain	pain	NOUN
cpe-2383	44	21	perception	perception	NOUN
cpe-2383	44	22	.	.	PUNCT
cpe-2383	45	1	it	it	PRON
cpe-2383	45	2	is	be	AUX
cpe-2383	45	3	thus	thus	ADV
cpe-2383	45	4	unsurprising	unsurprising	ADJ
cpe-2383	45	5	that	that	SCONJ
cpe-2383	45	6	1	1	NUM
cpe-2383	45	7	)	)	PUNCT
cpe-2383	45	8	cogni‐	cogni‐	ADP
cpe-2383	45	9	tive	tive	NOUN
cpe-2383	45	10	symptoms	symptom	NOUN
cpe-2383	45	11	(	(	PUNCT
cpe-2383	45	12	e.g.	e.g.	ADV
cpe-2383	45	13	,	,	PUNCT
cpe-2383	45	14	deficits	deficit	NOUN
cpe-2383	45	15	in	in	ADP
cpe-2383	45	16	working	working	NOUN
cpe-2383	45	17	memory	memory	NOUN
cpe-2383	45	18	)	)	PUNCT
cpe-2383	45	19	,	,	PUNCT
cpe-2383	45	20	as	as	SCONJ
cpe-2383	45	21	experienced	experience	VERB
cpe-2383	45	22	,	,	PUNCT
cpe-2383	45	23	for	for	ADP
cpe-2383	45	24	instance	instance	NOUN
cpe-2383	45	25	,	,	PUNCT
cpe-2383	45	26	by	by	ADP
cpe-2383	45	27	pa‐	pa‐	VERB
cpe-2383	45	28	tients	tient	NOUN
cpe-2383	45	29	with	with	ADP
cpe-2383	45	30	depressive	depressive	ADJ
cpe-2383	45	31	disorders	disorder	NOUN
cpe-2383	45	32	(	(	PUNCT
cpe-2383	45	33	maletic	maletic	ADJ
cpe-2383	45	34	,	,	PUNCT
cpe-2383	45	35	eramo	eramo	PROPN
cpe-2383	45	36	,	,	PUNCT
cpe-2383	45	37	gwin	gwin	PROPN
cpe-2383	45	38	,	,	PUNCT
cpe-2383	45	39	offord	offord	PROPN
cpe-2383	45	40	,	,	PUNCT
cpe-2383	45	41	&	&	CCONJ
cpe-2383	45	42	duffy	duffy	PROPN
cpe-2383	45	43	,	,	PUNCT
cpe-2383	45	44	2017	2017	NUM
cpe-2383	45	45	)	)	PUNCT
cpe-2383	45	46	,	,	PUNCT
cpe-2383	45	47	2	2	X
cpe-2383	45	48	)	)	PUNCT
cpe-2383	45	49	anxiety	anxiety	NOUN
cpe-2383	45	50	and	and	CCONJ
cpe-2383	45	51	hyperarousal	hyperarousal	ADJ
cpe-2383	45	52	,	,	PUNCT
cpe-2383	45	53	representing	represent	VERB
cpe-2383	45	54	key	key	ADJ
cpe-2383	45	55	clinical	clinical	ADJ
cpe-2383	45	56	features	feature	NOUN
cpe-2383	45	57	of	of	ADP
cpe-2383	45	58	panic	panic	NOUN
cpe-2383	45	59	disorder	disorder	NOUN
cpe-2383	45	60	and	and	CCONJ
cpe-2383	45	61	post	post	ADJ
cpe-2383	45	62	-	-	ADJ
cpe-2383	45	63	traumatic	traumatic	ADJ
cpe-2383	45	64	stress	stress	NOUN
cpe-2383	45	65	disorder	disorder	NOUN
cpe-2383	45	66	(	(	PUNCT
cpe-2383	45	67	bandelow	bandelow	NOUN
cpe-2383	45	68	et	et	PROPN
cpe-2383	45	69	al	al	PROPN
cpe-2383	45	70	.	.	PROPN
cpe-2383	45	71	,	,	PUNCT
cpe-2383	45	72	2017	2017	NUM
cpe-2383	45	73	)	)	PUNCT
cpe-2383	45	74	,	,	PUNCT
cpe-2383	45	75	and	and	CCONJ
cpe-2383	45	76	3	3	X
cpe-2383	45	77	)	)	PUNCT
cpe-2383	45	78	bodily	bodily	ADJ
cpe-2383	45	79	symptoms	symptom	NOUN
cpe-2383	45	80	such	such	ADJ
cpe-2383	45	81	as	as	ADP
cpe-2383	45	82	fatigue	fatigue	NOUN
cpe-2383	45	83	and	and	CCONJ
cpe-2383	45	84	pain	pain	NOUN
cpe-2383	45	85	,	,	PUNCT
cpe-2383	45	86	which	which	PRON
cpe-2383	45	87	feature	feature	VERB
cpe-2383	45	88	prominently	prominently	ADV
cpe-2383	45	89	in	in	ADP
cpe-2383	45	90	somatic	somatic	ADJ
cpe-2383	45	91	symptom	symptom	NOUN
cpe-2383	45	92	disorders	disorder	NOUN
cpe-2383	45	93	(	(	PUNCT
cpe-2383	45	94	nater	nater	NOUN
cpe-2383	45	95	,	,	PUNCT
cpe-2383	45	96	fischer	fischer	PROPN
cpe-2383	45	97	,	,	PUNCT
cpe-2383	45	98	&	&	CCONJ
cpe-2383	45	99	ehlert	ehlert	PROPN
cpe-2383	45	100	,	,	PUNCT
cpe-2383	45	101	2011	2011	NUM
cpe-2383	45	102	)	)	PUNCT
cpe-2383	45	103	,	,	PUNCT
cpe-2383	45	104	are	be	AUX
cpe-2383	45	105	all	all	PRON
cpe-2383	45	106	paralleled	parallel	VERB
cpe-2383	45	107	by	by	ADP
cpe-2383	45	108	altered	alter	VERB
cpe-2383	45	109	na	na	ADP
cpe-2383	45	110	functioning	function	VERB
cpe-2383	45	111	.	.	PUNCT
cpe-2383	46	1	notably	notably	ADV
cpe-2383	46	2	,	,	PUNCT
cpe-2383	46	3	findings	finding	NOUN
cpe-2383	46	4	are	be	AUX
cpe-2383	46	5	highly	highly	ADV
cpe-2383	46	6	complex	complex	ADJ
cpe-2383	46	7	;	;	PUNCT
cpe-2383	46	8	de‐	de‐	X
cpe-2383	46	9	pending	pende	VERB
cpe-2383	46	10	on	on	ADP
cpe-2383	46	11	the	the	DET
cpe-2383	46	12	tissue	tissue	NOUN
cpe-2383	46	13	(	(	PUNCT
cpe-2383	46	14	i.e.	i.e.	X
cpe-2383	46	15	,	,	PUNCT
cpe-2383	46	16	different	different	ADJ
cpe-2383	46	17	areas	area	NOUN
cpe-2383	46	18	within	within	ADP
cpe-2383	46	19	the	the	DET
cpe-2383	46	20	brain	brain	NOUN
cpe-2383	46	21	,	,	PUNCT
cpe-2383	46	22	blood	blood	NOUN
cpe-2383	46	23	)	)	PUNCT
cpe-2383	46	24	,	,	PUNCT
cpe-2383	46	25	both	both	PRON
cpe-2383	46	26	elevated	elevated	ADJ
cpe-2383	46	27	and	and	CCONJ
cpe-2383	46	28	attenuated	attenuated	ADJ
cpe-2383	46	29	concentrations	concentration	NOUN
cpe-2383	46	30	of	of	ADP
cpe-2383	46	31	na	na	NOUN
cpe-2383	46	32	are	be	AUX
cpe-2383	46	33	observed	observe	VERB
cpe-2383	46	34	,	,	PUNCT
cpe-2383	46	35	sometimes	sometimes	ADV
cpe-2383	46	36	within	within	ADP
cpe-2383	46	37	the	the	DET
cpe-2383	46	38	same	same	ADJ
cpe-2383	46	39	patient	patient	NOUN
cpe-2383	46	40	co‐	co‐	NOUN
cpe-2383	46	41	hort	hort	NOUN
cpe-2383	46	42	.	.	PUNCT
cpe-2383	47	1	drugs	drug	NOUN
cpe-2383	47	2	targeting	target	VERB
cpe-2383	47	3	the	the	DET
cpe-2383	47	4	na	na	NOUN
cpe-2383	47	5	system	system	NOUN
cpe-2383	47	6	(	(	PUNCT
cpe-2383	47	7	e.g.	e.g.	ADV
cpe-2383	47	8	,	,	PUNCT
cpe-2383	47	9	venlafaxine	venlafaxine	NOUN
cpe-2383	47	10	)	)	PUNCT
cpe-2383	47	11	constitute	constitute	VERB
cpe-2383	47	12	effective	effective	ADJ
cpe-2383	47	13	antidepressants	antidepressant	NOUN
cpe-2383	47	14	and	and	CCONJ
cpe-2383	47	15	anxiolytics	anxiolytic	NOUN
cpe-2383	47	16	(	(	PUNCT
cpe-2383	47	17	e.g.	e.g.	ADV
cpe-2383	47	18	,	,	PUNCT
cpe-2383	47	19	bandelow	bandelow	NOUN
cpe-2383	47	20	et	et	PROPN
cpe-2383	47	21	al	al	PROPN
cpe-2383	47	22	.	.	PROPN
cpe-2383	47	23	,	,	PUNCT
cpe-2383	47	24	2014	2014	NUM
cpe-2383	47	25	;	;	PUNCT
cpe-2383	47	26	dgppn	dgppn	NOUN
cpe-2383	47	27	et	et	PROPN
cpe-2383	47	28	al	al	PROPN
cpe-2383	47	29	.	.	PROPN
cpe-2383	47	30	,	,	PUNCT
cpe-2383	47	31	2015	2015	NUM
cpe-2383	47	32	)	)	PUNCT
cpe-2383	47	33	,	,	PUNCT
cpe-2383	47	34	thus	thus	ADV
cpe-2383	47	35	adding	add	VERB
cpe-2383	47	36	further	far	ADV
cpe-2383	47	37	evi‐	evi‐	VERB
cpe-2383	47	38	dence	dence	NOUN
cpe-2383	47	39	to	to	ADP
cpe-2383	47	40	the	the	DET
cpe-2383	47	41	assumption	assumption	NOUN
cpe-2383	47	42	that	that	SCONJ
cpe-2383	47	43	the	the	DET
cpe-2383	47	44	na	na	PROPN
cpe-2383	47	45	system	system	NOUN
cpe-2383	47	46	is	be	AUX
cpe-2383	47	47	instrumental	instrumental	ADJ
cpe-2383	47	48	in	in	ADP
cpe-2383	47	49	the	the	DET
cpe-2383	47	50	pathophysiology	pathophysiology	NOUN
cpe-2383	47	51	of	of	ADP
cpe-2383	47	52	depressive	depressive	ADJ
cpe-2383	47	53	and	and	CCONJ
cpe-2383	47	54	anxiety	anxiety	NOUN
cpe-2383	47	55	disorders	disorder	NOUN
cpe-2383	47	56	.	.	PUNCT
cpe-2383	48	1	clinicians	clinician	NOUN
cpe-2383	48	2	administering	administer	VERB
cpe-2383	48	3	such	such	ADJ
cpe-2383	48	4	drugs	drug	NOUN
cpe-2383	48	5	are	be	AUX
cpe-2383	48	6	advised	advise	VERB
cpe-2383	48	7	to	to	PART
cpe-2383	48	8	ex‐	ex‐	VERB
cpe-2383	48	9	plain	plain	VERB
cpe-2383	48	10	the	the	DET
cpe-2383	48	11	role	role	NOUN
cpe-2383	48	12	of	of	ADP
cpe-2383	48	13	na	na	INTJ
cpe-2383	48	14	to	to	ADP
cpe-2383	48	15	patients	patient	NOUN
cpe-2383	48	16	before	before	ADP
cpe-2383	48	17	initiating	initiate	VERB
cpe-2383	48	18	treatment	treatment	NOUN
cpe-2383	48	19	.	.	PUNCT
cpe-2383	49	1	by	by	ADP
cpe-2383	49	2	contrast	contrast	NOUN
cpe-2383	49	3	,	,	PUNCT
cpe-2383	49	4	in	in	ADP
cpe-2383	49	5	somatic	somatic	ADJ
cpe-2383	49	6	symp‐	symp‐	NOUN
cpe-2383	49	7	tom	tom	NOUN
cpe-2383	49	8	disorders	disorder	NOUN
cpe-2383	49	9	and	and	CCONJ
cpe-2383	49	10	in	in	ADP
cpe-2383	49	11	physical	physical	ADJ
cpe-2383	49	12	diseases	disease	NOUN
cpe-2383	49	13	,	,	PUNCT
cpe-2383	49	14	it	it	PRON
cpe-2383	49	15	is	be	AUX
cpe-2383	49	16	mainly	mainly	ADV
cpe-2383	49	17	the	the	DET
cpe-2383	49	18	peripheral	peripheral	ADJ
cpe-2383	49	19	actions	action	NOUN
cpe-2383	49	20	of	of	ADP
cpe-2383	49	21	na	na	X
cpe-2383	49	22	(	(	PUNCT
cpe-2383	49	23	e.g.	e.g.	ADV
cpe-2383	49	24	,	,	PUNCT
cpe-2383	49	25	its	its	PRON
cpe-2383	49	26	effects	effect	NOUN
cpe-2383	49	27	on	on	ADP
cpe-2383	49	28	the	the	DET
cpe-2383	49	29	musculoskeletal	musculoskeletal	ADJ
cpe-2383	49	30	or	or	CCONJ
cpe-2383	49	31	cardiovascular	cardiovascular	ADJ
cpe-2383	49	32	system	system	NOUN
cpe-2383	49	33	)	)	PUNCT
cpe-2383	49	34	which	which	PRON
cpe-2383	49	35	are	be	AUX
cpe-2383	49	36	critical	critical	ADJ
cpe-2383	49	37	.	.	PUNCT
cpe-2383	50	1	interestingly	interestingly	ADV
cpe-2383	50	2	,	,	PUNCT
cpe-2383	50	3	in	in	ADP
cpe-2383	50	4	patients	patient	NOUN
cpe-2383	50	5	undergoing	undergo	VERB
cpe-2383	50	6	coronary	coronary	ADJ
cpe-2383	50	7	artery	artery	NOUN
cpe-2383	50	8	bypass	bypass	NOUN
cpe-2383	50	9	graft	graft	NOUN
cpe-2383	50	10	surgery	surgery	NOUN
cpe-2383	50	11	,	,	PUNCT
cpe-2383	50	12	it	it	PRON
cpe-2383	50	13	was	be	AUX
cpe-2383	50	14	recently	recently	ADV
cpe-2383	50	15	shown	show	VERB
cpe-2383	50	16	that	that	SCONJ
cpe-2383	50	17	preoperative	preoperative	ADJ
cpe-2383	50	18	psychological	psychological	ADJ
cpe-2383	50	19	interventions	intervention	NOUN
cpe-2383	50	20	led	lead	VERB
cpe-2383	50	21	to	to	ADP
cpe-2383	50	22	significantly	significantly	ADV
cpe-2383	50	23	lower	lower	ADV
cpe-2383	50	24	(	(	PUNCT
cpe-2383	50	25	i.e.	i.e.	X
cpe-2383	50	26	,	,	PUNCT
cpe-2383	50	27	more	more	ADV
cpe-2383	50	28	adaptive	adaptive	ADJ
cpe-2383	50	29	)	)	PUNCT
cpe-2383	50	30	levels	level	NOUN
cpe-2383	50	31	of	of	ADP
cpe-2383	50	32	adrenaline	adrenaline	NOUN
cpe-2383	50	33	after	after	ADP
cpe-2383	50	34	surgery	surgery	NOUN
cpe-2383	50	35	when	when	SCONJ
cpe-2383	50	36	compared	compare	VERB
cpe-2383	50	37	to	to	ADP
cpe-2383	50	38	standard	standard	ADJ
cpe-2383	50	39	medical	medical	ADJ
cpe-2383	50	40	care	care	NOUN
cpe-2383	50	41	(	(	PUNCT
cpe-2383	50	42	salzmann	salzmann	PROPN
cpe-2383	50	43	et	et	PROPN
cpe-2383	50	44	al	al	PROPN
cpe-2383	50	45	.	.	PROPN
cpe-2383	50	46	,	,	PUNCT
cpe-2383	50	47	2017	2017	NUM
cpe-2383	50	48	)	)	PUNCT
cpe-2383	50	49	.	.	PUNCT
cpe-2383	51	1	this	this	DET
cpe-2383	51	2	finding	finding	NOUN
cpe-2383	51	3	highlights	highlight	VERB
cpe-2383	51	4	the	the	DET
cpe-2383	51	5	value	value	NOUN
cpe-2383	51	6	of	of	ADP
cpe-2383	51	7	catecholamines	catecholamine	NOUN
cpe-2383	51	8	as	as	ADP
cpe-2383	51	9	markers	marker	NOUN
cpe-2383	51	10	of	of	ADP
cpe-2383	51	11	therapeutic	therapeutic	ADJ
cpe-2383	51	12	efficacy	efficacy	NOUN
cpe-2383	51	13	.	.	PUNCT
cpe-2383	52	1	notably	notably	ADV
cpe-2383	52	2	,	,	PUNCT
cpe-2383	52	3	na	na	ADP
cpe-2383	52	4	activity	activity	NOUN
cpe-2383	52	5	can	can	AUX
cpe-2383	52	6	also	also	ADV
cpe-2383	52	7	be	be	AUX
cpe-2383	52	8	determined	determine	VERB
cpe-2383	52	9	non	non	ADJ
cpe-2383	52	10	-	-	ADJ
cpe-2383	52	11	invasively	invasively	ADV
cpe-2383	52	12	,	,	PUNCT
cpe-2383	52	13	namely	namely	ADV
cpe-2383	52	14	via	via	ADP
cpe-2383	52	15	salivary	salivary	ADJ
cpe-2383	52	16	alpha	alpha	NOUN
cpe-2383	52	17	-	-	PUNCT
cpe-2383	52	18	amylase	amylase	NOUN
cpe-2383	52	19	,	,	PUNCT
cpe-2383	52	20	an	an	DET
cpe-2383	52	21	enzyme	enzyme	NOUN
cpe-2383	52	22	involved	involve	VERB
cpe-2383	52	23	in	in	ADP
cpe-2383	52	24	the	the	DET
cpe-2383	52	25	digestion	digestion	NOUN
cpe-2383	52	26	of	of	ADP
cpe-2383	52	27	starch	starch	NOUN
cpe-2383	52	28	,	,	PUNCT
cpe-2383	52	29	thus	thus	ADV
cpe-2383	52	30	facilitating	facilitate	VERB
cpe-2383	52	31	its	its	PRON
cpe-2383	52	32	use	use	NOUN
cpe-2383	52	33	in	in	ADP
cpe-2383	52	34	clinical	clinical	ADJ
cpe-2383	52	35	practice	practice	NOUN
cpe-2383	52	36	(	(	PUNCT
cpe-2383	52	37	nater	nater	NOUN
cpe-2383	52	38	&	&	CCONJ
cpe-2383	52	39	rohleder	rohleder	NOUN
cpe-2383	52	40	,	,	PUNCT
cpe-2383	52	41	2009	2009	NUM
cpe-2383	52	42	)	)	PUNCT
cpe-2383	52	43	.	.	PUNCT
cpe-2383	53	1	the	the	DET
cpe-2383	53	2	glucocorticoid	glucocorticoid	ADJ
cpe-2383	53	3	cortisol	cortisol	NOUN
cpe-2383	53	4	,	,	PUNCT
cpe-2383	53	5	the	the	DET
cpe-2383	53	6	other	other	ADJ
cpe-2383	53	7	major	major	ADJ
cpe-2383	53	8	stress	stress	NOUN
cpe-2383	53	9	hormone	hormone	NOUN
cpe-2383	53	10	,	,	PUNCT
cpe-2383	53	11	is	be	AUX
cpe-2383	53	12	the	the	DET
cpe-2383	53	13	end	end	NOUN
cpe-2383	53	14	point	point	NOUN
cpe-2383	53	15	of	of	ADP
cpe-2383	53	16	the	the	DET
cpe-2383	53	17	hypothalamic	hypothalamic	ADJ
cpe-2383	53	18	-	-	PUNCT
cpe-2383	53	19	pituitary	pituitary	ADJ
cpe-2383	53	20	-	-	PUNCT
cpe-2383	53	21	adrenal	adrenal	ADJ
cpe-2383	53	22	(	(	PUNCT
cpe-2383	53	23	hpa	hpa	NOUN
cpe-2383	53	24	)	)	PUNCT
cpe-2383	53	25	axis	axis	NOUN
cpe-2383	53	26	(	(	PUNCT
cpe-2383	53	27	ehlert	ehlert	NOUN
cpe-2383	53	28	,	,	PUNCT
cpe-2383	53	29	2011	2011	NUM
cpe-2383	53	30	)	)	PUNCT
cpe-2383	53	31	.	.	PUNCT
cpe-2383	54	1	although	although	SCONJ
cpe-2383	54	2	cortisol	cortisol	NOUN
cpe-2383	54	3	is	be	AUX
cpe-2383	54	4	synthe‐	synthe‐	VERB
cpe-2383	54	5	sised	sise	VERB
cpe-2383	54	6	in	in	ADP
cpe-2383	54	7	the	the	DET
cpe-2383	54	8	adrenal	adrenal	ADJ
cpe-2383	54	9	cortex	cortex	NOUN
cpe-2383	54	10	,	,	PUNCT
cpe-2383	54	11	both	both	CCONJ
cpe-2383	54	12	central	central	ADJ
cpe-2383	54	13	(	(	PUNCT
cpe-2383	54	14	e.g.	e.g.	ADV
cpe-2383	54	15	,	,	PUNCT
cpe-2383	54	16	the	the	DET
cpe-2383	54	17	hippocampus	hippocampus	NOUN
cpe-2383	54	18	)	)	PUNCT
cpe-2383	54	19	and	and	CCONJ
cpe-2383	54	20	peripheral	peripheral	ADJ
cpe-2383	54	21	tissues	tissue	NOUN
cpe-2383	54	22	(	(	PUNCT
cpe-2383	54	23	e.g.	e.g.	ADV
cpe-2383	54	24	,	,	PUNCT
cpe-2383	54	25	lymphocytes	lymphocyte	VERB
cpe-2383	54	26	)	)	PUNCT
cpe-2383	54	27	are	be	AUX
cpe-2383	54	28	densely	densely	ADV
cpe-2383	54	29	populated	populate	VERB
cpe-2383	54	30	by	by	ADP
cpe-2383	54	31	mineralocorticoid	mineralocorticoid	NOUN
cpe-2383	54	32	and	and	CCONJ
cpe-2383	54	33	glucocorticoid	glucocorticoid	NOUN
cpe-2383	54	34	recep‐	recep‐	ADP
cpe-2383	54	35	psychoneuroendocrinology	psychoneuroendocrinology	NOUN
cpe-2383	54	36	and	and	CCONJ
cpe-2383	54	37	clinical	clinical	ADJ
cpe-2383	54	38	psychology	psychology	NOUN
cpe-2383	54	39	4	4	NUM
cpe-2383	54	40	clinical	clinical	ADJ
cpe-2383	54	41	psychology	psychology	NOUN
cpe-2383	54	42	in	in	ADP
cpe-2383	54	43	europe	europe	PROPN
cpe-2383	54	44	2019	2019	NUM
cpe-2383	54	45	,	,	PUNCT
cpe-2383	54	46	vol.1(2	vol.1(2	PROPN
cpe-2383	54	47	)	)	PUNCT
cpe-2383	54	48	,	,	PUNCT
cpe-2383	54	49	article	article	NOUN
cpe-2383	54	50	33030	33030	NUM
cpe-2383	54	51	https://doi.org/10.32872/cpe.v1i2.33030	https://doi.org/10.32872/cpe.v1i2.33030	PROPN
cpe-2383	54	52	https://www.psychopen.eu/	https://www.psychopen.eu/	VERB
cpe-2383	54	53	tors	tor	NOUN
cpe-2383	54	54	.	.	PUNCT
cpe-2383	55	1	apart	apart	ADV
cpe-2383	55	2	from	from	ADP
cpe-2383	55	3	the	the	DET
cpe-2383	55	4	gluconeogenetic	gluconeogenetic	ADJ
cpe-2383	55	5	and	and	CCONJ
cpe-2383	55	6	anti	anti	ADJ
cpe-2383	55	7	-	-	ADJ
cpe-2383	55	8	inflammatory	inflammatory	ADJ
cpe-2383	55	9	effects	effect	NOUN
cpe-2383	55	10	of	of	ADP
cpe-2383	55	11	cortisol	cortisol	NOUN
cpe-2383	55	12	,	,	PUNCT
cpe-2383	55	13	one	one	NUM
cpe-2383	55	14	of	of	ADP
cpe-2383	55	15	its	its	PRON
cpe-2383	55	16	main	main	ADJ
cpe-2383	55	17	effects	effect	NOUN
cpe-2383	55	18	lies	lie	VERB
cpe-2383	55	19	in	in	ADP
cpe-2383	55	20	influencing	influence	VERB
cpe-2383	55	21	cognition	cognition	NOUN
cpe-2383	55	22	.	.	PUNCT
cpe-2383	56	1	akin	akin	ADJ
cpe-2383	56	2	to	to	ADP
cpe-2383	56	3	the	the	DET
cpe-2383	56	4	findings	finding	NOUN
cpe-2383	56	5	on	on	ADP
cpe-2383	56	6	na	na	ADP
cpe-2383	56	7	,	,	PUNCT
cpe-2383	56	8	cortisol	cortisol	ADJ
cpe-2383	56	9	concentrations	concentration	NOUN
cpe-2383	56	10	have	have	AUX
cpe-2383	56	11	been	be	AUX
cpe-2383	56	12	found	find	VERB
cpe-2383	56	13	to	to	PART
cpe-2383	56	14	be	be	AUX
cpe-2383	56	15	abnormal	abnormal	ADJ
cpe-2383	56	16	in	in	ADP
cpe-2383	56	17	a	a	DET
cpe-2383	56	18	number	number	NOUN
cpe-2383	56	19	of	of	ADP
cpe-2383	56	20	patients	patient	NOUN
cpe-2383	56	21	presenting	present	VERB
cpe-2383	56	22	with	with	ADP
cpe-2383	56	23	cognitive	cognitive	ADJ
cpe-2383	56	24	problems	problem	NOUN
cpe-2383	56	25	(	(	PUNCT
cpe-2383	56	26	e.g.	e.g.	ADV
cpe-2383	56	27	,	,	PUNCT
cpe-2383	56	28	difficulty	difficulty	NOUN
cpe-2383	56	29	concentrat‐	concentrat‐	PROPN
cpe-2383	56	30	ing	ing	PROPN
cpe-2383	56	31	)	)	PUNCT
cpe-2383	56	32	,	,	PUNCT
cpe-2383	56	33	as	as	SCONJ
cpe-2383	56	34	is	be	AUX
cpe-2383	56	35	the	the	DET
cpe-2383	56	36	case	case	NOUN
cpe-2383	56	37	in	in	ADP
cpe-2383	56	38	affective	affective	ADJ
cpe-2383	56	39	disorders	disorder	NOUN
cpe-2383	56	40	(	(	PUNCT
cpe-2383	56	41	belvederi	belvederi	PROPN
cpe-2383	56	42	murri	murri	PROPN
cpe-2383	56	43	et	et	PROPN
cpe-2383	56	44	al	al	PROPN
cpe-2383	56	45	.	.	PROPN
cpe-2383	56	46	,	,	PUNCT
cpe-2383	56	47	2016	2016	NUM
cpe-2383	56	48	;	;	PUNCT
cpe-2383	56	49	stetler	stetler	PROPN
cpe-2383	56	50	&	&	CCONJ
cpe-2383	56	51	miller	miller	PROPN
cpe-2383	56	52	,	,	PUNCT
cpe-2383	56	53	2011	2011	NUM
cpe-2383	56	54	)	)	PUNCT
cpe-2383	56	55	.	.	PUNCT
cpe-2383	57	1	moreover	moreover	ADV
cpe-2383	57	2	,	,	PUNCT
cpe-2383	57	3	abnormal	abnormal	ADJ
cpe-2383	57	4	cortisol	cortisol	ADJ
cpe-2383	57	5	concentrations	concentration	NOUN
cpe-2383	57	6	have	have	AUX
cpe-2383	57	7	been	be	AUX
cpe-2383	57	8	demonstrated	demonstrate	VERB
cpe-2383	57	9	in	in	ADP
cpe-2383	57	10	patients	patient	NOUN
cpe-2383	57	11	with	with	ADP
cpe-2383	57	12	post	post	ADJ
cpe-2383	57	13	-	-	ADJ
cpe-2383	57	14	traumatic	traumatic	ADJ
cpe-2383	57	15	stress	stress	NOUN
cpe-2383	57	16	disorder	disorder	NOUN
cpe-2383	57	17	,	,	PUNCT
cpe-2383	57	18	where	where	SCONJ
cpe-2383	57	19	they	they	PRON
cpe-2383	57	20	may	may	AUX
cpe-2383	57	21	contribute	contribute	VERB
cpe-2383	57	22	to	to	AUX
cpe-2383	57	23	re	re	VERB
cpe-2383	57	24	-	-	VERB
cpe-2383	57	25	experiencing	experience	VERB
cpe-2383	57	26	of	of	ADP
cpe-2383	57	27	trauma	trauma	NOUN
cpe-2383	57	28	via	via	ADP
cpe-2383	57	29	constant	constant	ADJ
cpe-2383	57	30	retrieval	retrieval	NOUN
cpe-2383	57	31	of	of	ADP
cpe-2383	57	32	the	the	DET
cpe-2383	57	33	fear	fear	NOUN
cpe-2383	57	34	memory	memory	NOUN
cpe-2383	57	35	(	(	PUNCT
cpe-2383	57	36	morris	morris	PROPN
cpe-2383	57	37	,	,	PUNCT
cpe-2383	57	38	compas	compas	NOUN
cpe-2383	57	39	,	,	PUNCT
cpe-2383	57	40	&	&	CCONJ
cpe-2383	57	41	garber	garber	PROPN
cpe-2383	57	42	,	,	PUNCT
cpe-2383	57	43	2012	2012	NUM
cpe-2383	57	44	)	)	PUNCT
cpe-2383	57	45	,	,	PUNCT
cpe-2383	57	46	and	and	CCONJ
cpe-2383	57	47	in	in	ADP
cpe-2383	57	48	somatic	somatic	ADJ
cpe-2383	57	49	symptom	symptom	NOUN
cpe-2383	57	50	disorders	disorder	NOUN
cpe-2383	57	51	,	,	PUNCT
cpe-2383	57	52	where	where	SCONJ
cpe-2383	57	53	they	they	PRON
cpe-2383	57	54	may	may	AUX
cpe-2383	57	55	contribute	contribute	VERB
cpe-2383	57	56	to	to	ADP
cpe-2383	57	57	bodily	bodily	ADJ
cpe-2383	57	58	complaints	complaint	NOUN
cpe-2383	57	59	(	(	PUNCT
cpe-2383	57	60	tak	tak	NOUN
cpe-2383	57	61	et	et	NOUN
cpe-2383	57	62	al	al	PROPN
cpe-2383	57	63	.	.	PROPN
cpe-2383	57	64	,	,	PUNCT
cpe-2383	57	65	2011	2011	NUM
cpe-2383	57	66	)	)	PUNCT
cpe-2383	57	67	.	.	PUNCT
cpe-2383	58	1	interestingly	interestingly	ADV
cpe-2383	58	2	,	,	PUNCT
cpe-2383	58	3	while	while	SCONJ
cpe-2383	58	4	patients	patient	NOUN
cpe-2383	58	5	with	with	ADP
cpe-2383	58	6	affective	affective	ADJ
cpe-2383	58	7	disorders	disorder	NOUN
cpe-2383	58	8	are	be	AUX
cpe-2383	58	9	characterised	characterise	VERB
cpe-2383	58	10	by	by	ADP
cpe-2383	58	11	com‐	com‐	PROPN
cpe-2383	58	12	parably	parably	ADV
cpe-2383	58	13	elevated	elevated	ADJ
cpe-2383	58	14	levels	level	NOUN
cpe-2383	58	15	of	of	ADP
cpe-2383	58	16	cortisol	cortisol	NOUN
cpe-2383	58	17	(	(	PUNCT
cpe-2383	58	18	i.e.	i.e.	X
cpe-2383	58	19	,	,	PUNCT
cpe-2383	58	20	hypercortisolism	hypercortisolism	PROPN
cpe-2383	58	21	)	)	PUNCT
cpe-2383	58	22	,	,	PUNCT
cpe-2383	58	23	patients	patient	NOUN
cpe-2383	58	24	with	with	ADP
cpe-2383	58	25	posttraumatic	posttraumatic	ADJ
cpe-2383	58	26	stress	stress	NOUN
cpe-2383	58	27	disorder	disorder	NOUN
cpe-2383	58	28	or	or	CCONJ
cpe-2383	58	29	somatic	somatic	ADJ
cpe-2383	58	30	symptom	symptom	NOUN
cpe-2383	58	31	disorders	disorder	NOUN
cpe-2383	58	32	mostly	mostly	ADV
cpe-2383	58	33	exhibit	exhibit	VERB
cpe-2383	58	34	diminished	diminished	ADJ
cpe-2383	58	35	levels	level	NOUN
cpe-2383	58	36	(	(	PUNCT
cpe-2383	58	37	i.e.	i.e.	X
cpe-2383	58	38	,	,	PUNCT
cpe-2383	58	39	hy‐	hy‐	PROPN
cpe-2383	58	40	pocortisolism	pocortisolism	NOUN
cpe-2383	58	41	;	;	PUNCT
cpe-2383	58	42	ehlert	ehlert	PROPN
cpe-2383	58	43	,	,	PUNCT
cpe-2383	58	44	gaab	gaab	ADJ
cpe-2383	58	45	,	,	PUNCT
cpe-2383	58	46	&	&	CCONJ
cpe-2383	58	47	heinrichs	heinrichs	PROPN
cpe-2383	58	48	,	,	PUNCT
cpe-2383	58	49	2001	2001	NUM
cpe-2383	58	50	;	;	PUNCT
cpe-2383	58	51	heim	heim	PROPN
cpe-2383	58	52	,	,	PUNCT
cpe-2383	58	53	ehlert	ehlert	PROPN
cpe-2383	58	54	,	,	PUNCT
cpe-2383	58	55	&	&	CCONJ
cpe-2383	58	56	hellhammer	hellhammer	PROPN
cpe-2383	58	57	,	,	PUNCT
cpe-2383	58	58	2000	2000	NUM
cpe-2383	58	59	)	)	PUNCT
cpe-2383	58	60	.	.	PUNCT
cpe-2383	59	1	these	these	DET
cpe-2383	59	2	differences	difference	NOUN
cpe-2383	59	3	may	may	AUX
cpe-2383	59	4	be	be	AUX
cpe-2383	59	5	attributable	attributable	ADJ
cpe-2383	59	6	to	to	ADP
cpe-2383	59	7	different	different	ADJ
cpe-2383	59	8	genetic	genetic	ADJ
cpe-2383	59	9	predispositions	predisposition	NOUN
cpe-2383	59	10	and/or	and/or	CCONJ
cpe-2383	59	11	different	different	ADJ
cpe-2383	59	12	amounts	amount	NOUN
cpe-2383	59	13	of	of	ADP
cpe-2383	59	14	stress	stress	NOUN
cpe-2383	59	15	experienced	experience	VERB
cpe-2383	59	16	during	during	ADP
cpe-2383	59	17	the	the	DET
cpe-2383	59	18	lifespan	lifespan	NOUN
cpe-2383	59	19	(	(	PUNCT
cpe-2383	59	20	ehlert	ehlert	ADJ
cpe-2383	59	21	,	,	PUNCT
cpe-2383	59	22	2013	2013	NUM
cpe-2383	59	23	)	)	PUNCT
cpe-2383	59	24	.	.	PUNCT
cpe-2383	60	1	together	together	ADV
cpe-2383	60	2	,	,	PUNCT
cpe-2383	60	3	these	these	DET
cpe-2383	60	4	findings	finding	NOUN
cpe-2383	60	5	underline	underline	VERB
cpe-2383	60	6	the	the	DET
cpe-2383	60	7	potential	potential	NOUN
cpe-2383	60	8	of	of	ADP
cpe-2383	60	9	cortisol	cortisol	NOUN
cpe-2383	60	10	for	for	ADP
cpe-2383	60	11	improving	improve	VERB
cpe-2383	60	12	differential	differential	ADJ
cpe-2383	60	13	diagnostics	diagnostic	NOUN
cpe-2383	60	14	.	.	PUNCT
cpe-2383	61	1	these	these	DET
cpe-2383	61	2	findings	finding	NOUN
cpe-2383	61	3	have	have	AUX
cpe-2383	61	4	been	be	AUX
cpe-2383	61	5	extended	extend	VERB
cpe-2383	61	6	by	by	ADP
cpe-2383	61	7	clinical	clinical	ADJ
cpe-2383	61	8	studies	study	NOUN
cpe-2383	61	9	,	,	PUNCT
cpe-2383	61	10	where	where	SCONJ
cpe-2383	61	11	a	a	DET
cpe-2383	61	12	similar	similar	ADJ
cpe-2383	61	13	dichotomy	dichotomy	NOUN
cpe-2383	61	14	ap‐	ap‐	NOUN
cpe-2383	61	15	pears	pear	NOUN
cpe-2383	61	16	to	to	PART
cpe-2383	61	17	prevail	prevail	VERB
cpe-2383	61	18	.	.	PUNCT
cpe-2383	62	1	in	in	ADP
cpe-2383	62	2	depression	depression	NOUN
cpe-2383	62	3	,	,	PUNCT
cpe-2383	62	4	the	the	DET
cpe-2383	62	5	current	current	ADJ
cpe-2383	62	6	state	state	NOUN
cpe-2383	62	7	of	of	ADP
cpe-2383	62	8	research	research	NOUN
cpe-2383	62	9	suggests	suggest	VERB
cpe-2383	62	10	that	that	SCONJ
cpe-2383	62	11	the	the	PRON
cpe-2383	62	12	higher	high	ADJ
cpe-2383	62	13	a	a	DET
cpe-2383	62	14	pa‐	pa‐	PROPN
cpe-2383	62	15	tient	tient	NOUN
cpe-2383	62	16	’s	’s	PART
cpe-2383	62	17	pre	pre	ADJ
cpe-2383	62	18	-	-	ADJ
cpe-2383	62	19	treatment	treatment	ADJ
cpe-2383	62	20	cortisol	cortisol	NOUN
cpe-2383	62	21	levels	level	NOUN
cpe-2383	62	22	,	,	PUNCT
cpe-2383	62	23	the	the	PRON
cpe-2383	62	24	lower	low	ADJ
cpe-2383	62	25	their	their	PRON
cpe-2383	62	26	chances	chance	NOUN
cpe-2383	62	27	of	of	ADP
cpe-2383	62	28	responding	respond	VERB
cpe-2383	62	29	to	to	ADP
cpe-2383	62	30	psychologi‐	psychologi‐	PRON
cpe-2383	62	31	cal	cal	NOUN
cpe-2383	62	32	therapy	therapy	NOUN
cpe-2383	62	33	(	(	PUNCT
cpe-2383	62	34	fischer	fischer	PROPN
cpe-2383	62	35	,	,	PUNCT
cpe-2383	62	36	strawbridge	strawbridge	VERB
cpe-2383	62	37	,	,	PUNCT
cpe-2383	62	38	herane	herane	NOUN
cpe-2383	62	39	vives	vive	NOUN
cpe-2383	62	40	,	,	PUNCT
cpe-2383	62	41	&	&	CCONJ
cpe-2383	62	42	cleare	cleare	PROPN
cpe-2383	62	43	,	,	PUNCT
cpe-2383	62	44	2017	2017	NUM
cpe-2383	62	45	)	)	PUNCT
cpe-2383	62	46	.	.	PUNCT
cpe-2383	63	1	in	in	ADP
cpe-2383	63	2	addition	addition	NOUN
cpe-2383	63	3	,	,	PUNCT
cpe-2383	63	4	initial	initial	ADJ
cpe-2383	63	5	at‐	at‐	NOUN
cpe-2383	63	6	tempts	tempt	VERB
cpe-2383	63	7	to	to	PART
cpe-2383	63	8	improve	improve	VERB
cpe-2383	63	9	memory	memory	NOUN
cpe-2383	63	10	performance	performance	NOUN
cpe-2383	63	11	in	in	ADP
cpe-2383	63	12	these	these	DET
cpe-2383	63	13	patients	patient	NOUN
cpe-2383	63	14	have	have	AUX
cpe-2383	63	15	been	be	AUX
cpe-2383	63	16	undertaken	undertake	VERB
cpe-2383	63	17	using	use	VERB
cpe-2383	63	18	agents	agent	NOUN
cpe-2383	63	19	which	which	PRON
cpe-2383	63	20	act	act	VERB
cpe-2383	63	21	on	on	ADP
cpe-2383	63	22	glucocorticoid	glucocorticoid	ADJ
cpe-2383	63	23	receptors	receptor	NOUN
cpe-2383	63	24	(	(	PUNCT
cpe-2383	63	25	e.g.	e.g.	ADV
cpe-2383	63	26	,	,	PUNCT
cpe-2383	63	27	mifepristone	mifepristone	NOUN
cpe-2383	63	28	)	)	PUNCT
cpe-2383	63	29	or	or	CCONJ
cpe-2383	63	30	influence	influence	VERB
cpe-2383	63	31	cortisol	cortisol	ADJ
cpe-2383	63	32	synthesis	synthesis	NOUN
cpe-2383	63	33	(	(	PUNCT
cpe-2383	63	34	e.g.	e.g.	ADV
cpe-2383	63	35	,	,	PUNCT
cpe-2383	63	36	ketoconazole	ketoconazole	NOUN
cpe-2383	63	37	;	;	PUNCT
cpe-2383	63	38	soria	soria	PROPN
cpe-2383	63	39	et	et	PROPN
cpe-2383	63	40	al	al	PROPN
cpe-2383	63	41	.	.	PROPN
cpe-2383	63	42	,	,	PUNCT
cpe-2383	63	43	2018	2018	NUM
cpe-2383	63	44	)	)	PUNCT
cpe-2383	63	45	.	.	PUNCT
cpe-2383	64	1	in	in	ADP
cpe-2383	64	2	anxiety	anxiety	NOUN
cpe-2383	64	3	disorders	disorder	NOUN
cpe-2383	64	4	,	,	PUNCT
cpe-2383	64	5	the	the	DET
cpe-2383	64	6	pattern	pattern	NOUN
cpe-2383	64	7	seems	seem	VERB
cpe-2383	64	8	to	to	PART
cpe-2383	64	9	be	be	AUX
cpe-2383	64	10	reversed	reverse	VERB
cpe-2383	64	11	,	,	PUNCT
cpe-2383	64	12	insofar	insofar	ADV
cpe-2383	64	13	as	as	SCONJ
cpe-2383	64	14	lower	low	ADJ
cpe-2383	64	15	cortisol	cortisol	ADJ
cpe-2383	64	16	levels	level	NOUN
cpe-2383	64	17	predict	predict	VERB
cpe-2383	64	18	worse	bad	ADJ
cpe-2383	64	19	treatment	treatment	NOUN
cpe-2383	64	20	outcomes	outcome	NOUN
cpe-2383	64	21	(	(	PUNCT
cpe-2383	64	22	fischer	fischer	PROPN
cpe-2383	64	23	&	&	CCONJ
cpe-2383	64	24	cleare	cleare	PROPN
cpe-2383	64	25	,	,	PUNCT
cpe-2383	64	26	2017	2017	NUM
cpe-2383	64	27	)	)	PUNCT
cpe-2383	64	28	,	,	PUNCT
cpe-2383	64	29	although	although	SCONJ
cpe-2383	64	30	importantly	importantly	ADV
cpe-2383	64	31	,	,	PUNCT
cpe-2383	64	32	this	this	PRON
cpe-2383	64	33	only	only	ADV
cpe-2383	64	34	appears	appear	VERB
cpe-2383	64	35	to	to	PART
cpe-2383	64	36	be	be	AUX
cpe-2383	64	37	true	true	ADJ
cpe-2383	64	38	for	for	ADP
cpe-2383	64	39	stimulated	stimulated	ADJ
cpe-2383	64	40	cortisol	cortisol	NOUN
cpe-2383	64	41	as	as	SCONJ
cpe-2383	64	42	measured	measure	VERB
cpe-2383	64	43	during	during	ADP
cpe-2383	64	44	exposure	exposure	NOUN
cpe-2383	64	45	sessions	session	NOUN
cpe-2383	64	46	.	.	PUNCT
cpe-2383	65	1	this	this	PRON
cpe-2383	65	2	has	have	AUX
cpe-2383	65	3	been	be	AUX
cpe-2383	65	4	interpreted	interpret	VERB
cpe-2383	65	5	as	as	ADP
cpe-2383	65	6	an	an	DET
cpe-2383	65	7	implication	implication	NOUN
cpe-2383	65	8	that	that	SCONJ
cpe-2383	65	9	a	a	DET
cpe-2383	65	10	certain	certain	ADJ
cpe-2383	65	11	amount	amount	NOUN
cpe-2383	65	12	of	of	ADP
cpe-2383	65	13	cortisol	cortisol	NOUN
cpe-2383	65	14	is	be	AUX
cpe-2383	65	15	a	a	DET
cpe-2383	65	16	prerequisite	prerequisite	NOUN
cpe-2383	65	17	for	for	SCONJ
cpe-2383	65	18	patients	patient	NOUN
cpe-2383	65	19	to	to	PART
cpe-2383	65	20	form	form	VERB
cpe-2383	65	21	an	an	DET
cpe-2383	65	22	extinction	extinction	NOUN
cpe-2383	65	23	memory	memory	NOUN
cpe-2383	65	24	,	,	PUNCT
cpe-2383	65	25	which	which	PRON
cpe-2383	65	26	is	be	AUX
cpe-2383	65	27	one	one	NUM
cpe-2383	65	28	of	of	ADP
cpe-2383	65	29	the	the	DET
cpe-2383	65	30	key	key	ADJ
cpe-2383	65	31	mechanisms	mechanism	NOUN
cpe-2383	65	32	underlying	underlie	VERB
cpe-2383	65	33	successful	successful	ADJ
cpe-2383	65	34	treatment	treatment	NOUN
cpe-2383	65	35	for	for	ADP
cpe-2383	65	36	fear	fear	NOUN
cpe-2383	65	37	-	-	PUNCT
cpe-2383	65	38	related	relate	VERB
cpe-2383	65	39	ill‐	ill‐	PUNCT
cpe-2383	65	40	nesses	ness	NOUN
cpe-2383	65	41	.	.	PUNCT
cpe-2383	66	1	more	more	ADV
cpe-2383	66	2	recent	recent	ADJ
cpe-2383	66	3	research	research	NOUN
cpe-2383	66	4	suggests	suggest	VERB
cpe-2383	66	5	that	that	SCONJ
cpe-2383	66	6	this	this	DET
cpe-2383	66	7	knowledge	knowledge	NOUN
cpe-2383	66	8	may	may	AUX
cpe-2383	66	9	be	be	AUX
cpe-2383	66	10	utilised	utilise	VERB
cpe-2383	66	11	to	to	PART
cpe-2383	66	12	optimise	optimise	VERB
cpe-2383	66	13	ex‐	ex‐	NOUN
cpe-2383	66	14	posure	posure	NOUN
cpe-2383	66	15	-	-	PUNCT
cpe-2383	66	16	based	base	VERB
cpe-2383	66	17	psychological	psychological	ADJ
cpe-2383	66	18	therapy	therapy	NOUN
cpe-2383	66	19	for	for	ADP
cpe-2383	66	20	anxiety	anxiety	NOUN
cpe-2383	66	21	disorders	disorder	NOUN
cpe-2383	66	22	.	.	PUNCT
cpe-2383	67	1	for	for	ADP
cpe-2383	67	2	instance	instance	NOUN
cpe-2383	67	3	,	,	PUNCT
cpe-2383	67	4	meuret	meuret	PROPN
cpe-2383	67	5	et	et	PROPN
cpe-2383	67	6	al	al	PROPN
cpe-2383	67	7	.	.	PUNCT
cpe-2383	68	1	(	(	PUNCT
cpe-2383	68	2	2016	2016	NUM
cpe-2383	68	3	)	)	PUNCT
cpe-2383	68	4	were	be	AUX
cpe-2383	68	5	able	able	ADJ
cpe-2383	68	6	to	to	PART
cpe-2383	68	7	demonstrate	demonstrate	VERB
cpe-2383	68	8	that	that	SCONJ
cpe-2383	68	9	early	early	ADJ
cpe-2383	68	10	-	-	PUNCT
cpe-2383	68	11	day	day	NOUN
cpe-2383	68	12	exposure	exposure	NOUN
cpe-2383	68	13	sessions	session	NOUN
cpe-2383	68	14	(	(	PUNCT
cpe-2383	68	15	i.e.	i.e.	X
cpe-2383	68	16	,	,	PUNCT
cpe-2383	68	17	when	when	SCONJ
cpe-2383	68	18	endogenous	endogenous	ADJ
cpe-2383	68	19	cortisol	cortisol	ADJ
cpe-2383	68	20	levels	level	NOUN
cpe-2383	68	21	are	be	AUX
cpe-2383	68	22	highest	high	ADJ
cpe-2383	68	23	)	)	PUNCT
cpe-2383	68	24	led	lead	VERB
cpe-2383	68	25	to	to	ADP
cpe-2383	68	26	greater	great	ADJ
cpe-2383	68	27	clinical	clinical	ADJ
cpe-2383	68	28	improvement	improvement	NOUN
cpe-2383	68	29	in	in	ADP
cpe-2383	68	30	patients	patient	NOUN
cpe-2383	68	31	with	with	ADP
cpe-2383	68	32	panic	panic	NOUN
cpe-2383	68	33	dis‐	dis‐	ADP
cpe-2383	68	34	order	order	NOUN
cpe-2383	68	35	and	and	CCONJ
cpe-2383	68	36	agoraphobia	agoraphobia	PROPN
cpe-2383	68	37	when	when	SCONJ
cpe-2383	68	38	compared	compare	VERB
cpe-2383	68	39	to	to	ADP
cpe-2383	68	40	sessions	session	NOUN
cpe-2383	68	41	held	hold	VERB
cpe-2383	68	42	later	later	ADV
cpe-2383	68	43	on	on	ADV
cpe-2383	68	44	during	during	ADP
cpe-2383	68	45	the	the	DET
cpe-2383	68	46	day	day	NOUN
cpe-2383	68	47	.	.	PUNCT
cpe-2383	69	1	sex	sex	NOUN
cpe-2383	69	2	hormones	hormone	NOUN
cpe-2383	69	3	,	,	PUNCT
cpe-2383	69	4	such	such	ADJ
cpe-2383	69	5	as	as	ADP
cpe-2383	69	6	testosterone	testosterone	NOUN
cpe-2383	69	7	,	,	PUNCT
cpe-2383	69	8	oestradiol	oestradiol	NOUN
cpe-2383	69	9	,	,	PUNCT
cpe-2383	69	10	and	and	CCONJ
cpe-2383	69	11	progesterone	progesterone	NOUN
cpe-2383	69	12	,	,	PUNCT
cpe-2383	69	13	are	be	AUX
cpe-2383	69	14	end	end	NOUN
cpe-2383	69	15	products	product	NOUN
cpe-2383	69	16	of	of	ADP
cpe-2383	69	17	the	the	DET
cpe-2383	69	18	hypothalamic	hypothalamic	ADJ
cpe-2383	69	19	-	-	PUNCT
cpe-2383	69	20	pituitary	pituitary	ADJ
cpe-2383	69	21	-	-	PUNCT
cpe-2383	69	22	gonadal	gonadal	NOUN
cpe-2383	69	23	(	(	PUNCT
cpe-2383	69	24	hpg	hpg	NOUN
cpe-2383	69	25	)	)	PUNCT
cpe-2383	69	26	axis	axis	NOUN
cpe-2383	69	27	(	(	PUNCT
cpe-2383	69	28	melcangi	melcangi	PROPN
cpe-2383	69	29	,	,	PUNCT
cpe-2383	69	30	giatti	giatti	PROPN
cpe-2383	69	31	,	,	PUNCT
cpe-2383	69	32	&	&	CCONJ
cpe-2383	69	33	garcia	garcia	PROPN
cpe-2383	69	34	-	-	PUNCT
cpe-2383	69	35	segura	segura	NOUN
cpe-2383	69	36	,	,	PUNCT
cpe-2383	69	37	2016	2016	NUM
cpe-2383	69	38	)	)	PUNCT
cpe-2383	69	39	.	.	PUNCT
cpe-2383	70	1	they	they	PRON
cpe-2383	70	2	are	be	AUX
cpe-2383	70	3	mainly	mainly	ADV
cpe-2383	70	4	produced	produce	VERB
cpe-2383	70	5	in	in	ADP
cpe-2383	70	6	the	the	DET
cpe-2383	70	7	testes	testis	NOUN
cpe-2383	70	8	in	in	ADP
cpe-2383	70	9	men	man	NOUN
cpe-2383	70	10	and	and	CCONJ
cpe-2383	70	11	in	in	ADP
cpe-2383	70	12	the	the	DET
cpe-2383	70	13	ovaries	ovary	NOUN
cpe-2383	70	14	in	in	ADP
cpe-2383	70	15	women	woman	NOUN
cpe-2383	70	16	,	,	PUNCT
cpe-2383	70	17	and	and	CCONJ
cpe-2383	70	18	their	their	PRON
cpe-2383	70	19	key	key	ADJ
cpe-2383	70	20	function	function	NOUN
cpe-2383	70	21	is	be	AUX
cpe-2383	70	22	to	to	PART
cpe-2383	70	23	orchestrate	orchestrate	VERB
cpe-2383	70	24	reproduction	reproduction	NOUN
cpe-2383	70	25	and	and	CCONJ
cpe-2383	70	26	sexual	sexual	ADJ
cpe-2383	70	27	functioning	functioning	NOUN
cpe-2383	70	28	.	.	PUNCT
cpe-2383	71	1	however	however	ADV
cpe-2383	71	2	,	,	PUNCT
cpe-2383	71	3	sex	sex	NOUN
cpe-2383	71	4	steroids	steroid	NOUN
cpe-2383	71	5	also	also	ADV
cpe-2383	71	6	act	act	VERB
cpe-2383	71	7	as	as	ADP
cpe-2383	71	8	neurosteroids	neurosteroid	NOUN
cpe-2383	71	9	(	(	PUNCT
cpe-2383	71	10	e.g.	e.g.	ADV
cpe-2383	71	11	,	,	PUNCT
cpe-2383	71	12	fostering	foster	VERB
cpe-2383	71	13	neurogenesis	neurogenesis	NOUN
cpe-2383	71	14	and	and	CCONJ
cpe-2383	71	15	differentiation	differentiation	NOUN
cpe-2383	71	16	)	)	PUNCT
cpe-2383	71	17	in	in	ADP
cpe-2383	71	18	various	various	ADJ
cpe-2383	71	19	parts	part	NOUN
cpe-2383	71	20	of	of	ADP
cpe-2383	71	21	the	the	DET
cpe-2383	71	22	brain	brain	NOUN
cpe-2383	71	23	,	,	PUNCT
cpe-2383	71	24	such	such	ADJ
cpe-2383	71	25	as	as	ADP
cpe-2383	71	26	the	the	DET
cpe-2383	71	27	hippocampus	hippocampus	NOUN
cpe-2383	71	28	and	and	CCONJ
cpe-2383	71	29	prefrontal	prefrontal	ADJ
cpe-2383	71	30	cortex	cortex	NOUN
cpe-2383	71	31	.	.	PUNCT
cpe-2383	72	1	fischer	fischer	PROPN
cpe-2383	72	2	&	&	CCONJ
cpe-2383	72	3	ehlert	ehlert	PROPN
cpe-2383	72	4	5	5	NUM
cpe-2383	72	5	clinical	clinical	ADJ
cpe-2383	72	6	psychology	psychology	NOUN
cpe-2383	72	7	in	in	ADP
cpe-2383	72	8	europe	europe	PROPN
cpe-2383	72	9	2019	2019	NUM
cpe-2383	72	10	,	,	PUNCT
cpe-2383	72	11	vol.1(2	vol.1(2	PROPN
cpe-2383	72	12	)	)	PUNCT
cpe-2383	72	13	,	,	PUNCT
cpe-2383	72	14	article	article	NOUN
cpe-2383	72	15	33030	33030	NUM
cpe-2383	72	16	https://doi.org/10.32872/cpe.v1i2.33030	https://doi.org/10.32872/cpe.v1i2.33030	PROPN
cpe-2383	72	17	https://www.psychopen.eu/	https://www.psychopen.eu/	VERB
cpe-2383	72	18	in	in	ADP
cpe-2383	72	19	terms	term	NOUN
cpe-2383	72	20	of	of	ADP
cpe-2383	72	21	mental	mental	ADJ
cpe-2383	72	22	disorders	disorder	NOUN
cpe-2383	72	23	,	,	PUNCT
cpe-2383	72	24	the	the	DET
cpe-2383	72	25	bulk	bulk	NOUN
cpe-2383	72	26	of	of	ADP
cpe-2383	72	27	research	research	NOUN
cpe-2383	72	28	to	to	ADP
cpe-2383	72	29	date	date	NOUN
cpe-2383	72	30	has	have	AUX
cpe-2383	72	31	studied	study	VERB
cpe-2383	72	32	the	the	DET
cpe-2383	72	33	role	role	NOUN
cpe-2383	72	34	of	of	ADP
cpe-2383	72	35	sex	sex	NOUN
cpe-2383	72	36	steroids	steroid	NOUN
cpe-2383	72	37	in	in	ADP
cpe-2383	72	38	sexual	sexual	ADJ
cpe-2383	72	39	dysfunctions	dysfunction	NOUN
cpe-2383	72	40	.	.	PUNCT
cpe-2383	73	1	testosterone	testosterone	NOUN
cpe-2383	73	2	,	,	PUNCT
cpe-2383	73	3	for	for	ADP
cpe-2383	73	4	instance	instance	NOUN
cpe-2383	73	5	,	,	PUNCT
cpe-2383	73	6	is	be	AUX
cpe-2383	73	7	lowered	lower	VERB
cpe-2383	73	8	in	in	ADP
cpe-2383	73	9	men	man	NOUN
cpe-2383	73	10	with	with	ADP
cpe-2383	73	11	erec‐	erec‐	NOUN
cpe-2383	73	12	tile	tile	NOUN
cpe-2383	73	13	disorder	disorder	NOUN
cpe-2383	73	14	(	(	PUNCT
cpe-2383	73	15	isidori	isidori	NOUN
cpe-2383	73	16	et	et	PROPN
cpe-2383	73	17	al	al	PROPN
cpe-2383	73	18	.	.	PROPN
cpe-2383	73	19	,	,	PUNCT
cpe-2383	73	20	2014	2014	NUM
cpe-2383	73	21	)	)	PUNCT
cpe-2383	73	22	,	,	PUNCT
cpe-2383	73	23	and	and	CCONJ
cpe-2383	73	24	hormonal	hormonal	ADJ
cpe-2383	73	25	(	(	PUNCT
cpe-2383	73	26	replacement	replacement	NOUN
cpe-2383	73	27	)	)	PUNCT
cpe-2383	73	28	therapy	therapy	NOUN
cpe-2383	73	29	has	have	AUX
cpe-2383	73	30	been	be	AUX
cpe-2383	73	31	proven	prove	VERB
cpe-2383	73	32	to	to	PART
cpe-2383	73	33	be	be	AUX
cpe-2383	73	34	useful	useful	ADJ
cpe-2383	73	35	in	in	ADP
cpe-2383	73	36	enhancing	enhance	VERB
cpe-2383	73	37	erectile	erectile	NOUN
cpe-2383	73	38	function	function	NOUN
cpe-2383	73	39	in	in	ADP
cpe-2383	73	40	hypogonadal	hypogonadal	ADJ
cpe-2383	73	41	men	man	NOUN
cpe-2383	73	42	(	(	PUNCT
cpe-2383	73	43	corona	corona	PROPN
cpe-2383	73	44	et	et	NOUN
cpe-2383	73	45	al	al	PROPN
cpe-2383	73	46	.	.	PROPN
cpe-2383	73	47	,	,	PUNCT
cpe-2383	73	48	2017	2017	NUM
cpe-2383	73	49	;	;	PUNCT
cpe-2383	73	50	elliott	elliott	PROPN
cpe-2383	73	51	et	et	PROPN
cpe-2383	73	52	al	al	PROPN
cpe-2383	73	53	.	.	PROPN
cpe-2383	73	54	,	,	PUNCT
cpe-2383	73	55	2017	2017	NUM
cpe-2383	73	56	)	)	PUNCT
cpe-2383	73	57	and	and	CCONJ
cpe-2383	73	58	sexual	sexual	ADJ
cpe-2383	73	59	function	function	NOUN
cpe-2383	73	60	in	in	ADP
cpe-2383	73	61	post	post	ADJ
cpe-2383	73	62	-	-	ADJ
cpe-2383	73	63	menopausal	menopausal	ADJ
cpe-2383	73	64	women	woman	NOUN
cpe-2383	73	65	(	(	PUNCT
cpe-2383	73	66	elraiyah	elraiyah	NOUN
cpe-2383	73	67	et	et	PROPN
cpe-2383	73	68	al	al	PROPN
cpe-2383	73	69	.	.	PROPN
cpe-2383	73	70	,	,	PUNCT
cpe-2383	73	71	2014	2014	NUM
cpe-2383	73	72	)	)	PUNCT
cpe-2383	73	73	.	.	PUNCT
cpe-2383	74	1	how‐	how‐	PROPN
cpe-2383	74	2	ever	ever	ADV
cpe-2383	74	3	,	,	PUNCT
cpe-2383	74	4	long	long	ADJ
cpe-2383	74	5	-	-	PUNCT
cpe-2383	74	6	term	term	NOUN
cpe-2383	74	7	follow	follow	NOUN
cpe-2383	74	8	-	-	PUNCT
cpe-2383	74	9	up	up	ADP
cpe-2383	74	10	studies	study	NOUN
cpe-2383	74	11	are	be	AUX
cpe-2383	74	12	scarce	scarce	ADJ
cpe-2383	74	13	and	and	CCONJ
cpe-2383	74	14	potential	potential	ADJ
cpe-2383	74	15	adverse	adverse	ADJ
cpe-2383	74	16	effects	effect	NOUN
cpe-2383	74	17	of	of	ADP
cpe-2383	74	18	exogenous	exogenous	ADJ
cpe-2383	74	19	testosterone	testosterone	NOUN
cpe-2383	74	20	(	(	PUNCT
cpe-2383	74	21	e.g.	e.g.	ADV
cpe-2383	74	22	,	,	PUNCT
cpe-2383	74	23	acne	acne	NOUN
cpe-2383	74	24	)	)	PUNCT
cpe-2383	74	25	need	need	VERB
cpe-2383	74	26	to	to	PART
cpe-2383	74	27	be	be	AUX
cpe-2383	74	28	carefully	carefully	ADV
cpe-2383	74	29	weighed	weigh	VERB
cpe-2383	74	30	against	against	ADP
cpe-2383	74	31	the	the	DET
cpe-2383	74	32	benefits	benefit	NOUN
cpe-2383	74	33	.	.	PUNCT
cpe-2383	75	1	similarly	similarly	ADV
cpe-2383	75	2	,	,	PUNCT
cpe-2383	75	3	oes‐	oes‐	PRON
cpe-2383	75	4	trogens	trogen	NOUN
cpe-2383	75	5	and	and	CCONJ
cpe-2383	75	6	combined	combine	VERB
cpe-2383	75	7	oestrogen	oestrogen	NOUN
cpe-2383	75	8	/	/	SYM
cpe-2383	75	9	progestogen	progestogen	NOUN
cpe-2383	75	10	treatments	treatment	NOUN
cpe-2383	75	11	appear	appear	VERB
cpe-2383	75	12	to	to	PART
cpe-2383	75	13	enhance	enhance	VERB
cpe-2383	75	14	sexual	sexual	ADJ
cpe-2383	75	15	func‐	func‐	NOUN
cpe-2383	75	16	tion	tion	NOUN
cpe-2383	75	17	in	in	ADP
cpe-2383	75	18	some	some	DET
cpe-2383	75	19	post	post	ADJ
cpe-2383	75	20	-	-	ADJ
cpe-2383	75	21	menopausal	menopausal	ADJ
cpe-2383	75	22	women	woman	NOUN
cpe-2383	75	23	(	(	PUNCT
cpe-2383	75	24	nastri	nastri	PROPN
cpe-2383	75	25	et	et	PROPN
cpe-2383	75	26	al	al	PROPN
cpe-2383	75	27	.	.	PROPN
cpe-2383	75	28	,	,	PUNCT
cpe-2383	75	29	2013	2013	NUM
cpe-2383	75	30	)	)	PUNCT
cpe-2383	75	31	,	,	PUNCT
cpe-2383	75	32	but	but	CCONJ
cpe-2383	75	33	again	again	ADV
cpe-2383	75	34	,	,	PUNCT
cpe-2383	75	35	side	side	NOUN
cpe-2383	75	36	effects	effect	NOUN
cpe-2383	75	37	need	need	VERB
cpe-2383	75	38	to	to	PART
cpe-2383	75	39	be	be	AUX
cpe-2383	75	40	considered	consider	VERB
cpe-2383	75	41	.	.	PUNCT
cpe-2383	76	1	these	these	DET
cpe-2383	76	2	findings	finding	NOUN
cpe-2383	76	3	are	be	AUX
cpe-2383	76	4	important	important	ADJ
cpe-2383	76	5	for	for	ADP
cpe-2383	76	6	any	any	DET
cpe-2383	76	7	clinical	clinical	ADJ
cpe-2383	76	8	psychologist	psychologist	NOUN
cpe-2383	76	9	advising	advise	VERB
cpe-2383	76	10	pa‐	pa‐	VERB
cpe-2383	76	11	tients	tient	NOUN
cpe-2383	76	12	with	with	ADP
cpe-2383	76	13	sexual	sexual	ADJ
cpe-2383	76	14	dysfunctions	dysfunction	NOUN
cpe-2383	76	15	in	in	ADP
cpe-2383	76	16	terms	term	NOUN
cpe-2383	76	17	of	of	ADP
cpe-2383	76	18	adjunct	adjunct	ADJ
cpe-2383	76	19	treatments	treatment	NOUN
cpe-2383	76	20	.	.	PUNCT
cpe-2383	77	1	a	a	DET
cpe-2383	77	2	burgeoning	burgeon	VERB
cpe-2383	77	3	literature	literature	NOUN
cpe-2383	77	4	also	also	ADV
cpe-2383	77	5	demonstrates	demonstrate	VERB
cpe-2383	77	6	the	the	DET
cpe-2383	77	7	involvement	involvement	NOUN
cpe-2383	77	8	of	of	ADP
cpe-2383	77	9	sex	sex	NOUN
cpe-2383	77	10	hormones	hormone	NOUN
cpe-2383	77	11	in	in	ADP
cpe-2383	77	12	other	other	ADJ
cpe-2383	77	13	mental	mental	ADJ
cpe-2383	77	14	disorders	disorder	NOUN
cpe-2383	77	15	,	,	PUNCT
cpe-2383	77	16	which	which	PRON
cpe-2383	77	17	is	be	AUX
cpe-2383	77	18	attributable	attributable	ADJ
cpe-2383	77	19	to	to	ADP
cpe-2383	77	20	the	the	DET
cpe-2383	77	21	aforementioned	aforementioned	ADJ
cpe-2383	77	22	central	central	ADJ
cpe-2383	77	23	expression	expression	NOUN
cpe-2383	77	24	of	of	ADP
cpe-2383	77	25	ste‐	ste‐	PROPN
cpe-2383	77	26	roid	roid	PROPN
cpe-2383	77	27	receptors	receptor	NOUN
cpe-2383	77	28	.	.	PUNCT
cpe-2383	78	1	in	in	ADP
cpe-2383	78	2	schizophrenia	schizophrenia	NOUN
cpe-2383	78	3	,	,	PUNCT
cpe-2383	78	4	it	it	PRON
cpe-2383	78	5	was	be	AUX
cpe-2383	78	6	shown	show	VERB
cpe-2383	78	7	that	that	SCONJ
cpe-2383	78	8	oestradiol	oestradiol	NOUN
cpe-2383	78	9	and	and	CCONJ
cpe-2383	78	10	selective	selective	ADJ
cpe-2383	78	11	oestradiol	oestradiol	NOUN
cpe-2383	78	12	re‐	re‐	DET
cpe-2383	78	13	ceptor	ceptor	NOUN
cpe-2383	78	14	modulators	modulator	NOUN
cpe-2383	78	15	(	(	PUNCT
cpe-2383	78	16	e.g.	e.g.	ADV
cpe-2383	78	17	,	,	PUNCT
cpe-2383	78	18	raloxifene	raloxifene	NOUN
cpe-2383	78	19	)	)	PUNCT
cpe-2383	78	20	can	can	AUX
cpe-2383	78	21	enhance	enhance	VERB
cpe-2383	78	22	memory	memory	NOUN
cpe-2383	78	23	and	and	CCONJ
cpe-2383	78	24	executive	executive	ADJ
cpe-2383	78	25	functions	function	NOUN
cpe-2383	78	26	(	(	PUNCT
cpe-2383	78	27	soria	soria	PROPN
cpe-2383	78	28	et	et	PROPN
cpe-2383	78	29	al	al	PROPN
cpe-2383	78	30	.	.	PROPN
cpe-2383	78	31	,	,	PUNCT
cpe-2383	78	32	2018	2018	NUM
cpe-2383	78	33	)	)	PUNCT
cpe-2383	78	34	.	.	PUNCT
cpe-2383	79	1	in	in	ADP
cpe-2383	79	2	addition	addition	NOUN
cpe-2383	79	3	,	,	PUNCT
cpe-2383	79	4	recent	recent	ADJ
cpe-2383	79	5	research	research	NOUN
cpe-2383	79	6	suggests	suggest	VERB
cpe-2383	79	7	that	that	SCONJ
cpe-2383	79	8	sex	sex	NOUN
cpe-2383	79	9	steroids	steroid	NOUN
cpe-2383	79	10	may	may	AUX
cpe-2383	79	11	exert	exert	VERB
cpe-2383	79	12	positive	positive	ADJ
cpe-2383	79	13	ef‐	ef‐	NOUN
cpe-2383	79	14	fects	fect	NOUN
cpe-2383	79	15	on	on	ADP
cpe-2383	79	16	mood	mood	NOUN
cpe-2383	79	17	.	.	PUNCT
cpe-2383	80	1	for	for	ADP
cpe-2383	80	2	instance	instance	NOUN
cpe-2383	80	3	,	,	PUNCT
cpe-2383	80	4	longer	long	ADV
cpe-2383	80	5	lifetime	lifetime	VERB
cpe-2383	80	6	exposure	exposure	NOUN
cpe-2383	80	7	to	to	ADP
cpe-2383	80	8	endogenous	endogenous	ADJ
cpe-2383	80	9	and	and	CCONJ
cpe-2383	80	10	exogenous	exogenous	ADJ
cpe-2383	80	11	oes‐	oes‐	PRON
cpe-2383	80	12	tradiol	tradiol	NOUN
cpe-2383	80	13	was	be	AUX
cpe-2383	80	14	found	find	VERB
cpe-2383	80	15	to	to	PART
cpe-2383	80	16	be	be	AUX
cpe-2383	80	17	linked	link	VERB
cpe-2383	80	18	to	to	ADP
cpe-2383	80	19	fewer	few	ADJ
cpe-2383	80	20	depressive	depressive	ADJ
cpe-2383	80	21	symptoms	symptom	NOUN
cpe-2383	80	22	during	during	ADP
cpe-2383	80	23	the	the	DET
cpe-2383	80	24	menopausal	menopausal	ADJ
cpe-2383	80	25	transition	transition	NOUN
cpe-2383	80	26	(	(	PUNCT
cpe-2383	80	27	marsh	marsh	PROPN
cpe-2383	80	28	et	et	PROPN
cpe-2383	80	29	al	al	PROPN
cpe-2383	80	30	.	.	PROPN
cpe-2383	80	31	,	,	PUNCT
cpe-2383	80	32	2017	2017	NUM
cpe-2383	80	33	)	)	PUNCT
cpe-2383	80	34	,	,	PUNCT
cpe-2383	80	35	whereas	whereas	SCONJ
cpe-2383	80	36	greater	great	ADJ
cpe-2383	80	37	fluctuations	fluctuation	NOUN
cpe-2383	80	38	in	in	ADP
cpe-2383	80	39	endogenous	endogenous	ADJ
cpe-2383	80	40	oestradiol	oestradiol	NOUN
cpe-2383	80	41	during	during	ADP
cpe-2383	80	42	the	the	DET
cpe-2383	80	43	menopausal	menopausal	ADJ
cpe-2383	80	44	transition	transition	NOUN
cpe-2383	80	45	predicted	predict	VERB
cpe-2383	80	46	more	more	ADJ
cpe-2383	80	47	depressive	depressive	ADJ
cpe-2383	80	48	symptoms	symptom	NOUN
cpe-2383	80	49	in	in	ADP
cpe-2383	80	50	women	woman	NOUN
cpe-2383	80	51	report‐	report‐	VERB
cpe-2383	80	52	ing	ing	ADJ
cpe-2383	80	53	high	high	ADJ
cpe-2383	80	54	amounts	amount	NOUN
cpe-2383	80	55	of	of	ADP
cpe-2383	80	56	stress	stress	NOUN
cpe-2383	80	57	(	(	PUNCT
cpe-2383	80	58	gordon	gordon	PROPN
cpe-2383	80	59	,	,	PUNCT
cpe-2383	80	60	rubinow	rubinow	ADJ
cpe-2383	80	61	,	,	PUNCT
cpe-2383	80	62	eisenlohr	eisenlohr	NOUN
cpe-2383	80	63	-	-	PUNCT
cpe-2383	80	64	moul	moul	NOUN
cpe-2383	80	65	,	,	PUNCT
cpe-2383	80	66	leserman	leserman	NOUN
cpe-2383	80	67	,	,	PUNCT
cpe-2383	80	68	&	&	CCONJ
cpe-2383	80	69	girdler	girdler	NOUN
cpe-2383	80	70	,	,	PUNCT
cpe-2383	80	71	2016	2016	NUM
cpe-2383	80	72	)	)	PUNCT
cpe-2383	80	73	.	.	PUNCT
cpe-2383	81	1	these	these	DET
cpe-2383	81	2	findings	finding	NOUN
cpe-2383	81	3	not	not	PART
cpe-2383	81	4	only	only	ADV
cpe-2383	81	5	contribute	contribute	VERB
cpe-2383	81	6	to	to	ADP
cpe-2383	81	7	a	a	DET
cpe-2383	81	8	more	more	ADV
cpe-2383	81	9	profound	profound	ADJ
cpe-2383	81	10	understanding	understanding	NOUN
cpe-2383	81	11	of	of	ADP
cpe-2383	81	12	the	the	DET
cpe-2383	81	13	symp‐	symp‐	NOUN
cpe-2383	81	14	toms	tom	NOUN
cpe-2383	81	15	pertaining	pertain	VERB
cpe-2383	81	16	to	to	ADP
cpe-2383	81	17	psychotic	psychotic	ADJ
cpe-2383	81	18	and	and	CCONJ
cpe-2383	81	19	mood	mood	NOUN
cpe-2383	81	20	disorders	disorder	NOUN
cpe-2383	81	21	,	,	PUNCT
cpe-2383	81	22	but	but	CCONJ
cpe-2383	81	23	may	may	AUX
cpe-2383	81	24	ultimately	ultimately	ADV
cpe-2383	81	25	be	be	AUX
cpe-2383	81	26	put	put	VERB
cpe-2383	81	27	to	to	PART
cpe-2383	81	28	use	use	VERB
cpe-2383	81	29	in	in	ADP
cpe-2383	81	30	or‐	or‐	NOUN
cpe-2383	81	31	der	der	ADJ
cpe-2383	81	32	to	to	PART
cpe-2383	81	33	guide	guide	VERB
cpe-2383	81	34	(	(	PUNCT
cpe-2383	81	35	sex	sex	NOUN
cpe-2383	81	36	-	-	PUNCT
cpe-2383	81	37	oriented	orient	VERB
cpe-2383	81	38	)	)	PUNCT
cpe-2383	81	39	treatment	treatment	NOUN
cpe-2383	81	40	choices	choice	NOUN
cpe-2383	81	41	.	.	PUNCT
cpe-2383	82	1	how	how	SCONJ
cpe-2383	82	2	hormones	hormone	NOUN
cpe-2383	82	3	affect	affect	VERB
cpe-2383	82	4	hunger	hunger	NOUN
cpe-2383	82	5	and	and	CCONJ
cpe-2383	82	6	satiety	satiety	VERB
cpe-2383	82	7	a	a	DET
cpe-2383	82	8	number	number	NOUN
cpe-2383	82	9	of	of	ADP
cpe-2383	82	10	hormones	hormone	NOUN
cpe-2383	82	11	regulating	regulate	VERB
cpe-2383	82	12	hunger	hunger	NOUN
cpe-2383	82	13	and	and	CCONJ
cpe-2383	82	14	satiety	satiety	NOUN
cpe-2383	82	15	,	,	PUNCT
cpe-2383	82	16	such	such	ADJ
cpe-2383	82	17	as	as	ADP
cpe-2383	82	18	ghrelin	ghrelin	NOUN
cpe-2383	82	19	,	,	PUNCT
cpe-2383	82	20	leptin	leptin	NOUN
cpe-2383	82	21	,	,	PUNCT
cpe-2383	82	22	or	or	CCONJ
cpe-2383	82	23	insulin	insulin	NOUN
cpe-2383	82	24	,	,	PUNCT
cpe-2383	82	25	have	have	AUX
cpe-2383	82	26	been	be	AUX
cpe-2383	82	27	related	relate	VERB
cpe-2383	82	28	to	to	ADP
cpe-2383	82	29	different	different	ADJ
cpe-2383	82	30	mental	mental	ADJ
cpe-2383	82	31	disorders	disorder	NOUN
cpe-2383	82	32	(	(	PUNCT
cpe-2383	82	33	drobnjak	drobnjak	ADV
cpe-2383	82	34	&	&	CCONJ
cpe-2383	82	35	ehlert	ehlert	PROPN
cpe-2383	82	36	,	,	PUNCT
cpe-2383	82	37	2011	2011	NUM
cpe-2383	82	38	)	)	PUNCT
cpe-2383	82	39	.	.	PUNCT
cpe-2383	83	1	whereas	whereas	SCONJ
cpe-2383	83	2	the	the	DET
cpe-2383	83	3	orexigenic	orexigenic	ADJ
cpe-2383	83	4	hormone	hormone	NOUN
cpe-2383	83	5	ghrelin	ghrelin	NOUN
cpe-2383	83	6	is	be	AUX
cpe-2383	83	7	produced	produce	VERB
cpe-2383	83	8	in	in	ADP
cpe-2383	83	9	the	the	DET
cpe-2383	83	10	stomach	stomach	NOUN
cpe-2383	83	11	,	,	PUNCT
cpe-2383	83	12	the	the	DET
cpe-2383	83	13	anorexic	anorexic	ADJ
cpe-2383	83	14	hormones	hormone	NOUN
cpe-2383	83	15	leptin	leptin	VERB
cpe-2383	83	16	and	and	CCONJ
cpe-2383	83	17	insulin	insulin	NOUN
cpe-2383	83	18	are	be	AUX
cpe-2383	83	19	produced	produce	VERB
cpe-2383	83	20	in	in	ADP
cpe-2383	83	21	adipose	adipose	ADJ
cpe-2383	83	22	tissue	tissue	NOUN
cpe-2383	83	23	and	and	CCONJ
cpe-2383	83	24	in	in	ADP
cpe-2383	83	25	the	the	DET
cpe-2383	83	26	pancreas	pancrea	NOUN
cpe-2383	83	27	,	,	PUNCT
cpe-2383	83	28	respectively	respectively	ADV
cpe-2383	83	29	.	.	PUNCT
cpe-2383	84	1	all	all	DET
cpe-2383	84	2	three	three	NUM
cpe-2383	84	3	hormones	hormone	NOUN
cpe-2383	84	4	are	be	AUX
cpe-2383	84	5	capable	capable	ADJ
cpe-2383	84	6	of	of	ADP
cpe-2383	84	7	crossing	cross	VERB
cpe-2383	84	8	the	the	DET
cpe-2383	84	9	blood	blood	NOUN
cpe-2383	84	10	-	-	PUNCT
cpe-2383	84	11	brain	brain	NOUN
cpe-2383	84	12	barrier	barrier	NOUN
cpe-2383	84	13	and	and	CCONJ
cpe-2383	84	14	thus	thus	ADV
cpe-2383	84	15	directly	directly	ADV
cpe-2383	84	16	influence	influence	VERB
cpe-2383	84	17	en‐	en‐	PROPN
cpe-2383	84	18	ergy	ergy	NOUN
cpe-2383	84	19	homoeostasis	homoeostasis	NOUN
cpe-2383	84	20	by	by	ADP
cpe-2383	84	21	acting	act	VERB
cpe-2383	84	22	on	on	ADP
cpe-2383	84	23	the	the	DET
cpe-2383	84	24	hypothalamus	hypothalamus	PROPN
cpe-2383	84	25	.	.	PUNCT
cpe-2383	85	1	ghrelin	ghrelin	NOUN
cpe-2383	85	2	,	,	PUNCT
cpe-2383	85	3	leptin	leptin	NOUN
cpe-2383	85	4	,	,	PUNCT
cpe-2383	85	5	and	and	CCONJ
cpe-2383	85	6	insulin	insulin	NOUN
cpe-2383	85	7	have	have	AUX
cpe-2383	85	8	,	,	PUNCT
cpe-2383	85	9	for	for	ADP
cpe-2383	85	10	the	the	DET
cpe-2383	85	11	most	most	ADJ
cpe-2383	85	12	part	part	NOUN
cpe-2383	85	13	,	,	PUNCT
cpe-2383	85	14	been	be	AUX
cpe-2383	85	15	objects	object	NOUN
cpe-2383	85	16	of	of	ADP
cpe-2383	85	17	research	research	NOUN
cpe-2383	85	18	into	into	ADP
cpe-2383	85	19	eat‐	eat‐	PUNCT
cpe-2383	85	20	ing	ing	ADJ
cpe-2383	85	21	disorders	disorder	NOUN
cpe-2383	85	22	.	.	PUNCT
cpe-2383	86	1	for	for	ADP
cpe-2383	86	2	instance	instance	NOUN
cpe-2383	86	3	,	,	PUNCT
cpe-2383	86	4	enhanced	enhance	VERB
cpe-2383	86	5	baseline	baseline	ADJ
cpe-2383	86	6	ghrelin	ghrelin	NOUN
cpe-2383	86	7	levels	level	NOUN
cpe-2383	86	8	were	be	AUX
cpe-2383	86	9	reported	report	VERB
cpe-2383	86	10	in	in	ADP
cpe-2383	86	11	patients	patient	NOUN
cpe-2383	86	12	with	with	ADP
cpe-2383	86	13	eating	eat	VERB
cpe-2383	86	14	disorders	disorder	NOUN
cpe-2383	86	15	(	(	PUNCT
cpe-2383	86	16	prince	prince	PROPN
cpe-2383	86	17	,	,	PUNCT
cpe-2383	86	18	brooks	brooks	PROPN
cpe-2383	86	19	,	,	PUNCT
cpe-2383	86	20	stahl	stahl	PROPN
cpe-2383	86	21	,	,	PUNCT
cpe-2383	86	22	&	&	CCONJ
cpe-2383	86	23	treasure	treasure	NOUN
cpe-2383	86	24	,	,	PUNCT
cpe-2383	86	25	2009	2009	NUM
cpe-2383	86	26	)	)	PUNCT
cpe-2383	86	27	,	,	PUNCT
cpe-2383	86	28	likely	likely	ADV
cpe-2383	86	29	as	as	ADP
cpe-2383	86	30	a	a	DET
cpe-2383	86	31	consequence	consequence	NOUN
cpe-2383	86	32	of	of	ADP
cpe-2383	86	33	restrained	restrained	ADJ
cpe-2383	86	34	eating	eating	NOUN
cpe-2383	86	35	.	.	PUNCT
cpe-2383	87	1	importantly	importantly	ADV
cpe-2383	87	2	,	,	PUNCT
cpe-2383	87	3	elevated	elevated	ADJ
cpe-2383	87	4	levels	level	NOUN
cpe-2383	87	5	of	of	ADP
cpe-2383	87	6	ghrelin	ghrelin	NOUN
cpe-2383	87	7	may	may	AUX
cpe-2383	87	8	in	in	ADP
cpe-2383	87	9	turn	turn	NOUN
cpe-2383	87	10	facilitate	facilitate	VERB
cpe-2383	87	11	other	other	ADJ
cpe-2383	87	12	dys‐	dys‐	ADJ
cpe-2383	87	13	functional	functional	ADJ
cpe-2383	87	14	behaviours	behaviour	NOUN
cpe-2383	87	15	,	,	PUNCT
cpe-2383	87	16	such	such	ADJ
cpe-2383	87	17	as	as	ADP
cpe-2383	87	18	hoarding	hoard	VERB
cpe-2383	87	19	food	food	NOUN
cpe-2383	87	20	in	in	ADP
cpe-2383	87	21	anorexia	anorexia	PROPN
cpe-2383	87	22	nervosa	nervosa	NOUN
cpe-2383	87	23	or	or	CCONJ
cpe-2383	87	24	binge	binge	ADJ
cpe-2383	87	25	eating	eat	VERB
cpe-2383	87	26	in	in	ADP
cpe-2383	87	27	buli‐	buli‐	PROPN
cpe-2383	87	28	mia	mia	PROPN
cpe-2383	87	29	nervosa	nervosa	NOUN
cpe-2383	87	30	or	or	CCONJ
cpe-2383	87	31	binge	binge	VERB
cpe-2383	87	32	eating	eat	VERB
cpe-2383	87	33	disorder	disorder	NOUN
cpe-2383	87	34	.	.	PUNCT
cpe-2383	88	1	furthermore	furthermore	ADV
cpe-2383	88	2	,	,	PUNCT
cpe-2383	88	3	patients	patient	NOUN
cpe-2383	88	4	with	with	ADP
cpe-2383	88	5	anorexia	anorexia	PROPN
cpe-2383	88	6	nervosa	nervosa	NOUN
cpe-2383	88	7	have	have	AUX
cpe-2383	88	8	been	be	AUX
cpe-2383	88	9	found	find	VERB
cpe-2383	88	10	to	to	PART
cpe-2383	88	11	present	present	VERB
cpe-2383	88	12	with	with	ADP
cpe-2383	88	13	increased	increase	VERB
cpe-2383	88	14	insulin	insulin	NOUN
cpe-2383	88	15	sensitivity	sensitivity	NOUN
cpe-2383	88	16	,	,	PUNCT
cpe-2383	88	17	whereas	whereas	SCONJ
cpe-2383	88	18	patients	patient	NOUN
cpe-2383	88	19	with	with	ADP
cpe-2383	88	20	bulimia	bulimia	NOUN
cpe-2383	88	21	psychoneuroendocrinology	psychoneuroendocrinology	NOUN
cpe-2383	88	22	and	and	CCONJ
cpe-2383	88	23	clinical	clinical	ADJ
cpe-2383	88	24	psychology	psychology	NOUN
cpe-2383	88	25	6	6	NUM
cpe-2383	88	26	clinical	clinical	ADJ
cpe-2383	88	27	psychology	psychology	NOUN
cpe-2383	88	28	in	in	ADP
cpe-2383	88	29	europe	europe	PROPN
cpe-2383	88	30	2019	2019	NUM
cpe-2383	88	31	,	,	PUNCT
cpe-2383	88	32	vol.1(2	vol.1(2	PROPN
cpe-2383	88	33	)	)	PUNCT
cpe-2383	88	34	,	,	PUNCT
cpe-2383	88	35	article	article	NOUN
cpe-2383	88	36	33030	33030	NUM
cpe-2383	88	37	https://doi.org/10.32872/cpe.v1i2.33030	https://doi.org/10.32872/cpe.v1i2.33030	PROPN
cpe-2383	88	38	https://www.psychopen.eu/	https://www.psychopen.eu/	VERB
cpe-2383	88	39	nervosa	nervosa	NOUN
cpe-2383	88	40	or	or	CCONJ
cpe-2383	88	41	binge	binge	ADJ
cpe-2383	88	42	eating	eat	VERB
cpe-2383	88	43	disorder	disorder	NOUN
cpe-2383	88	44	exhibit	exhibit	NOUN
cpe-2383	88	45	decreased	decrease	VERB
cpe-2383	88	46	insulin	insulin	NOUN
cpe-2383	88	47	sensitivity	sensitivity	NOUN
cpe-2383	88	48	(	(	PUNCT
cpe-2383	88	49	ilyas	ilyas	PROPN
cpe-2383	88	50	et	et	PROPN
cpe-2383	88	51	al	al	PROPN
cpe-2383	88	52	.	.	PROPN
cpe-2383	88	53	,	,	PUNCT
cpe-2383	88	54	2018	2018	NUM
cpe-2383	88	55	)	)	PUNCT
cpe-2383	88	56	.	.	PUNCT
cpe-2383	89	1	similar	similar	ADJ
cpe-2383	89	2	to	to	ADP
cpe-2383	89	3	ghrelin	ghrelin	NOUN
cpe-2383	89	4	,	,	PUNCT
cpe-2383	89	5	these	these	DET
cpe-2383	89	6	findings	finding	NOUN
cpe-2383	89	7	have	have	AUX
cpe-2383	89	8	been	be	AUX
cpe-2383	89	9	interpreted	interpret	VERB
cpe-2383	89	10	as	as	ADP
cpe-2383	89	11	being	be	AUX
cpe-2383	89	12	the	the	DET
cpe-2383	89	13	result	result	NOUN
cpe-2383	89	14	of	of	ADP
cpe-2383	89	15	dietary	dietary	ADJ
cpe-2383	89	16	re‐	re‐	PRON
cpe-2383	89	17	striction	striction	NOUN
cpe-2383	89	18	and	and	CCONJ
cpe-2383	89	19	weight	weight	NOUN
cpe-2383	89	20	loss	loss	NOUN
cpe-2383	89	21	/	/	SYM
cpe-2383	89	22	weight	weight	NOUN
cpe-2383	89	23	gain	gain	NOUN
cpe-2383	89	24	,	,	PUNCT
cpe-2383	89	25	respectively	respectively	ADV
cpe-2383	89	26	,	,	PUNCT
cpe-2383	89	27	while	while	SCONJ
cpe-2383	89	28	at	at	ADP
cpe-2383	89	29	the	the	DET
cpe-2383	89	30	same	same	ADJ
cpe-2383	89	31	time	time	NOUN
cpe-2383	89	32	further	far	ADV
cpe-2383	89	33	contri‐	contri‐	PROPN
cpe-2383	89	34	buting	bute	VERB
cpe-2383	89	35	to	to	ADP
cpe-2383	89	36	dysfunctional	dysfunctional	ADJ
cpe-2383	89	37	eating	eating	NOUN
cpe-2383	89	38	patterns	pattern	NOUN
cpe-2383	89	39	by	by	ADP
cpe-2383	89	40	affecting	affect	VERB
cpe-2383	89	41	appetite	appetite	ADJ
cpe-2383	89	42	regulation	regulation	NOUN
cpe-2383	89	43	in	in	ADP
cpe-2383	89	44	the	the	DET
cpe-2383	89	45	brain	brain	NOUN
cpe-2383	89	46	(	(	PUNCT
cpe-2383	89	47	i.e.	i.e.	X
cpe-2383	89	48	,	,	PUNCT
cpe-2383	89	49	diminishing	diminishing	NOUN
cpe-2383	89	50	/	/	SYM
cpe-2383	89	51	enhancing	enhance	VERB
cpe-2383	89	52	appetite	appetite	NOUN
cpe-2383	89	53	)	)	PUNCT
cpe-2383	89	54	.	.	PUNCT
cpe-2383	90	1	this	this	PRON
cpe-2383	90	2	is	be	AUX
cpe-2383	90	3	important	important	ADJ
cpe-2383	90	4	knowledge	knowledge	NOUN
cpe-2383	90	5	when	when	SCONJ
cpe-2383	90	6	trying	try	VERB
cpe-2383	90	7	to	to	PART
cpe-2383	90	8	make	make	VERB
cpe-2383	90	9	sense	sense	NOUN
cpe-2383	90	10	of	of	ADP
cpe-2383	90	11	the	the	DET
cpe-2383	90	12	vicious	vicious	ADJ
cpe-2383	90	13	circles	circle	NOUN
cpe-2383	90	14	that	that	PRON
cpe-2383	90	15	perpetuate	perpetuate	VERB
cpe-2383	90	16	eating	eat	VERB
cpe-2383	90	17	disorders	disorder	NOUN
cpe-2383	90	18	.	.	PUNCT
cpe-2383	91	1	evidence	evidence	NOUN
cpe-2383	91	2	is	be	AUX
cpe-2383	91	3	now	now	ADV
cpe-2383	91	4	also	also	ADV
cpe-2383	91	5	accumulating	accumulate	VERB
cpe-2383	91	6	that	that	DET
cpe-2383	91	7	hunger	hunger	NOUN
cpe-2383	91	8	and	and	CCONJ
cpe-2383	91	9	satiety	satiety	NOUN
cpe-2383	91	10	hormones	hormone	NOUN
cpe-2383	91	11	are	be	AUX
cpe-2383	91	12	abnormal	abnormal	ADJ
cpe-2383	91	13	in	in	ADP
cpe-2383	91	14	other	other	ADJ
cpe-2383	91	15	mental	mental	ADJ
cpe-2383	91	16	disorders	disorder	NOUN
cpe-2383	91	17	,	,	PUNCT
cpe-2383	91	18	mainly	mainly	ADV
cpe-2383	91	19	those	those	PRON
cpe-2383	91	20	presenting	present	VERB
cpe-2383	91	21	with	with	ADP
cpe-2383	91	22	metabolic	metabolic	NOUN
cpe-2383	91	23	symptoms	symptom	NOUN
cpe-2383	91	24	and/or	and/or	CCONJ
cpe-2383	91	25	comor‐	comor‐	NOUN
cpe-2383	91	26	bid	bid	VERB
cpe-2383	91	27	metabolic	metabolic	NOUN
cpe-2383	91	28	diseases	disease	NOUN
cpe-2383	91	29	(	(	PUNCT
cpe-2383	91	30	e.g.	e.g.	ADV
cpe-2383	91	31	,	,	PUNCT
cpe-2383	91	32	diabetes	diabetes	NOUN
cpe-2383	91	33	mellitus	mellitus	NOUN
cpe-2383	91	34	)	)	PUNCT
cpe-2383	91	35	.	.	PUNCT
cpe-2383	92	1	findings	finding	NOUN
cpe-2383	92	2	include	include	VERB
cpe-2383	92	3	elevated	elevated	ADJ
cpe-2383	92	4	levels	level	NOUN
cpe-2383	92	5	of	of	ADP
cpe-2383	92	6	leptin	leptin	NOUN
cpe-2383	92	7	and	and	CCONJ
cpe-2383	92	8	insulin	insulin	NOUN
cpe-2383	92	9	resistance	resistance	NOUN
cpe-2383	92	10	in	in	ADP
cpe-2383	92	11	patients	patient	NOUN
cpe-2383	92	12	with	with	ADP
cpe-2383	92	13	psychotic	psychotic	ADJ
cpe-2383	92	14	disorders	disorder	NOUN
cpe-2383	92	15	(	(	PUNCT
cpe-2383	92	16	greenhalgh	greenhalgh	PROPN
cpe-2383	92	17	et	et	PROPN
cpe-2383	92	18	al	al	PROPN
cpe-2383	92	19	.	.	PROPN
cpe-2383	92	20	,	,	PUNCT
cpe-2383	92	21	2017	2017	NUM
cpe-2383	92	22	;	;	PUNCT
cpe-2383	92	23	pillinger	pillinger	NOUN
cpe-2383	92	24	et	et	PROPN
cpe-2383	92	25	al	al	PROPN
cpe-2383	92	26	.	.	PROPN
cpe-2383	92	27	,	,	PUNCT
cpe-2383	92	28	2017	2017	NUM
cpe-2383	92	29	;	;	PUNCT
cpe-2383	92	30	stubbs	stubbs	PROPN
cpe-2383	92	31	,	,	PUNCT
cpe-2383	92	32	wang	wang	PROPN
cpe-2383	92	33	,	,	PUNCT
cpe-2383	92	34	vancampfort	vancampfort	PROPN
cpe-2383	92	35	,	,	PUNCT
cpe-2383	92	36	&	&	CCONJ
cpe-2383	92	37	miller	miller	PROPN
cpe-2383	92	38	,	,	PUNCT
cpe-2383	92	39	2016	2016	NUM
cpe-2383	92	40	)	)	PUNCT
cpe-2383	92	41	and	and	CCONJ
cpe-2383	92	42	depressive	depressive	ADJ
cpe-2383	92	43	disorders	disorder	NOUN
cpe-2383	92	44	(	(	PUNCT
cpe-2383	92	45	kan	kan	PROPN
cpe-2383	92	46	et	et	PROPN
cpe-2383	92	47	al	al	PROPN
cpe-2383	92	48	.	.	PROPN
cpe-2383	92	49	,	,	PUNCT
cpe-2383	92	50	2013	2013	NUM
cpe-2383	92	51	)	)	PUNCT
cpe-2383	92	52	.	.	PUNCT
cpe-2383	93	1	notably	notably	ADV
cpe-2383	93	2	,	,	PUNCT
cpe-2383	93	3	these	these	PRON
cpe-2383	93	4	seem	seem	VERB
cpe-2383	93	5	to	to	PART
cpe-2383	93	6	be	be	AUX
cpe-2383	93	7	independent	independent	ADJ
cpe-2383	93	8	of	of	ADP
cpe-2383	93	9	bmi	bmi	NOUN
cpe-2383	93	10	and	and	CCONJ
cpe-2383	93	11	intake	intake	NOUN
cpe-2383	93	12	of	of	ADP
cpe-2383	93	13	antipsy‐	antipsy‐	PROPN
cpe-2383	93	14	chotic	chotic	ADJ
cpe-2383	93	15	medication	medication	NOUN
cpe-2383	93	16	(	(	PUNCT
cpe-2383	93	17	which	which	PRON
cpe-2383	93	18	are	be	AUX
cpe-2383	93	19	known	know	VERB
cpe-2383	93	20	to	to	PART
cpe-2383	93	21	have	have	VERB
cpe-2383	93	22	several	several	ADJ
cpe-2383	93	23	metabolic	metabolic	ADJ
cpe-2383	93	24	side	side	NOUN
cpe-2383	93	25	effects	effect	NOUN
cpe-2383	93	26	)	)	PUNCT
cpe-2383	93	27	.	.	PUNCT
cpe-2383	94	1	this	this	PRON
cpe-2383	94	2	suggests	suggest	VERB
cpe-2383	94	3	that	that	SCONJ
cpe-2383	94	4	these	these	DET
cpe-2383	94	5	hormonal	hormonal	ADJ
cpe-2383	94	6	abnormalities	abnormality	NOUN
cpe-2383	94	7	are	be	AUX
cpe-2383	94	8	not	not	PART
cpe-2383	94	9	a	a	DET
cpe-2383	94	10	mere	mere	ADJ
cpe-2383	94	11	consequence	consequence	NOUN
cpe-2383	94	12	of	of	ADP
cpe-2383	94	13	lifestyle	lifestyle	NOUN
cpe-2383	94	14	behaviours	behaviour	NOUN
cpe-2383	94	15	as‐	as‐	PUNCT
cpe-2383	94	16	sociated	sociate	VERB
cpe-2383	94	17	with	with	ADP
cpe-2383	94	18	suffering	suffer	VERB
cpe-2383	94	19	from	from	ADP
cpe-2383	94	20	a	a	DET
cpe-2383	94	21	chronic	chronic	ADJ
cpe-2383	94	22	illness	illness	NOUN
cpe-2383	94	23	,	,	PUNCT
cpe-2383	94	24	but	but	CCONJ
cpe-2383	94	25	may	may	AUX
cpe-2383	94	26	be	be	AUX
cpe-2383	94	27	antecedents	antecedent	NOUN
cpe-2383	94	28	of	of	ADP
cpe-2383	94	29	highly	highly	ADV
cpe-2383	94	30	debilitat‐	debilitat‐	PRON
cpe-2383	94	31	ing	ing	ADJ
cpe-2383	94	32	ancillary	ancillary	ADJ
cpe-2383	94	33	symptoms	symptom	NOUN
cpe-2383	94	34	pertaining	pertain	VERB
cpe-2383	94	35	to	to	ADP
cpe-2383	94	36	psychotic	psychotic	ADJ
cpe-2383	94	37	and	and	CCONJ
cpe-2383	94	38	depressive	depressive	ADJ
cpe-2383	94	39	disorders	disorder	NOUN
cpe-2383	94	40	.	.	PUNCT
cpe-2383	95	1	importantly	importantly	ADV
cpe-2383	95	2	,	,	PUNCT
cpe-2383	95	3	recent	recent	ADJ
cpe-2383	95	4	studies	study	NOUN
cpe-2383	95	5	support	support	VERB
cpe-2383	95	6	the	the	DET
cpe-2383	95	7	notion	notion	NOUN
cpe-2383	95	8	that	that	SCONJ
cpe-2383	95	9	endogenous	endogenous	ADJ
cpe-2383	95	10	ghrelin	ghrelin	NOUN
cpe-2383	95	11	and	and	CCONJ
cpe-2383	95	12	leptin	leptin	NOUN
cpe-2383	95	13	may	may	AUX
cpe-2383	95	14	also	also	ADV
cpe-2383	95	15	influence	influence	VERB
cpe-2383	95	16	treatment	treatment	NOUN
cpe-2383	95	17	outcomes	outcome	NOUN
cpe-2383	95	18	:	:	PUNCT
cpe-2383	95	19	whereas	whereas	SCONJ
cpe-2383	95	20	increases	increase	NOUN
cpe-2383	95	21	in	in	ADP
cpe-2383	95	22	ghrelin	ghrelin	NOUN
cpe-2383	95	23	predicted	predict	VERB
cpe-2383	95	24	non	non	ADJ
cpe-2383	95	25	-	-	ADJ
cpe-2383	95	26	re‐	re‐	PRON
cpe-2383	95	27	sponses	sponse	NOUN
cpe-2383	95	28	to	to	ADP
cpe-2383	95	29	treatment	treatment	NOUN
cpe-2383	95	30	with	with	ADP
cpe-2383	95	31	lithium	lithium	NOUN
cpe-2383	95	32	-	-	PUNCT
cpe-2383	95	33	augmented	augment	VERB
cpe-2383	95	34	antidepressants	antidepressant	NOUN
cpe-2383	95	35	in	in	ADP
cpe-2383	95	36	patients	patient	NOUN
cpe-2383	95	37	with	with	ADP
cpe-2383	95	38	depres‐	depres‐	NOUN
cpe-2383	95	39	sion	sion	NOUN
cpe-2383	95	40	(	(	PUNCT
cpe-2383	95	41	ricken	ricken	VERB
cpe-2383	95	42	et	et	PROPN
cpe-2383	95	43	al	al	PROPN
cpe-2383	95	44	.	.	PROPN
cpe-2383	95	45	,	,	PUNCT
cpe-2383	95	46	2017	2017	NUM
cpe-2383	95	47	)	)	PUNCT
cpe-2383	95	48	,	,	PUNCT
cpe-2383	95	49	leptin	leptin	NOUN
cpe-2383	95	50	was	be	AUX
cpe-2383	95	51	positively	positively	ADV
cpe-2383	95	52	linked	link	VERB
cpe-2383	95	53	to	to	ADP
cpe-2383	95	54	increases	increase	NOUN
cpe-2383	95	55	in	in	ADP
cpe-2383	95	56	bmi	bmi	NOUN
cpe-2383	95	57	(	(	PUNCT
cpe-2383	95	58	ricken	ricken	VERB
cpe-2383	95	59	et	et	PROPN
cpe-2383	95	60	al	al	PROPN
cpe-2383	95	61	.	.	PROPN
cpe-2383	95	62	,	,	PUNCT
cpe-2383	95	63	2016	2016	NUM
cpe-2383	95	64	)	)	PUNCT
cpe-2383	95	65	.	.	PUNCT
cpe-2383	96	1	in	in	ADP
cpe-2383	96	2	terms	term	NOUN
cpe-2383	96	3	of	of	ADP
cpe-2383	96	4	ghrelin	ghrelin	NOUN
cpe-2383	96	5	,	,	PUNCT
cpe-2383	96	6	the	the	DET
cpe-2383	96	7	observed	observe	VERB
cpe-2383	96	8	increases	increase	NOUN
cpe-2383	96	9	in	in	ADP
cpe-2383	96	10	non	non	NOUN
cpe-2383	96	11	-	-	NOUN
cpe-2383	96	12	responders	responder	NOUN
cpe-2383	96	13	could	could	AUX
cpe-2383	96	14	be	be	AUX
cpe-2383	96	15	interpreted	interpret	VERB
cpe-2383	96	16	as	as	ADP
cpe-2383	96	17	being	be	AUX
cpe-2383	96	18	secondary	secondary	ADJ
cpe-2383	96	19	to	to	ADP
cpe-2383	96	20	reduced	reduced	ADJ
cpe-2383	96	21	appetite	appetite	NOUN
cpe-2383	96	22	,	,	PUNCT
cpe-2383	96	23	a	a	DET
cpe-2383	96	24	core	core	NOUN
cpe-2383	96	25	symptom	symptom	NOUN
cpe-2383	96	26	of	of	ADP
cpe-2383	96	27	severe	severe	ADJ
cpe-2383	96	28	depression	depression	NOUN
cpe-2383	96	29	.	.	PUNCT
cpe-2383	97	1	in	in	ADP
cpe-2383	97	2	terms	term	NOUN
cpe-2383	97	3	of	of	ADP
cpe-2383	97	4	leptin	leptin	NOUN
cpe-2383	97	5	,	,	PUNCT
cpe-2383	97	6	synergistic	synergistic	ADJ
cpe-2383	97	7	actions	action	NOUN
cpe-2383	97	8	with	with	ADP
cpe-2383	97	9	lithium	lithium	NOUN
cpe-2383	97	10	on	on	ADP
cpe-2383	97	11	the	the	DET
cpe-2383	97	12	serotonergic	serotonergic	ADJ
cpe-2383	97	13	system	system	NOUN
cpe-2383	97	14	could	could	AUX
cpe-2383	97	15	have	have	AUX
cpe-2383	97	16	resulted	result	VERB
cpe-2383	97	17	in	in	ADP
cpe-2383	97	18	an	an	DET
cpe-2383	97	19	attenuation	attenuation	NOUN
cpe-2383	97	20	of	of	ADP
cpe-2383	97	21	leptin	leptin	PROPN
cpe-2383	97	22	’s	’s	PART
cpe-2383	97	23	anorexic	anorexic	ADJ
cpe-2383	97	24	effect	effect	NOUN
cpe-2383	97	25	,	,	PUNCT
cpe-2383	97	26	but	but	CCONJ
cpe-2383	97	27	more	more	ADJ
cpe-2383	97	28	research	research	NOUN
cpe-2383	97	29	is	be	AUX
cpe-2383	97	30	warranted	warrant	VERB
cpe-2383	97	31	to	to	PART
cpe-2383	97	32	investigate	investigate	VERB
cpe-2383	97	33	the	the	DET
cpe-2383	97	34	intricate	intricate	ADJ
cpe-2383	97	35	interplay	interplay	NOUN
cpe-2383	97	36	between	between	ADP
cpe-2383	97	37	the	the	DET
cpe-2383	97	38	two	two	NUM
cpe-2383	97	39	systems	system	NOUN
cpe-2383	97	40	.	.	PUNCT
cpe-2383	98	1	these	these	DET
cpe-2383	98	2	findings	finding	NOUN
cpe-2383	98	3	are	be	AUX
cpe-2383	98	4	important	important	ADJ
cpe-2383	98	5	to	to	PART
cpe-2383	98	6	consider	consider	VERB
cpe-2383	98	7	by	by	ADP
cpe-2383	98	8	clinicians	clinician	NOUN
cpe-2383	98	9	prescribing	prescribe	VERB
cpe-2383	98	10	psychoactive	psychoactive	ADJ
cpe-2383	98	11	drugs	drug	NOUN
cpe-2383	98	12	,	,	PUNCT
cpe-2383	98	13	and	and	CCONJ
cpe-2383	98	14	will	will	AUX
cpe-2383	98	15	hopefully	hopefully	ADV
cpe-2383	98	16	allow	allow	VERB
cpe-2383	98	17	the	the	DET
cpe-2383	98	18	adjusting	adjusting	NOUN
cpe-2383	98	19	of	of	ADP
cpe-2383	98	20	treatments	treatment	NOUN
cpe-2383	98	21	to	to	ADP
cpe-2383	98	22	the	the	DET
cpe-2383	98	23	needs	need	NOUN
cpe-2383	98	24	of	of	ADP
cpe-2383	98	25	the	the	DET
cpe-2383	98	26	individual	individual	ADJ
cpe-2383	98	27	patient	patient	NOUN
cpe-2383	98	28	in	in	ADP
cpe-2383	98	29	the	the	DET
cpe-2383	98	30	future	future	NOUN
cpe-2383	98	31	.	.	PUNCT
cpe-2383	99	1	summary	summary	NOUN
cpe-2383	99	2	and	and	CCONJ
cpe-2383	99	3	integration	integration	NOUN
cpe-2383	99	4	it	it	PRON
cpe-2383	99	5	is	be	AUX
cpe-2383	99	6	evident	evident	ADJ
cpe-2383	99	7	from	from	ADP
cpe-2383	99	8	this	this	DET
cpe-2383	99	9	brief	brief	ADJ
cpe-2383	99	10	overview	overview	NOUN
cpe-2383	99	11	that	that	SCONJ
cpe-2383	99	12	hormones	hormone	NOUN
cpe-2383	99	13	are	be	AUX
cpe-2383	99	14	intrinsic	intrinsic	ADJ
cpe-2383	99	15	to	to	ADP
cpe-2383	99	16	both	both	DET
cpe-2383	99	17	the	the	DET
cpe-2383	99	18	development	development	NOUN
cpe-2383	99	19	and	and	CCONJ
cpe-2383	99	20	maintenance	maintenance	NOUN
cpe-2383	99	21	of	of	ADP
cpe-2383	99	22	mental	mental	ADJ
cpe-2383	99	23	disorders	disorder	NOUN
cpe-2383	99	24	,	,	PUNCT
cpe-2383	99	25	and	and	CCONJ
cpe-2383	99	26	there	there	PRON
cpe-2383	99	27	are	be	VERB
cpe-2383	99	28	several	several	ADJ
cpe-2383	99	29	conceivable	conceivable	ADJ
cpe-2383	99	30	ways	way	NOUN
cpe-2383	99	31	in	in	ADP
cpe-2383	99	32	which	which	PRON
cpe-2383	99	33	this	this	DET
cpe-2383	99	34	knowledge	knowledge	NOUN
cpe-2383	99	35	may	may	AUX
cpe-2383	99	36	be	be	AUX
cpe-2383	99	37	useful	useful	ADJ
cpe-2383	99	38	to	to	ADP
cpe-2383	99	39	clinical	clinical	ADJ
cpe-2383	99	40	psychology	psychology	NOUN
cpe-2383	99	41	.	.	PUNCT
cpe-2383	100	1	first	first	ADV
cpe-2383	100	2	,	,	PUNCT
cpe-2383	100	3	neuroendocrine	neuroendocrine	ADJ
cpe-2383	100	4	research	research	NOUN
cpe-2383	100	5	should	should	AUX
cpe-2383	100	6	find	find	VERB
cpe-2383	100	7	its	its	PRON
cpe-2383	100	8	way	way	NOUN
cpe-2383	100	9	into	into	ADP
cpe-2383	100	10	clinical	clinical	ADJ
cpe-2383	100	11	practice	practice	NOUN
cpe-2383	100	12	when	when	SCONJ
cpe-2383	100	13	clinicians	clinician	NOUN
cpe-2383	100	14	and	and	CCONJ
cpe-2383	100	15	patients	patient	NOUN
cpe-2383	100	16	are	be	AUX
cpe-2383	100	17	developing	develop	VERB
cpe-2383	100	18	multidimensional	multidimensional	ADJ
cpe-2383	100	19	illness	illness	NOUN
cpe-2383	100	20	models	model	NOUN
cpe-2383	100	21	together	together	ADV
cpe-2383	100	22	,	,	PUNCT
cpe-2383	100	23	such	such	ADJ
cpe-2383	100	24	as	as	ADP
cpe-2383	100	25	at	at	ADP
cpe-2383	100	26	the	the	DET
cpe-2383	100	27	beginning	beginning	NOUN
cpe-2383	100	28	of	of	ADP
cpe-2383	100	29	psychological	psychological	ADJ
cpe-2383	100	30	ther‐	ther‐	PROPN
cpe-2383	100	31	apy	apy	NOUN
cpe-2383	100	32	.	.	PUNCT
cpe-2383	101	1	this	this	PRON
cpe-2383	101	2	is	be	AUX
cpe-2383	101	3	important	important	ADJ
cpe-2383	101	4	given	give	VERB
cpe-2383	101	5	that	that	SCONJ
cpe-2383	101	6	mental	mental	ADJ
cpe-2383	101	7	disorders	disorder	NOUN
cpe-2383	101	8	are	be	AUX
cpe-2383	101	9	still	still	ADV
cpe-2383	101	10	stigmatised	stigmatise	VERB
cpe-2383	101	11	by	by	ADP
cpe-2383	101	12	a	a	DET
cpe-2383	101	13	large	large	ADJ
cpe-2383	101	14	propor‐	propor‐	NOUN
cpe-2383	101	15	tion	tion	NOUN
cpe-2383	101	16	of	of	ADP
cpe-2383	101	17	the	the	DET
cpe-2383	101	18	general	general	ADJ
cpe-2383	101	19	population	population	NOUN
cpe-2383	101	20	due	due	ADP
cpe-2383	101	21	to	to	PART
cpe-2383	101	22	lay	lay	VERB
cpe-2383	101	23	concepts	concept	NOUN
cpe-2383	101	24	about	about	ADP
cpe-2383	101	25	their	their	PRON
cpe-2383	101	26	origins	origin	NOUN
cpe-2383	101	27	(	(	PUNCT
cpe-2383	101	28	e.g.	e.g.	ADV
cpe-2383	101	29	,	,	PUNCT
cpe-2383	101	30	depressive	depressive	ADJ
cpe-2383	101	31	dis‐	dis‐	ADJ
cpe-2383	101	32	orders	order	NOUN
cpe-2383	101	33	being	be	AUX
cpe-2383	101	34	seen	see	VERB
cpe-2383	101	35	as	as	ADP
cpe-2383	101	36	a	a	DET
cpe-2383	101	37	lack	lack	NOUN
cpe-2383	101	38	of	of	ADP
cpe-2383	101	39	willpower	willpower	NOUN
cpe-2383	101	40	)	)	PUNCT
cpe-2383	101	41	.	.	PUNCT
cpe-2383	102	1	second	second	ADJ
cpe-2383	102	2	,	,	PUNCT
cpe-2383	102	3	endocrine	endocrine	ADJ
cpe-2383	102	4	markers	marker	NOUN
cpe-2383	102	5	may	may	AUX
cpe-2383	102	6	be	be	AUX
cpe-2383	102	7	used	use	VERB
cpe-2383	102	8	to	to	PART
cpe-2383	102	9	aid	aid	VERB
cpe-2383	102	10	the	the	DET
cpe-2383	102	11	(	(	PUNCT
cpe-2383	102	12	differential	differential	ADJ
cpe-2383	102	13	)	)	PUNCT
cpe-2383	102	14	diagnostics	diagnostic	NOUN
cpe-2383	102	15	of	of	ADP
cpe-2383	102	16	mental	mental	ADJ
cpe-2383	102	17	disorders	disorder	NOUN
cpe-2383	102	18	.	.	PUNCT
cpe-2383	103	1	this	this	PRON
cpe-2383	103	2	is	be	AUX
cpe-2383	103	3	important	important	ADJ
cpe-2383	103	4	in	in	ADP
cpe-2383	103	5	light	light	NOUN
cpe-2383	103	6	of	of	ADP
cpe-2383	103	7	the	the	DET
cpe-2383	103	8	fact	fact	NOUN
cpe-2383	103	9	that	that	SCONJ
cpe-2383	103	10	not	not	PART
cpe-2383	103	11	all	all	DET
cpe-2383	103	12	aspects	aspect	NOUN
cpe-2383	103	13	of	of	ADP
cpe-2383	103	14	mental	mental	ADJ
cpe-2383	103	15	health	health	NOUN
cpe-2383	103	16	are	be	AUX
cpe-2383	103	17	accessible	accessible	ADJ
cpe-2383	103	18	by	by	ADP
cpe-2383	103	19	means	mean	NOUN
cpe-2383	103	20	of	of	ADP
cpe-2383	103	21	introspection	introspection	NOUN
cpe-2383	103	22	,	,	PUNCT
cpe-2383	103	23	let	let	VERB
cpe-2383	103	24	alone	alone	ADV
cpe-2383	103	25	by	by	ADP
cpe-2383	103	26	in‐	in‐	ADJ
cpe-2383	103	27	fischer	fischer	PROPN
cpe-2383	103	28	&	&	CCONJ
cpe-2383	103	29	ehlert	ehlert	VERB
cpe-2383	103	30	7	7	NUM
cpe-2383	103	31	clinical	clinical	ADJ
cpe-2383	103	32	psychology	psychology	NOUN
cpe-2383	103	33	in	in	ADP
cpe-2383	103	34	europe	europe	PROPN
cpe-2383	103	35	2019	2019	NUM
cpe-2383	103	36	,	,	PUNCT
cpe-2383	103	37	vol.1(2	vol.1(2	PROPN
cpe-2383	103	38	)	)	PUNCT
cpe-2383	103	39	,	,	PUNCT
cpe-2383	103	40	article	article	NOUN
cpe-2383	103	41	33030	33030	NUM
cpe-2383	103	42	https://doi.org/10.32872/cpe.v1i2.33030	https://doi.org/10.32872/cpe.v1i2.33030	PROPN
cpe-2383	103	43	https://www.psychopen.eu/	https://www.psychopen.eu/	VERB
cpe-2383	103	44	dividuals	dividual	NOUN
cpe-2383	103	45	who	who	PRON
cpe-2383	103	46	suffer	suffer	VERB
cpe-2383	103	47	from	from	ADP
cpe-2383	103	48	deficits	deficit	NOUN
cpe-2383	103	49	in	in	ADP
cpe-2383	103	50	detecting	detect	VERB
cpe-2383	103	51	and	and	CCONJ
cpe-2383	103	52	reporting	report	VERB
cpe-2383	103	53	signs	sign	NOUN
cpe-2383	103	54	of	of	ADP
cpe-2383	103	55	psychological	psychological	ADJ
cpe-2383	103	56	dis‐	dis‐	ADJ
cpe-2383	103	57	tress	tress	NOUN
cpe-2383	103	58	(	(	PUNCT
cpe-2383	103	59	e.g.	e.g.	ADV
cpe-2383	103	60	,	,	PUNCT
cpe-2383	103	61	those	those	PRON
cpe-2383	103	62	scoring	score	VERB
cpe-2383	103	63	high	high	ADJ
cpe-2383	103	64	on	on	ADP
cpe-2383	103	65	alexithymia	alexithymia	NOUN
cpe-2383	103	66	)	)	PUNCT
cpe-2383	103	67	.	.	PUNCT
cpe-2383	104	1	similarly	similarly	ADV
cpe-2383	104	2	,	,	PUNCT
cpe-2383	104	3	hormones	hormone	NOUN
cpe-2383	104	4	may	may	AUX
cpe-2383	104	5	be	be	AUX
cpe-2383	104	6	used	use	VERB
cpe-2383	104	7	to	to	PART
cpe-2383	104	8	assess	assess	VERB
cpe-2383	104	9	treatment	treatment	NOUN
cpe-2383	104	10	outcomes	outcome	NOUN
cpe-2383	104	11	above	above	ADP
cpe-2383	104	12	and	and	CCONJ
cpe-2383	104	13	beyond	beyond	ADP
cpe-2383	104	14	self	self	NOUN
cpe-2383	104	15	-	-	PUNCT
cpe-2383	104	16	report	report	NOUN
cpe-2383	104	17	symptom	symptom	NOUN
cpe-2383	104	18	measures	measure	NOUN
cpe-2383	104	19	or	or	CCONJ
cpe-2383	104	20	clinical	clinical	ADJ
cpe-2383	104	21	rating	rating	NOUN
cpe-2383	104	22	scales	scale	NOUN
cpe-2383	104	23	.	.	PUNCT
cpe-2383	105	1	these	these	DET
cpe-2383	105	2	ideas	idea	NOUN
cpe-2383	105	3	align	align	VERB
cpe-2383	105	4	well	well	ADV
cpe-2383	105	5	with	with	ADP
cpe-2383	105	6	the	the	DET
cpe-2383	105	7	us	us	PROPN
cpe-2383	105	8	national	national	PROPN
cpe-2383	105	9	institute	institute	PROPN
cpe-2383	105	10	of	of	ADP
cpe-2383	105	11	mental	mental	PROPN
cpe-2383	105	12	health	health	PROPN
cpe-2383	105	13	(	(	PUNCT
cpe-2383	105	14	nimh	nimh	PROPN
cpe-2383	105	15	)	)	PUNCT
cpe-2383	105	16	re‐	re‐	PRON
cpe-2383	105	17	search	search	NOUN
cpe-2383	105	18	domain	domain	NOUN
cpe-2383	105	19	criteria	criterion	NOUN
cpe-2383	105	20	(	(	PUNCT
cpe-2383	105	21	rdoc	rdoc	PROPN
cpe-2383	105	22	)	)	PUNCT
cpe-2383	105	23	,	,	PUNCT
cpe-2383	105	24	which	which	PRON
cpe-2383	105	25	aim	aim	VERB
cpe-2383	105	26	to	to	PART
cpe-2383	105	27	provide	provide	VERB
cpe-2383	105	28	more	more	ADV
cpe-2383	105	29	precise	precise	ADJ
cpe-2383	105	30	characterisations	characterisation	NOUN
cpe-2383	105	31	of	of	ADP
cpe-2383	105	32	a	a	DET
cpe-2383	105	33	patient	patient	NOUN
cpe-2383	105	34	by	by	ADP
cpe-2383	105	35	integrating	integrate	VERB
cpe-2383	105	36	biological	biological	ADJ
cpe-2383	105	37	and	and	CCONJ
cpe-2383	105	38	psychological	psychological	ADJ
cpe-2383	105	39	research	research	NOUN
cpe-2383	105	40	(	(	PUNCT
cpe-2383	105	41	e.g.	e.g.	ADV
cpe-2383	105	42	,	,	PUNCT
cpe-2383	105	43	insel	insel	PROPN
cpe-2383	105	44	et	et	PROPN
cpe-2383	105	45	al	al	PROPN
cpe-2383	105	46	.	.	PROPN
cpe-2383	105	47	,	,	PUNCT
cpe-2383	105	48	2010	2010	NUM
cpe-2383	105	49	)	)	PUNCT
cpe-2383	105	50	.	.	PUNCT
cpe-2383	106	1	to	to	ADP
cpe-2383	106	2	this	this	DET
cpe-2383	106	3	end	end	NOUN
cpe-2383	106	4	,	,	PUNCT
cpe-2383	106	5	a	a	DET
cpe-2383	106	6	matrix	matrix	NOUN
cpe-2383	106	7	combining	combine	VERB
cpe-2383	106	8	five	five	NUM
cpe-2383	106	9	psychological	psychological	ADJ
cpe-2383	106	10	domains	domain	NOUN
cpe-2383	106	11	(	(	PUNCT
cpe-2383	106	12	social	social	ADJ
cpe-2383	106	13	processes	process	NOUN
cpe-2383	106	14	,	,	PUNCT
cpe-2383	106	15	arousal	arousal	NOUN
cpe-2383	106	16	/	/	SYM
cpe-2383	106	17	regu‐	regu‐	VERB
cpe-2383	106	18	lation	lation	NOUN
cpe-2383	106	19	,	,	PUNCT
cpe-2383	106	20	negative	negative	ADJ
cpe-2383	106	21	valence	valence	NOUN
cpe-2383	106	22	,	,	PUNCT
cpe-2383	106	23	positive	positive	ADJ
cpe-2383	106	24	valence	valence	NOUN
cpe-2383	106	25	,	,	PUNCT
cpe-2383	106	26	and	and	CCONJ
cpe-2383	106	27	cognition	cognition	NOUN
cpe-2383	106	28	)	)	PUNCT
cpe-2383	106	29	with	with	ADP
cpe-2383	106	30	different	different	ADJ
cpe-2383	106	31	units	unit	NOUN
cpe-2383	106	32	of	of	ADP
cpe-2383	106	33	analysis	analysis	NOUN
cpe-2383	106	34	(	(	PUNCT
cpe-2383	106	35	genes	gene	NOUN
cpe-2383	106	36	,	,	PUNCT
cpe-2383	106	37	molecules	molecule	NOUN
cpe-2383	106	38	,	,	PUNCT
cpe-2383	106	39	cells	cell	NOUN
cpe-2383	106	40	,	,	PUNCT
cpe-2383	106	41	neural	neural	ADJ
cpe-2383	106	42	circuits	circuit	NOUN
cpe-2383	106	43	,	,	PUNCT
cpe-2383	106	44	physiology	physiology	NOUN
cpe-2383	106	45	,	,	PUNCT
cpe-2383	106	46	behaviour	behaviour	NOUN
cpe-2383	106	47	,	,	PUNCT
cpe-2383	106	48	self	self	NOUN
cpe-2383	106	49	-	-	PUNCT
cpe-2383	106	50	reported	report	VERB
cpe-2383	106	51	information	information	NOUN
cpe-2383	106	52	,	,	PUNCT
cpe-2383	106	53	and	and	CCONJ
cpe-2383	106	54	paradigms	paradigm	VERB
cpe-2383	106	55	)	)	PUNCT
cpe-2383	106	56	has	have	AUX
cpe-2383	106	57	been	be	AUX
cpe-2383	106	58	proposed	propose	VERB
cpe-2383	106	59	.	.	PUNCT
cpe-2383	107	1	this	this	PRON
cpe-2383	107	2	allows	allow	VERB
cpe-2383	107	3	for	for	SCONJ
cpe-2383	107	4	a	a	DET
cpe-2383	107	5	particular	particular	ADJ
cpe-2383	107	6	state	state	NOUN
cpe-2383	107	7	of	of	ADP
cpe-2383	107	8	mental	mental	ADJ
cpe-2383	107	9	illness	illness	NOUN
cpe-2383	107	10	to	to	PART
cpe-2383	107	11	be	be	AUX
cpe-2383	107	12	described	describe	VERB
cpe-2383	107	13	by	by	ADP
cpe-2383	107	14	deficits	deficit	NOUN
cpe-2383	107	15	in	in	ADP
cpe-2383	107	16	different	different	ADJ
cpe-2383	107	17	psychological	psychological	ADJ
cpe-2383	107	18	domains	domain	NOUN
cpe-2383	107	19	,	,	PUNCT
cpe-2383	107	20	which	which	PRON
cpe-2383	107	21	map	map	VERB
cpe-2383	107	22	on	on	ADP
cpe-2383	107	23	to	to	ADP
cpe-2383	107	24	specific	specific	ADJ
cpe-2383	107	25	bio‐	bio‐	NOUN
cpe-2383	107	26	logical	logical	ADJ
cpe-2383	107	27	substrates	substrate	NOUN
cpe-2383	107	28	(	(	PUNCT
cpe-2383	107	29	e.g.	e.g.	ADV
cpe-2383	107	30	,	,	PUNCT
cpe-2383	107	31	neuroendocrine	neuroendocrine	ADJ
cpe-2383	107	32	abnormalities	abnormality	NOUN
cpe-2383	107	33	)	)	PUNCT
cpe-2383	107	34	.	.	PUNCT
cpe-2383	108	1	third	third	ADJ
cpe-2383	108	2	,	,	PUNCT
cpe-2383	108	3	the	the	DET
cpe-2383	108	4	results	result	NOUN
cpe-2383	108	5	of	of	ADP
cpe-2383	108	6	neuroendo‐	neuroendo‐	VERB
cpe-2383	108	7	crine	crine	NOUN
cpe-2383	108	8	testing	testing	NOUN
cpe-2383	108	9	may	may	AUX
cpe-2383	108	10	guide	guide	VERB
cpe-2383	108	11	treatment	treatment	NOUN
cpe-2383	108	12	choices	choice	NOUN
cpe-2383	108	13	,	,	PUNCT
cpe-2383	108	14	that	that	ADV
cpe-2383	108	15	is	is	ADV
cpe-2383	108	16	,	,	PUNCT
cpe-2383	108	17	they	they	PRON
cpe-2383	108	18	may	may	AUX
cpe-2383	108	19	support	support	VERB
cpe-2383	108	20	clinicians	clinician	NOUN
cpe-2383	108	21	in	in	ADP
cpe-2383	108	22	finding	find	VERB
cpe-2383	108	23	out	out	ADP
cpe-2383	108	24	what	what	PRON
cpe-2383	108	25	is	be	AUX
cpe-2383	108	26	likely	likely	ADJ
cpe-2383	108	27	to	to	PART
cpe-2383	108	28	work	work	VERB
cpe-2383	108	29	for	for	ADP
cpe-2383	108	30	whom	whom	PRON
cpe-2383	108	31	and	and	CCONJ
cpe-2383	108	32	why	why	SCONJ
cpe-2383	108	33	.	.	PUNCT
cpe-2383	109	1	this	this	PRON
cpe-2383	109	2	resonates	resonate	VERB
cpe-2383	109	3	well	well	ADV
cpe-2383	109	4	with	with	ADP
cpe-2383	109	5	the	the	DET
cpe-2383	109	6	central	central	ADJ
cpe-2383	109	7	tenet	tenet	NOUN
cpe-2383	109	8	of	of	ADP
cpe-2383	109	9	precision	precision	NOUN
cpe-2383	109	10	psychiatry	psychiatry	NOUN
cpe-2383	109	11	,	,	PUNCT
cpe-2383	109	12	which	which	PRON
cpe-2383	109	13	advocates	advocate	VERB
cpe-2383	109	14	the	the	DET
cpe-2383	109	15	tailoring	tailoring	NOUN
cpe-2383	109	16	of	of	ADP
cpe-2383	109	17	treatments	treatment	NOUN
cpe-2383	109	18	to	to	ADP
cpe-2383	109	19	the	the	DET
cpe-2383	109	20	needs	need	NOUN
cpe-2383	109	21	of	of	ADP
cpe-2383	109	22	the	the	DET
cpe-2383	109	23	individual	individual	ADJ
cpe-2383	109	24	patient	patient	NOUN
cpe-2383	109	25	by	by	ADP
cpe-2383	109	26	integrating	integrate	VERB
cpe-2383	109	27	data	datum	NOUN
cpe-2383	109	28	from	from	ADP
cpe-2383	109	29	multiple	multiple	ADJ
cpe-2383	109	30	levels	level	NOUN
cpe-2383	109	31	of	of	ADP
cpe-2383	109	32	information	information	NOUN
cpe-2383	109	33	(	(	PUNCT
cpe-2383	109	34	e.g.	e.g.	ADV
cpe-2383	109	35	,	,	PUNCT
cpe-2383	109	36	biological	biological	ADJ
cpe-2383	109	37	,	,	PUNCT
cpe-2383	109	38	personality	personality	NOUN
cpe-2383	109	39	,	,	PUNCT
cpe-2383	109	40	and	and	CCONJ
cpe-2383	109	41	behavioural	behavioural	ADJ
cpe-2383	109	42	measures	measure	NOUN
cpe-2383	109	43	)	)	PUNCT
cpe-2383	109	44	.	.	PUNCT
cpe-2383	110	1	on	on	ADP
cpe-2383	110	2	a	a	DET
cpe-2383	110	3	related	relate	VERB
cpe-2383	110	4	note	note	NOUN
cpe-2383	110	5	,	,	PUNCT
cpe-2383	110	6	alternative	alternative	ADJ
cpe-2383	110	7	or	or	CCONJ
cpe-2383	110	8	additional	additional	ADJ
cpe-2383	110	9	treat‐	treat‐	ADJ
cpe-2383	110	10	ments	ment	NOUN
cpe-2383	110	11	for	for	ADP
cpe-2383	110	12	mental	mental	ADJ
cpe-2383	110	13	disorders	disorder	NOUN
cpe-2383	110	14	may	may	AUX
cpe-2383	110	15	be	be	AUX
cpe-2383	110	16	developed	develop	VERB
cpe-2383	110	17	that	that	PRON
cpe-2383	110	18	are	be	AUX
cpe-2383	110	19	based	base	VERB
cpe-2383	110	20	on	on	ADP
cpe-2383	110	21	a	a	DET
cpe-2383	110	22	more	more	ADJ
cpe-2383	110	23	in	in	ADP
cpe-2383	110	24	-	-	PUNCT
cpe-2383	110	25	depth	depth	NOUN
cpe-2383	110	26	account	account	NOUN
cpe-2383	110	27	of	of	ADP
cpe-2383	110	28	patients	patient	NOUN
cpe-2383	110	29	’	'	PUNCT
cpe-2383	110	30	pathophysiology	pathophysiology	NOUN
cpe-2383	110	31	(	(	PUNCT
cpe-2383	110	32	e.g.	e.g.	ADJ
cpe-2383	110	33	,	,	PUNCT
cpe-2383	110	34	hormonal	hormonal	ADJ
cpe-2383	110	35	substitution	substitution	NOUN
cpe-2383	110	36	as	as	ADP
cpe-2383	110	37	an	an	DET
cpe-2383	110	38	augmentation	augmentation	NOUN
cpe-2383	110	39	to	to	PART
cpe-2383	110	40	psycho‐	psycho‐	VERB
cpe-2383	110	41	logical	logical	ADJ
cpe-2383	110	42	therapy	therapy	NOUN
cpe-2383	110	43	)	)	PUNCT
cpe-2383	110	44	.	.	PUNCT
cpe-2383	111	1	in	in	ADP
cpe-2383	111	2	the	the	DET
cpe-2383	111	3	foreseeable	foreseeable	ADJ
cpe-2383	111	4	future	future	NOUN
cpe-2383	111	5	,	,	PUNCT
cpe-2383	111	6	clinical	clinical	ADJ
cpe-2383	111	7	psychology	psychology	NOUN
cpe-2383	111	8	is	be	AUX
cpe-2383	111	9	likely	likely	ADJ
cpe-2383	111	10	to	to	PART
cpe-2383	111	11	benefit	benefit	VERB
cpe-2383	111	12	from	from	ADP
cpe-2383	111	13	a	a	DET
cpe-2383	111	14	number	number	NOUN
cpe-2383	111	15	of	of	ADP
cpe-2383	111	16	emerging	emerge	VERB
cpe-2383	111	17	trends	trend	NOUN
cpe-2383	111	18	in	in	ADP
cpe-2383	111	19	psychoneuroendocrinological	psychoneuroendocrinological	ADJ
cpe-2383	111	20	research	research	NOUN
cpe-2383	111	21	.	.	PUNCT
cpe-2383	112	1	elucidating	elucidate	VERB
cpe-2383	112	2	the	the	DET
cpe-2383	112	3	genetic	genetic	ADJ
cpe-2383	112	4	and	and	CCONJ
cpe-2383	112	5	epigenetic	epigenetic	ADJ
cpe-2383	112	6	underpinnings	underpinning	NOUN
cpe-2383	112	7	of	of	ADP
cpe-2383	112	8	endocrine	endocrine	NOUN
cpe-2383	112	9	functioning	functioning	NOUN
cpe-2383	112	10	will	will	AUX
cpe-2383	112	11	be	be	AUX
cpe-2383	112	12	crucial	crucial	ADJ
cpe-2383	112	13	to	to	PART
cpe-2383	112	14	fully	fully	ADV
cpe-2383	112	15	comprehend	comprehend	VERB
cpe-2383	112	16	its	its	PRON
cpe-2383	112	17	role	role	NOUN
cpe-2383	112	18	in	in	ADP
cpe-2383	112	19	mental	mental	ADJ
cpe-2383	112	20	disorders	disorder	NOUN
cpe-2383	112	21	.	.	PUNCT
cpe-2383	113	1	as	as	SCONJ
cpe-2383	113	2	both	both	DET
cpe-2383	113	3	the	the	DET
cpe-2383	113	4	distribution	distribution	NOUN
cpe-2383	113	5	and	and	CCONJ
cpe-2383	113	6	sensitivity	sensitivity	NOUN
cpe-2383	113	7	of	of	ADP
cpe-2383	113	8	endocrine	endocrine	NOUN
cpe-2383	113	9	receptors	receptor	NOUN
cpe-2383	113	10	are	be	AUX
cpe-2383	113	11	governed	govern	VERB
cpe-2383	113	12	by	by	ADP
cpe-2383	113	13	genetic	genetic	ADJ
cpe-2383	113	14	variation	variation	NOUN
cpe-2383	113	15	as	as	ADV
cpe-2383	113	16	well	well	ADV
cpe-2383	113	17	as	as	ADP
cpe-2383	113	18	by	by	ADP
cpe-2383	113	19	the	the	DET
cpe-2383	113	20	individual	individual	NOUN
cpe-2383	113	21	’s	’s	PART
cpe-2383	113	22	epigenetic	epigenetic	ADJ
cpe-2383	113	23	make	make	NOUN
cpe-2383	113	24	-	-	PUNCT
cpe-2383	113	25	up	up	NOUN
cpe-2383	113	26	(	(	PUNCT
cpe-2383	113	27	e.g.	e.g.	ADV
cpe-2383	113	28	,	,	PUNCT
cpe-2383	113	29	dna	dna	NOUN
cpe-2383	113	30	methylation	methylation	NOUN
cpe-2383	113	31	)	)	PUNCT
cpe-2383	113	32	,	,	PUNCT
cpe-2383	113	33	this	this	PRON
cpe-2383	113	34	could	could	AUX
cpe-2383	113	35	ultimately	ultimately	ADV
cpe-2383	113	36	enable	enable	VERB
cpe-2383	113	37	the	the	DET
cpe-2383	113	38	identification	identification	NOUN
cpe-2383	113	39	of	of	ADP
cpe-2383	113	40	patients	patient	NOUN
cpe-2383	113	41	who	who	PRON
cpe-2383	113	42	run	run	VERB
cpe-2383	113	43	the	the	DET
cpe-2383	113	44	risk	risk	NOUN
cpe-2383	113	45	of	of	ADP
cpe-2383	113	46	developing	develop	VERB
cpe-2383	113	47	mental	mental	ADJ
cpe-2383	113	48	illnesses	illness	NOUN
cpe-2383	113	49	.	.	PUNCT
cpe-2383	114	1	similarly	similarly	ADV
cpe-2383	114	2	,	,	PUNCT
cpe-2383	114	3	learning	learn	VERB
cpe-2383	114	4	more	more	ADJ
cpe-2383	114	5	about	about	ADP
cpe-2383	114	6	the	the	DET
cpe-2383	114	7	cross	cross	NOUN
cpe-2383	114	8	-	-	NOUN
cpe-2383	114	9	talk	talk	NOUN
cpe-2383	114	10	between	between	ADP
cpe-2383	114	11	different	different	ADJ
cpe-2383	114	12	endocrine	endocrine	NOUN
cpe-2383	114	13	systems	system	NOUN
cpe-2383	114	14	and	and	CCONJ
cpe-2383	114	15	between	between	ADP
cpe-2383	114	16	endocrine	endocrine	NOUN
cpe-2383	114	17	and	and	CCONJ
cpe-2383	114	18	other	other	ADJ
cpe-2383	114	19	bodily	bodily	ADJ
cpe-2383	114	20	systems	system	NOUN
cpe-2383	114	21	(	(	PUNCT
cpe-2383	114	22	e.g.	e.g.	ADV
cpe-2383	114	23	,	,	PUNCT
cpe-2383	114	24	cen‐	cen‐	NOUN
cpe-2383	114	25	tral	tral	ADJ
cpe-2383	114	26	monoaminergic	monoaminergic	ADJ
cpe-2383	114	27	systems	system	NOUN
cpe-2383	114	28	)	)	PUNCT
cpe-2383	114	29	should	should	AUX
cpe-2383	114	30	allow	allow	VERB
cpe-2383	114	31	for	for	ADP
cpe-2383	114	32	a	a	DET
cpe-2383	114	33	more	more	ADV
cpe-2383	114	34	accurate	accurate	ADJ
cpe-2383	114	35	description	description	NOUN
cpe-2383	114	36	of	of	ADP
cpe-2383	114	37	how	how	SCONJ
cpe-2383	114	38	,	,	PUNCT
cpe-2383	114	39	pre‐	pre‐	NOUN
cpe-2383	114	40	cisely	cisely	ADV
cpe-2383	114	41	,	,	PUNCT
cpe-2383	114	42	endocrine	endocrine	ADJ
cpe-2383	114	43	disturbances	disturbance	NOUN
cpe-2383	114	44	contribute	contribute	VERB
cpe-2383	114	45	to	to	ADP
cpe-2383	114	46	the	the	DET
cpe-2383	114	47	onset	onset	NOUN
cpe-2383	114	48	of	of	ADP
cpe-2383	114	49	mental	mental	ADJ
cpe-2383	114	50	disorders	disorder	NOUN
cpe-2383	114	51	–	–	PUNCT
cpe-2383	114	52	and	and	CCONJ
cpe-2383	114	53	provide	provide	VERB
cpe-2383	114	54	more	more	ADV
cpe-2383	114	55	precise	precise	ADJ
cpe-2383	114	56	targets	target	NOUN
cpe-2383	114	57	for	for	ADP
cpe-2383	114	58	additional	additional	ADJ
cpe-2383	114	59	or	or	CCONJ
cpe-2383	114	60	alternative	alternative	ADJ
cpe-2383	114	61	treatment	treatment	NOUN
cpe-2383	114	62	options	option	NOUN
cpe-2383	114	63	.	.	PUNCT
cpe-2383	115	1	finally	finally	ADV
cpe-2383	115	2	,	,	PUNCT
cpe-2383	115	3	the	the	DET
cpe-2383	115	4	advent	advent	NOUN
cpe-2383	115	5	of	of	ADP
cpe-2383	115	6	novel	novel	ADJ
cpe-2383	115	7	methodologies	methodology	NOUN
cpe-2383	115	8	to	to	PART
cpe-2383	115	9	assess	assess	VERB
cpe-2383	115	10	hormones	hormone	NOUN
cpe-2383	115	11	in	in	ADP
cpe-2383	115	12	a	a	DET
cpe-2383	115	13	reliable	reliable	ADJ
cpe-2383	115	14	,	,	PUNCT
cpe-2383	115	15	non	non	ADJ
cpe-2383	115	16	-	-	ADJ
cpe-2383	115	17	invasive	invasive	ADJ
cpe-2383	115	18	manner	manner	NOUN
cpe-2383	115	19	(	(	PUNCT
cpe-2383	115	20	e.g.	e.g.	ADV
cpe-2383	115	21	,	,	PUNCT
cpe-2383	115	22	finger‐	finger‐	NOUN
cpe-2383	115	23	nail	nail	NOUN
cpe-2383	115	24	cortisol	cortisol	NOUN
cpe-2383	115	25	)	)	PUNCT
cpe-2383	115	26	holds	hold	VERB
cpe-2383	115	27	the	the	DET
cpe-2383	115	28	promise	promise	NOUN
cpe-2383	115	29	to	to	PART
cpe-2383	115	30	translate	translate	VERB
cpe-2383	115	31	neuroendocrine	neuroendocrine	ADJ
cpe-2383	115	32	knowledge	knowledge	NOUN
cpe-2383	115	33	into	into	ADP
cpe-2383	115	34	clinical	clinical	ADJ
cpe-2383	115	35	prac‐	prac‐	PROPN
cpe-2383	115	36	tice	tice	NOUN
cpe-2383	115	37	–	–	PUNCT
cpe-2383	115	38	and	and	CCONJ
cpe-2383	115	39	hopefully	hopefully	ADV
cpe-2383	115	40	to	to	ADP
cpe-2383	115	41	the	the	DET
cpe-2383	115	42	benefit	benefit	NOUN
cpe-2383	115	43	of	of	ADP
cpe-2383	115	44	patients	patient	NOUN
cpe-2383	115	45	and	and	CCONJ
cpe-2383	115	46	clinical	clinical	ADJ
cpe-2383	115	47	psychologists	psychologist	NOUN
cpe-2383	115	48	alike	alike	ADV
cpe-2383	115	49	.	.	PUNCT
cpe-2383	116	1	funding	funding	NOUN
cpe-2383	116	2	:	:	PUNCT
cpe-2383	116	3	the	the	DET
cpe-2383	116	4	authors	author	NOUN
cpe-2383	116	5	received	receive	VERB
cpe-2383	116	6	no	no	DET
cpe-2383	116	7	financial	financial	ADJ
cpe-2383	116	8	support	support	NOUN
cpe-2383	116	9	for	for	ADP
cpe-2383	116	10	the	the	DET
cpe-2383	116	11	research	research	NOUN
cpe-2383	116	12	,	,	PUNCT
cpe-2383	116	13	authorship	authorship	NOUN
cpe-2383	116	14	,	,	PUNCT
cpe-2383	116	15	and/or	and/or	CCONJ
cpe-2383	116	16	publication	publication	NOUN
cpe-2383	116	17	of	of	ADP
cpe-2383	116	18	this	this	DET
cpe-2383	116	19	article	article	NOUN
cpe-2383	116	20	.	.	PUNCT
cpe-2383	117	1	competing	compete	VERB
cpe-2383	117	2	interests	interest	NOUN
cpe-2383	117	3	:	:	PUNCT
cpe-2383	117	4	the	the	DET
cpe-2383	117	5	authors	author	NOUN
cpe-2383	117	6	declare	declare	VERB
cpe-2383	117	7	no	no	DET
cpe-2383	117	8	conflicts	conflict	NOUN
cpe-2383	117	9	of	of	ADP
cpe-2383	117	10	interest	interest	NOUN
cpe-2383	117	11	.	.	PUNCT
cpe-2383	118	1	acknowledgments	acknowledgment	NOUN
cpe-2383	118	2	:	:	PUNCT
cpe-2383	118	3	the	the	DET
cpe-2383	118	4	authors	author	NOUN
cpe-2383	118	5	have	have	VERB
cpe-2383	118	6	no	no	DET
cpe-2383	118	7	support	support	NOUN
cpe-2383	118	8	to	to	PART
cpe-2383	118	9	report	report	VERB
cpe-2383	118	10	.	.	PUNCT
cpe-2383	119	1	psychoneuroendocrinology	psychoneuroendocrinology	NOUN
cpe-2383	119	2	and	and	CCONJ
cpe-2383	119	3	clinical	clinical	ADJ
cpe-2383	119	4	psychology	psychology	NOUN
cpe-2383	119	5	8	8	NUM
cpe-2383	119	6	clinical	clinical	ADJ
cpe-2383	119	7	psychology	psychology	NOUN
cpe-2383	119	8	in	in	ADP
cpe-2383	119	9	europe	europe	PROPN
cpe-2383	119	10	2019	2019	NUM
cpe-2383	119	11	,	,	PUNCT
cpe-2383	119	12	vol.1(2	vol.1(2	PROPN
cpe-2383	119	13	)	)	PUNCT
cpe-2383	119	14	,	,	PUNCT
cpe-2383	119	15	article	article	NOUN
cpe-2383	119	16	33030	33030	NUM
cpe-2383	119	17	https://doi.org/10.32872/cpe.v1i2.33030	https://doi.org/10.32872/cpe.v1i2.33030	PROPN
cpe-2383	119	18	https://www.psychopen.eu/	https://www.psychopen.eu/	VERB
cpe-2383	119	19	references	reference	NOUN
cpe-2383	119	20	bandelow	bandelow	NOUN
cpe-2383	119	21	,	,	PUNCT
cpe-2383	119	22	b.	b.	PROPN
cpe-2383	119	23	,	,	PUNCT
cpe-2383	119	24	baldwin	baldwin	PROPN
cpe-2383	119	25	,	,	PUNCT
cpe-2383	119	26	d.	d.	PROPN
cpe-2383	119	27	,	,	PUNCT
cpe-2383	119	28	abelli	abelli	PROPN
cpe-2383	119	29	,	,	PUNCT
cpe-2383	119	30	m.	m.	NOUN
cpe-2383	119	31	,	,	PUNCT
cpe-2383	119	32	bolea	bolea	NOUN
cpe-2383	119	33	-	-	PUNCT
cpe-2383	119	34	alamanac	alamanac	NOUN
cpe-2383	119	35	,	,	PUNCT
cpe-2383	119	36	b.	b.	PROPN
cpe-2383	119	37	,	,	PUNCT
cpe-2383	119	38	bourin	bourin	NOUN
cpe-2383	119	39	,	,	PUNCT
cpe-2383	119	40	m.	m.	NOUN
cpe-2383	119	41	,	,	PUNCT
cpe-2383	119	42	chamberlain	chamberlain	PROPN
cpe-2383	119	43	,	,	PUNCT
cpe-2383	119	44	s.	s.	PROPN
cpe-2383	119	45	r.	r.	PROPN
cpe-2383	119	46	,	,	PUNCT
cpe-2383	119	47	.	.	PUNCT
cpe-2383	119	48	.	.	PUNCT
cpe-2383	119	49	.	.	PUNCT
cpe-2383	120	1	riederer	riederer	NOUN
cpe-2383	120	2	,	,	PUNCT
cpe-2383	120	3	p.	p.	NOUN
cpe-2383	120	4	(	(	PUNCT
cpe-2383	120	5	2017	2017	NUM
cpe-2383	120	6	)	)	PUNCT
cpe-2383	120	7	.	.	PUNCT
cpe-2383	121	1	biological	biological	ADJ
cpe-2383	121	2	markers	marker	NOUN
cpe-2383	121	3	for	for	ADP
cpe-2383	121	4	anxiety	anxiety	NOUN
cpe-2383	121	5	disorders	disorder	NOUN
cpe-2383	121	6	,	,	PUNCT
cpe-2383	121	7	ocd	ocd	NOUN
cpe-2383	121	8	and	and	CCONJ
cpe-2383	121	9	ptsd	ptsd	PROPN
cpe-2383	121	10	:	:	PUNCT
cpe-2383	121	11	a	a	DET
cpe-2383	121	12	consensus	consensus	NOUN
cpe-2383	121	13	statement	statement	NOUN
cpe-2383	121	14	.	.	PUNCT
cpe-2383	122	1	part	part	NOUN
cpe-2383	122	2	ii	ii	PROPN
cpe-2383	122	3	:	:	PUNCT
cpe-2383	122	4	neurochemistry	neurochemistry	NOUN
cpe-2383	122	5	,	,	PUNCT
cpe-2383	122	6	neurophysiology	neurophysiology	NOUN
cpe-2383	122	7	and	and	CCONJ
cpe-2383	122	8	neurocognition	neurocognition	NOUN
cpe-2383	122	9	.	.	PUNCT
cpe-2383	123	1	the	the	DET
cpe-2383	123	2	world	world	PROPN
cpe-2383	123	3	journal	journal	PROPN
cpe-2383	123	4	of	of	ADP
cpe-2383	123	5	biological	biological	ADJ
cpe-2383	123	6	psychiatry	psychiatry	NOUN
cpe-2383	123	7	,	,	PUNCT
cpe-2383	123	8	18(3	18(3	NUM
cpe-2383	123	9	)	)	PUNCT
cpe-2383	123	10	,	,	PUNCT
cpe-2383	123	11	162	162	NUM
cpe-2383	123	12	-	-	SYM
cpe-2383	123	13	214	214	NUM
cpe-2383	123	14	.	.	PUNCT
cpe-2383	124	1	https://doi.org/10.1080/15622975.2016.1190867	https://doi.org/10.1080/15622975.2016.1190867	PRON
cpe-2383	125	1	bandelow	bandelow	PROPN
cpe-2383	125	2	,	,	PUNCT
cpe-2383	125	3	b.	b.	PROPN
cpe-2383	125	4	,	,	PUNCT
cpe-2383	125	5	wiltink	wiltink	PROPN
cpe-2383	125	6	,	,	PUNCT
cpe-2383	125	7	j.	j.	PROPN
cpe-2383	125	8	,	,	PUNCT
cpe-2383	125	9	alpers	alper	NOUN
cpe-2383	125	10	,	,	PUNCT
cpe-2383	125	11	g.	g.	PROPN
cpe-2383	125	12	w.	w.	PROPN
cpe-2383	125	13	,	,	PUNCT
cpe-2383	125	14	benecke	benecke	PROPN
cpe-2383	125	15	,	,	PUNCT
cpe-2383	125	16	c.	c.	PROPN
cpe-2383	125	17	,	,	PUNCT
cpe-2383	125	18	deckert	deckert	PROPN
cpe-2383	125	19	,	,	PUNCT
cpe-2383	125	20	j.	j.	PROPN
cpe-2383	125	21	,	,	PUNCT
cpe-2383	125	22	eckhardt	eckhardt	PROPN
cpe-2383	125	23	-	-	PUNCT
cpe-2383	125	24	henn	henn	PROPN
cpe-2383	125	25	,	,	PUNCT
cpe-2383	125	26	a.	a.	NOUN
cpe-2383	125	27	,	,	PUNCT
cpe-2383	125	28	.	.	PUNCT
cpe-2383	125	29	.	.	PUNCT
cpe-2383	125	30	.	.	PUNCT
cpe-2383	126	1	beutel	beutel	PROPN
cpe-2383	126	2	,	,	PUNCT
cpe-2383	126	3	m.	m.	PROPN
cpe-2383	126	4	e.	e.	PROPN
cpe-2383	126	5	(	(	PUNCT
cpe-2383	126	6	2014	2014	NUM
cpe-2383	126	7	)	)	PUNCT
cpe-2383	126	8	.	.	PUNCT
cpe-2383	127	1	deutsche	deutsche	PROPN
cpe-2383	127	2	s3	s3	PROPN
cpe-2383	127	3	-	-	PUNCT
cpe-2383	127	4	leitlinie	leitlinie	PROPN
cpe-2383	127	5	behandlung	behandlung	PROPN
cpe-2383	127	6	von	von	PROPN
cpe-2383	127	7	angststörungen	angststörungen	PROPN
cpe-2383	127	8	.	.	PUNCT
cpe-2383	128	1	retrieved	retrieve	VERB
cpe-2383	128	2	from	from	ADP
cpe-2383	128	3	www.awmf.org/leitlinien.html	www.awmf.org/leitlinien.html	PROPN
cpe-2383	128	4	belvederi	belvederi	PROPN
cpe-2383	128	5	murri	murri	PROPN
cpe-2383	128	6	,	,	PUNCT
cpe-2383	128	7	m.	m.	NOUN
cpe-2383	128	8	,	,	PUNCT
cpe-2383	128	9	prestia	prestia	PROPN
cpe-2383	128	10	,	,	PUNCT
cpe-2383	128	11	d.	d.	PROPN
cpe-2383	128	12	,	,	PUNCT
cpe-2383	128	13	mondelli	mondelli	PROPN
cpe-2383	128	14	,	,	PUNCT
cpe-2383	128	15	v.	v.	ADV
cpe-2383	128	16	,	,	PUNCT
cpe-2383	128	17	pariante	pariante	NOUN
cpe-2383	128	18	,	,	PUNCT
cpe-2383	128	19	c.	c.	PROPN
cpe-2383	128	20	,	,	PUNCT
cpe-2383	128	21	patti	patti	PROPN
cpe-2383	128	22	,	,	PUNCT
cpe-2383	128	23	s.	s.	PROPN
cpe-2383	128	24	,	,	PUNCT
cpe-2383	128	25	olivieri	olivieri	PROPN
cpe-2383	128	26	,	,	PUNCT
cpe-2383	128	27	b.	b.	PROPN
cpe-2383	128	28	,	,	PUNCT
cpe-2383	128	29	.	.	PUNCT
cpe-2383	128	30	.	.	PUNCT
cpe-2383	129	1	.	.	PUNCT
cpe-2383	130	1	amore	amore	PROPN
cpe-2383	130	2	,	,	PUNCT
cpe-2383	130	3	m.	m.	NOUN
cpe-2383	130	4	(	(	PUNCT
cpe-2383	130	5	2016	2016	NUM
cpe-2383	130	6	)	)	PUNCT
cpe-2383	130	7	.	.	PUNCT
cpe-2383	131	1	the	the	DET
cpe-2383	131	2	hpa	hpa	NOUN
cpe-2383	131	3	axis	axis	NOUN
cpe-2383	131	4	in	in	ADP
cpe-2383	131	5	bipolar	bipolar	ADJ
cpe-2383	131	6	disorder	disorder	NOUN
cpe-2383	131	7	:	:	PUNCT
cpe-2383	131	8	systematic	systematic	ADJ
cpe-2383	131	9	review	review	NOUN
cpe-2383	131	10	and	and	CCONJ
cpe-2383	131	11	meta	meta	ADJ
cpe-2383	131	12	-	-	PUNCT
cpe-2383	131	13	analysis	analysis	NOUN
cpe-2383	131	14	.	.	PUNCT
cpe-2383	132	1	psychoneuroendocrinology	psychoneuroendocrinology	NOUN
cpe-2383	132	2	,	,	PUNCT
cpe-2383	132	3	63	63	NUM
cpe-2383	132	4	,	,	PUNCT
cpe-2383	132	5	327	327	NUM
cpe-2383	132	6	-	-	SYM
cpe-2383	132	7	342	342	NUM
cpe-2383	132	8	.	.	PUNCT
cpe-2383	133	1	https://doi.org/10.1016/j.psyneuen.2015.10.014	https://doi.org/10.1016/j.psyneuen.2015.10.014	PROPN
cpe-2383	133	2	corona	corona	PROPN
cpe-2383	133	3	,	,	PUNCT
cpe-2383	133	4	g.	g.	PROPN
cpe-2383	133	5	,	,	PUNCT
cpe-2383	133	6	rastrelli	rastrelli	PROPN
cpe-2383	133	7	,	,	PUNCT
cpe-2383	133	8	g.	g.	PROPN
cpe-2383	133	9	,	,	PUNCT
cpe-2383	133	10	morgentaler	morgentaler	NOUN
cpe-2383	133	11	,	,	PUNCT
cpe-2383	133	12	a.	a.	NOUN
cpe-2383	133	13	,	,	PUNCT
cpe-2383	133	14	sforza	sforza	NOUN
cpe-2383	133	15	,	,	PUNCT
cpe-2383	133	16	a.	a.	NOUN
cpe-2383	133	17	,	,	PUNCT
cpe-2383	133	18	mannucci	mannucci	PROPN
cpe-2383	133	19	,	,	PUNCT
cpe-2383	133	20	e.	e.	PROPN
cpe-2383	133	21	,	,	PUNCT
cpe-2383	133	22	&	&	CCONJ
cpe-2383	133	23	maggi	maggi	PROPN
cpe-2383	133	24	,	,	PUNCT
cpe-2383	133	25	m.	m.	NOUN
cpe-2383	133	26	(	(	PUNCT
cpe-2383	133	27	2017	2017	NUM
cpe-2383	133	28	)	)	PUNCT
cpe-2383	133	29	.	.	PUNCT
cpe-2383	134	1	metaanalysis	metaanalysis	NOUN
cpe-2383	134	2	of	of	ADP
cpe-2383	134	3	results	result	NOUN
cpe-2383	134	4	of	of	ADP
cpe-2383	134	5	testosterone	testosterone	NOUN
cpe-2383	134	6	therapy	therapy	NOUN
cpe-2383	134	7	on	on	ADP
cpe-2383	134	8	sexual	sexual	ADJ
cpe-2383	134	9	function	function	NOUN
cpe-2383	134	10	based	base	VERB
cpe-2383	134	11	on	on	ADP
cpe-2383	134	12	international	international	ADJ
cpe-2383	134	13	index	index	NOUN
cpe-2383	134	14	of	of	ADP
cpe-2383	134	15	erectile	erectile	ADJ
cpe-2383	134	16	function	function	NOUN
cpe-2383	134	17	scores	score	NOUN
cpe-2383	134	18	.	.	PUNCT
cpe-2383	135	1	european	european	ADJ
cpe-2383	135	2	urology	urology	NOUN
cpe-2383	135	3	,	,	PUNCT
cpe-2383	135	4	72(6	72(6	NOUN
cpe-2383	135	5	)	)	PUNCT
cpe-2383	135	6	,	,	PUNCT
cpe-2383	135	7	1000	1000	NUM
cpe-2383	135	8	-	-	SYM
cpe-2383	135	9	1011	1011	NUM
cpe-2383	135	10	.	.	PUNCT
cpe-2383	136	1	https://doi.org/10.1016/j.eururo.2017.03.032	https://doi.org/10.1016/j.eururo.2017.03.032	NOUN
cpe-2383	136	2	dgppn	dgppn	NOUN
cpe-2383	136	3	,	,	PUNCT
cpe-2383	136	4	bäk	bäk	NOUN
cpe-2383	136	5	,	,	PUNCT
cpe-2383	136	6	kbv	kbv	PROPN
cpe-2383	136	7	,	,	PUNCT
cpe-2383	136	8	awmf	awmf	ADV
cpe-2383	136	9	,	,	PUNCT
cpe-2383	136	10	akdä	akdä	VERB
cpe-2383	136	11	,	,	PUNCT
cpe-2383	136	12	bptk	bptk	ADV
cpe-2383	136	13	,	,	PUNCT
cpe-2383	136	14	…	…	PUNCT
cpe-2383	136	15	dgrw	dgrw	PROPN
cpe-2383	136	16	(	(	PUNCT
cpe-2383	136	17	2015	2015	NUM
cpe-2383	136	18	)	)	PUNCT
cpe-2383	136	19	.	.	PUNCT
cpe-2383	137	1	unipolare	unipolare	VERB
cpe-2383	137	2	depression	depression	NOUN
cpe-2383	137	3	(	(	PUNCT
cpe-2383	137	4	s3	s3	PROPN
cpe-2383	137	5	-	-	PUNCT
cpe-2383	137	6	leitlinie/	leitlinie/	NUM
cpe-2383	137	7	nationale	nationale	ADJ
cpe-2383	137	8	versorgungsleitlinie	versorgungsleitlinie	PROPN
cpe-2383	137	9	,	,	PUNCT
cpe-2383	137	10	version	version	NOUN
cpe-2383	137	11	5	5	NUM
cpe-2383	137	12	,	,	PUNCT
cpe-2383	137	13	2nd	2nd	ADJ
cpe-2383	137	14	ed	ed	NOUN
cpe-2383	137	15	.	.	PUNCT
cpe-2383	137	16	)	)	PUNCT
cpe-2383	137	17	.	.	PUNCT
cpe-2383	138	1	berlin	berlin	PROPN
cpe-2383	138	2	,	,	PUNCT
cpe-2383	138	3	germany	germany	PROPN
cpe-2383	138	4	:	:	PUNCT
cpe-2383	138	5	äzq	äzq	PROPN
cpe-2383	138	6	.	.	PUNCT
cpe-2383	139	1	ditzen	ditzen	PROPN
cpe-2383	139	2	,	,	PUNCT
cpe-2383	139	3	b.	b.	PROPN
cpe-2383	139	4	,	,	PUNCT
cpe-2383	139	5	schaer	schaer	PROPN
cpe-2383	139	6	,	,	PUNCT
cpe-2383	139	7	m.	m.	NOUN
cpe-2383	139	8	,	,	PUNCT
cpe-2383	139	9	gabriel	gabriel	PROPN
cpe-2383	139	10	,	,	PUNCT
cpe-2383	139	11	b.	b.	PROPN
cpe-2383	139	12	,	,	PUNCT
cpe-2383	139	13	bodenmann	bodenmann	PROPN
cpe-2383	139	14	,	,	PUNCT
cpe-2383	139	15	g.	g.	PROPN
cpe-2383	139	16	,	,	PUNCT
cpe-2383	139	17	ehlert	ehlert	PROPN
cpe-2383	139	18	,	,	PUNCT
cpe-2383	139	19	u.	u.	PROPN
cpe-2383	139	20	,	,	PUNCT
cpe-2383	139	21	&	&	CCONJ
cpe-2383	139	22	heinrichs	heinrichs	PROPN
cpe-2383	139	23	,	,	PUNCT
cpe-2383	139	24	m.	m.	NOUN
cpe-2383	139	25	(	(	PUNCT
cpe-2383	139	26	2009	2009	NUM
cpe-2383	139	27	)	)	PUNCT
cpe-2383	139	28	.	.	PUNCT
cpe-2383	140	1	intranasal	intranasal	ADJ
cpe-2383	140	2	oxytocin	oxytocin	PROPN
cpe-2383	140	3	increases	increase	VERB
cpe-2383	140	4	positive	positive	ADJ
cpe-2383	140	5	communication	communication	NOUN
cpe-2383	140	6	and	and	CCONJ
cpe-2383	140	7	reduces	reduce	VERB
cpe-2383	140	8	cortisol	cortisol	ADJ
cpe-2383	140	9	levels	level	NOUN
cpe-2383	140	10	during	during	ADP
cpe-2383	140	11	couple	couple	NOUN
cpe-2383	140	12	conflict	conflict	NOUN
cpe-2383	140	13	.	.	PUNCT
cpe-2383	141	1	biological	biological	ADJ
cpe-2383	141	2	psychiatry	psychiatry	NOUN
cpe-2383	141	3	,	,	PUNCT
cpe-2383	141	4	65(9	65(9	NUM
cpe-2383	141	5	)	)	PUNCT
cpe-2383	141	6	,	,	PUNCT
cpe-2383	141	7	728	728	NUM
cpe-2383	141	8	-	-	SYM
cpe-2383	141	9	731	731	NUM
cpe-2383	141	10	.	.	PUNCT
cpe-2383	142	1	https://doi.org/10.1016/j.biopsych.2008.10.011	https://doi.org/10.1016/j.biopsych.2008.10.011	NOUN
cpe-2383	142	2	drobnjak	drobnjak	PROPN
cpe-2383	142	3	,	,	PUNCT
cpe-2383	142	4	s.	s.	PROPN
cpe-2383	142	5	,	,	PUNCT
cpe-2383	142	6	&	&	CCONJ
cpe-2383	142	7	ehlert	ehlert	PROPN
cpe-2383	142	8	,	,	PUNCT
cpe-2383	142	9	u.	u.	PROPN
cpe-2383	142	10	(	(	PUNCT
cpe-2383	142	11	2011	2011	NUM
cpe-2383	142	12	)	)	PUNCT
cpe-2383	142	13	.	.	PUNCT
cpe-2383	143	1	hungerund	hungerund	ADJ
cpe-2383	143	2	sättigungsregulation	sättigungsregulation	NOUN
cpe-2383	143	3	.	.	PUNCT
cpe-2383	144	1	in	in	ADP
cpe-2383	144	2	u.	u.	PROPN
cpe-2383	144	3	ehlert	ehlert	PROPN
cpe-2383	144	4	&	&	CCONJ
cpe-2383	144	5	r.	r.	PROPN
cpe-2383	144	6	von	von	PROPN
cpe-2383	144	7	känel	känel	PROPN
cpe-2383	144	8	(	(	PUNCT
cpe-2383	144	9	eds	ed	NOUN
cpe-2383	144	10	.	.	PUNCT
cpe-2383	144	11	)	)	PUNCT
cpe-2383	144	12	,	,	PUNCT
cpe-2383	144	13	psychoendokrinologie	psychoendokrinologie	X
cpe-2383	144	14	und	und	VERB
cpe-2383	144	15	psychoimmunologie	psychoimmunologie	NOUN
cpe-2383	144	16	(	(	PUNCT
cpe-2383	144	17	pp	pp	ADJ
cpe-2383	144	18	.	.	PUNCT
cpe-2383	144	19	151	151	NUM
cpe-2383	144	20	-	-	SYM
cpe-2383	144	21	162	162	NUM
cpe-2383	144	22	)	)	PUNCT
cpe-2383	144	23	.	.	PUNCT
cpe-2383	145	1	heidelberg	heidelberg	PROPN
cpe-2383	145	2	,	,	PUNCT
cpe-2383	145	3	germany	germany	PROPN
cpe-2383	145	4	:	:	PUNCT
cpe-2383	145	5	springer	springer	NOUN
cpe-2383	145	6	.	.	PUNCT
cpe-2383	146	1	ehlert	ehlert	PROPN
cpe-2383	146	2	,	,	PUNCT
cpe-2383	146	3	u.	u.	PROPN
cpe-2383	146	4	(	(	PUNCT
cpe-2383	146	5	2011	2011	NUM
cpe-2383	146	6	)	)	PUNCT
cpe-2383	146	7	.	.	PUNCT
cpe-2383	147	1	das	das	PROPN
cpe-2383	147	2	endokrine	endokrine	ADJ
cpe-2383	147	3	system	system	NOUN
cpe-2383	147	4	.	.	PUNCT
cpe-2383	148	1	in	in	ADP
cpe-2383	148	2	u.	u.	PROPN
cpe-2383	148	3	ehlert	ehlert	PROPN
cpe-2383	148	4	&	&	CCONJ
cpe-2383	148	5	r.	r.	PROPN
cpe-2383	148	6	von	von	PROPN
cpe-2383	148	7	känel	känel	PROPN
cpe-2383	148	8	(	(	PUNCT
cpe-2383	148	9	eds	ed	NOUN
cpe-2383	148	10	.	.	PUNCT
cpe-2383	148	11	)	)	PUNCT
cpe-2383	148	12	,	,	PUNCT
cpe-2383	148	13	psychoendokrinologie	psychoendokrinologie	X
cpe-2383	148	14	und	und	VERB
cpe-2383	148	15	psychoimmunologie	psychoimmunologie	NOUN
cpe-2383	148	16	(	(	PUNCT
cpe-2383	148	17	pp	pp	ADJ
cpe-2383	148	18	.	.	PUNCT
cpe-2383	149	1	3	3	NUM
cpe-2383	149	2	-	-	SYM
cpe-2383	149	3	36	36	NUM
cpe-2383	149	4	)	)	PUNCT
cpe-2383	149	5	.	.	PUNCT
cpe-2383	150	1	heidelberg	heidelberg	PROPN
cpe-2383	150	2	,	,	PUNCT
cpe-2383	150	3	germany	germany	PROPN
cpe-2383	150	4	:	:	PUNCT
cpe-2383	150	5	springer	springer	NOUN
cpe-2383	150	6	.	.	PUNCT
cpe-2383	151	1	ehlert	ehlert	PROPN
cpe-2383	151	2	,	,	PUNCT
cpe-2383	151	3	u.	u.	PROPN
cpe-2383	151	4	(	(	PUNCT
cpe-2383	151	5	2013	2013	NUM
cpe-2383	151	6	)	)	PUNCT
cpe-2383	151	7	.	.	PUNCT
cpe-2383	152	1	enduring	endure	VERB
cpe-2383	152	2	psychobiological	psychobiological	ADJ
cpe-2383	152	3	effects	effect	NOUN
cpe-2383	152	4	of	of	ADP
cpe-2383	152	5	childhood	childhood	NOUN
cpe-2383	152	6	adversity	adversity	NOUN
cpe-2383	152	7	.	.	PUNCT
cpe-2383	153	1	psychoneuroendocrinology	psychoneuroendocrinology	NOUN
cpe-2383	153	2	,	,	PUNCT
cpe-2383	153	3	38(9	38(9	NOUN
cpe-2383	153	4	)	)	PUNCT
cpe-2383	153	5	,	,	PUNCT
cpe-2383	153	6	1850	1850	NUM
cpe-2383	153	7	-	-	SYM
cpe-2383	153	8	1857	1857	NUM
cpe-2383	153	9	.	.	PUNCT
cpe-2383	154	1	https://doi.org/10.1016/j.psyneuen.2013.06.007	https://doi.org/10.1016/j.psyneuen.2013.06.007	PRON
cpe-2383	154	2	ehlert	ehlert	NOUN
cpe-2383	154	3	,	,	PUNCT
cpe-2383	154	4	u.	u.	PROPN
cpe-2383	154	5	,	,	PUNCT
cpe-2383	154	6	gaab	gaab	PROPN
cpe-2383	154	7	,	,	PUNCT
cpe-2383	154	8	j.	j.	PROPN
cpe-2383	154	9	,	,	PUNCT
cpe-2383	154	10	&	&	CCONJ
cpe-2383	154	11	heinrichs	heinrichs	PROPN
cpe-2383	154	12	,	,	PUNCT
cpe-2383	154	13	m.	m.	NOUN
cpe-2383	154	14	(	(	PUNCT
cpe-2383	154	15	2001	2001	NUM
cpe-2383	154	16	)	)	PUNCT
cpe-2383	154	17	.	.	PUNCT
cpe-2383	155	1	psychoneuroendocrinological	psychoneuroendocrinological	ADJ
cpe-2383	155	2	contributions	contribution	NOUN
cpe-2383	155	3	to	to	ADP
cpe-2383	155	4	the	the	DET
cpe-2383	155	5	etiology	etiology	NOUN
cpe-2383	155	6	of	of	ADP
cpe-2383	155	7	depression	depression	NOUN
cpe-2383	155	8	,	,	PUNCT
cpe-2383	155	9	posttraumatic	posttraumatic	ADJ
cpe-2383	155	10	stress	stress	NOUN
cpe-2383	155	11	disorder	disorder	NOUN
cpe-2383	155	12	,	,	PUNCT
cpe-2383	155	13	and	and	CCONJ
cpe-2383	155	14	stress	stress	NOUN
cpe-2383	155	15	-	-	PUNCT
cpe-2383	155	16	related	relate	VERB
cpe-2383	155	17	bodily	bodily	ADJ
cpe-2383	155	18	disorders	disorder	NOUN
cpe-2383	155	19	:	:	PUNCT
cpe-2383	155	20	the	the	DET
cpe-2383	155	21	role	role	NOUN
cpe-2383	155	22	of	of	ADP
cpe-2383	155	23	the	the	DET
cpe-2383	155	24	hypothalamus	hypothalamus	NOUN
cpe-2383	155	25	-	-	PUNCT
cpe-2383	155	26	pituitary	pituitary	ADJ
cpe-2383	155	27	-	-	PUNCT
cpe-2383	155	28	adrenal	adrenal	ADJ
cpe-2383	155	29	axis	axis	NOUN
cpe-2383	155	30	.	.	PUNCT
cpe-2383	156	1	biological	biological	ADJ
cpe-2383	156	2	psychology	psychology	NOUN
cpe-2383	156	3	,	,	PUNCT
cpe-2383	156	4	57(1	57(1	NUM
cpe-2383	156	5	-	-	SYM
cpe-2383	156	6	3	3	NUM
cpe-2383	156	7	)	)	PUNCT
cpe-2383	156	8	,	,	PUNCT
cpe-2383	156	9	141	141	NUM
cpe-2383	156	10	-	-	SYM
cpe-2383	156	11	152	152	NUM
cpe-2383	156	12	.	.	PUNCT
cpe-2383	157	1	https://doi.org/10.1016/s0301-0511(01)00092-8	https://doi.org/10.1016/s0301-0511(01)00092-8	PROPN
cpe-2383	157	2	elliott	elliott	PROPN
cpe-2383	157	3	,	,	PUNCT
cpe-2383	157	4	j.	j.	PROPN
cpe-2383	157	5	,	,	PUNCT
cpe-2383	157	6	kelly	kelly	PROPN
cpe-2383	157	7	,	,	PUNCT
cpe-2383	157	8	s.	s.	PROPN
cpe-2383	157	9	e.	e.	PROPN
cpe-2383	157	10	,	,	PUNCT
cpe-2383	157	11	millar	millar	PROPN
cpe-2383	157	12	,	,	PUNCT
cpe-2383	157	13	a.	a.	PROPN
cpe-2383	157	14	c.	c.	PROPN
cpe-2383	157	15	,	,	PUNCT
cpe-2383	157	16	peterson	peterson	PROPN
cpe-2383	157	17	,	,	PUNCT
cpe-2383	157	18	j.	j.	PROPN
cpe-2383	157	19	,	,	PUNCT
cpe-2383	157	20	chen	chen	PROPN
cpe-2383	157	21	,	,	PUNCT
cpe-2383	157	22	l.	l.	PROPN
cpe-2383	157	23	,	,	PUNCT
cpe-2383	157	24	johnston	johnston	PROPN
cpe-2383	157	25	,	,	PUNCT
cpe-2383	157	26	a.	a.	PROPN
cpe-2383	157	27	,	,	PUNCT
cpe-2383	157	28	.	.	PUNCT
cpe-2383	157	29	.	.	PUNCT
cpe-2383	157	30	.	.	PUNCT
cpe-2383	158	1	wells	wells	PROPN
cpe-2383	158	2	,	,	PUNCT
cpe-2383	158	3	g.	g.	PROPN
cpe-2383	158	4	a.	a.	PROPN
cpe-2383	158	5	(	(	PUNCT
cpe-2383	158	6	2017	2017	NUM
cpe-2383	158	7	)	)	PUNCT
cpe-2383	158	8	.	.	PUNCT
cpe-2383	159	1	testosterone	testosterone	NOUN
cpe-2383	159	2	therapy	therapy	NOUN
cpe-2383	159	3	in	in	ADP
cpe-2383	159	4	hypogonadal	hypogonadal	ADJ
cpe-2383	159	5	men	man	NOUN
cpe-2383	159	6	:	:	PUNCT
cpe-2383	159	7	a	a	DET
cpe-2383	159	8	systematic	systematic	ADJ
cpe-2383	159	9	review	review	NOUN
cpe-2383	159	10	and	and	CCONJ
cpe-2383	159	11	network	network	NOUN
cpe-2383	159	12	meta	meta	ADJ
cpe-2383	159	13	-	-	PUNCT
cpe-2383	159	14	analysis	analysis	NOUN
cpe-2383	159	15	.	.	PUNCT
cpe-2383	160	1	bmj	bmj	PROPN
cpe-2383	160	2	open	open	ADJ
cpe-2383	160	3	,	,	PUNCT
cpe-2383	160	4	7(11	7(11	NUM
cpe-2383	160	5	)	)	PUNCT
cpe-2383	160	6	,	,	PUNCT
cpe-2383	161	1	article	article	NOUN
cpe-2383	161	2	e015284	e015284	PROPN
cpe-2383	161	3	.	.	PROPN
cpe-2383	161	4	elraiyah	elraiyah	PROPN
cpe-2383	161	5	,	,	PUNCT
cpe-2383	161	6	t.	t.	PROPN
cpe-2383	161	7	,	,	PUNCT
cpe-2383	161	8	sonbol	sonbol	PROPN
cpe-2383	161	9	,	,	PUNCT
cpe-2383	161	10	m.	m.	PROPN
cpe-2383	161	11	b.	b.	PROPN
cpe-2383	161	12	,	,	PUNCT
cpe-2383	161	13	wang	wang	PROPN
cpe-2383	161	14	,	,	PUNCT
cpe-2383	161	15	z.	z.	PROPN
cpe-2383	161	16	,	,	PUNCT
cpe-2383	161	17	khairalseed	khairalseed	VERB
cpe-2383	161	18	,	,	PUNCT
cpe-2383	161	19	t.	t.	PROPN
cpe-2383	161	20	,	,	PUNCT
cpe-2383	161	21	asi	asi	NOUN
cpe-2383	161	22	,	,	PUNCT
cpe-2383	161	23	n.	n.	NOUN
cpe-2383	161	24	,	,	PUNCT
cpe-2383	161	25	undavalli	undavalli	PROPN
cpe-2383	161	26	,	,	PUNCT
cpe-2383	161	27	c.	c.	PROPN
cpe-2383	161	28	,	,	PUNCT
cpe-2383	161	29	.	.	PUNCT
cpe-2383	161	30	.	.	PUNCT
cpe-2383	162	1	.	.	PUNCT
cpe-2383	163	1	murad	murad	NOUN
cpe-2383	163	2	,	,	PUNCT
cpe-2383	163	3	m.	m.	NOUN
cpe-2383	163	4	h.	h.	PROPN
cpe-2383	163	5	(	(	PUNCT
cpe-2383	163	6	2014	2014	NUM
cpe-2383	163	7	)	)	PUNCT
cpe-2383	163	8	.	.	PUNCT
cpe-2383	164	1	clinical	clinical	ADJ
cpe-2383	164	2	review	review	NOUN
cpe-2383	164	3	:	:	PUNCT
cpe-2383	164	4	the	the	DET
cpe-2383	164	5	benefits	benefit	NOUN
cpe-2383	164	6	and	and	CCONJ
cpe-2383	164	7	harms	harm	NOUN
cpe-2383	164	8	of	of	ADP
cpe-2383	164	9	systemic	systemic	ADJ
cpe-2383	164	10	testosterone	testosterone	NOUN
cpe-2383	164	11	therapy	therapy	NOUN
cpe-2383	164	12	in	in	ADP
cpe-2383	164	13	postmenopausal	postmenopausal	ADJ
cpe-2383	164	14	women	woman	NOUN
cpe-2383	164	15	with	with	ADP
cpe-2383	164	16	normal	normal	ADJ
cpe-2383	164	17	adrenal	adrenal	ADJ
cpe-2383	164	18	function	function	NOUN
cpe-2383	164	19	:	:	PUNCT
cpe-2383	164	20	a	a	DET
cpe-2383	164	21	systematic	systematic	ADJ
cpe-2383	164	22	review	review	NOUN
cpe-2383	164	23	and	and	CCONJ
cpe-2383	164	24	meta	meta	ADJ
cpe-2383	164	25	-	-	PUNCT
cpe-2383	164	26	analysis	analysis	NOUN
cpe-2383	164	27	.	.	PUNCT
cpe-2383	165	1	the	the	DET
cpe-2383	165	2	journal	journal	NOUN
cpe-2383	165	3	of	of	ADP
cpe-2383	165	4	clinical	clinical	ADJ
cpe-2383	165	5	endocrinology	endocrinology	NOUN
cpe-2383	165	6	&	&	CCONJ
cpe-2383	165	7	metabolism	metabolism	NOUN
cpe-2383	165	8	,	,	PUNCT
cpe-2383	165	9	99(10	99(10	NUM
cpe-2383	165	10	)	)	PUNCT
cpe-2383	165	11	,	,	PUNCT
cpe-2383	165	12	3543	3543	NUM
cpe-2383	165	13	-	-	SYM
cpe-2383	165	14	3550	3550	NUM
cpe-2383	165	15	.	.	PUNCT
cpe-2383	166	1	https://doi.org/10.1210/jc.2014-2262	https://doi.org/10.1210/jc.2014-2262	PROPN
cpe-2383	166	2	fischer	fischer	PROPN
cpe-2383	166	3	&	&	CCONJ
cpe-2383	166	4	ehlert	ehlert	PROPN
cpe-2383	166	5	9	9	NUM
cpe-2383	166	6	clinical	clinical	ADJ
cpe-2383	166	7	psychology	psychology	NOUN
cpe-2383	166	8	in	in	ADP
cpe-2383	166	9	europe	europe	PROPN
cpe-2383	166	10	2019	2019	NUM
cpe-2383	166	11	,	,	PUNCT
cpe-2383	166	12	vol.1(2	vol.1(2	PROPN
cpe-2383	166	13	)	)	PUNCT
cpe-2383	166	14	,	,	PUNCT
cpe-2383	166	15	article	article	NOUN
cpe-2383	166	16	33030	33030	NUM
cpe-2383	166	17	https://doi.org/10.32872/cpe.v1i2.33030	https://doi.org/10.32872/cpe.v1i2.33030	PROPN
cpe-2383	166	18	https://doi.org/10.1080/15622975.2016.1190867	https://doi.org/10.1080/15622975.2016.1190867	CCONJ
cpe-2383	167	1	http://www.awmf.org/leitlinien.html	http://www.awmf.org/leitlinien.html	PROPN
cpe-2383	167	2	https://doi.org/10.1016/j.psyneuen.2015.10.014	https://doi.org/10.1016/j.psyneuen.2015.10.014	PROPN
cpe-2383	167	3	https://doi.org/10.1016/j.eururo.2017.03.032	https://doi.org/10.1016/j.eururo.2017.03.032	PROPN
cpe-2383	167	4	https://doi.org/10.1016/j.biopsych.2008.10.011	https://doi.org/10.1016/j.biopsych.2008.10.011	NOUN
cpe-2383	167	5	https://doi.org/10.1016/j.psyneuen.2013.06.007	https://doi.org/10.1016/j.psyneuen.2013.06.007	NUM
cpe-2383	167	6	https://doi.org/10.1016/s0301-0511(01)00092-8	https://doi.org/10.1016/s0301-0511(01)00092-8	PROPN
cpe-2383	167	7	https://doi.org/10.1210/jc.2014-2262	https://doi.org/10.1210/jc.2014-2262	NOUN
cpe-2383	167	8	https://www.psychopen.eu/	https://www.psychopen.eu/	VERB
cpe-2383	167	9	fischer	fischer	PROPN
cpe-2383	167	10	,	,	PUNCT
cpe-2383	167	11	s.	s.	PROPN
cpe-2383	167	12	,	,	PUNCT
cpe-2383	167	13	&	&	CCONJ
cpe-2383	167	14	cleare	cleare	PROPN
cpe-2383	167	15	,	,	PUNCT
cpe-2383	167	16	a.	a.	PROPN
cpe-2383	167	17	j.	j.	PROPN
cpe-2383	167	18	(	(	PUNCT
cpe-2383	167	19	2017	2017	NUM
cpe-2383	167	20	)	)	PUNCT
cpe-2383	167	21	.	.	PUNCT
cpe-2383	168	1	cortisol	cortisol	NOUN
cpe-2383	168	2	as	as	ADP
cpe-2383	168	3	a	a	DET
cpe-2383	168	4	predictor	predictor	NOUN
cpe-2383	168	5	of	of	ADP
cpe-2383	168	6	psychological	psychological	ADJ
cpe-2383	168	7	therapy	therapy	NOUN
cpe-2383	168	8	response	response	NOUN
cpe-2383	168	9	in	in	ADP
cpe-2383	168	10	anxiety	anxiety	NOUN
cpe-2383	168	11	disorders	disorder	NOUN
cpe-2383	168	12	:	:	PUNCT
cpe-2383	168	13	systematic	systematic	ADJ
cpe-2383	168	14	review	review	NOUN
cpe-2383	168	15	and	and	CCONJ
cpe-2383	168	16	meta	meta	ADJ
cpe-2383	168	17	-	-	PUNCT
cpe-2383	168	18	analysis	analysis	NOUN
cpe-2383	168	19	.	.	PUNCT
cpe-2383	169	1	journal	journal	NOUN
cpe-2383	169	2	of	of	ADP
cpe-2383	169	3	anxiety	anxiety	NOUN
cpe-2383	169	4	disorders	disorder	NOUN
cpe-2383	169	5	,	,	PUNCT
cpe-2383	169	6	47	47	NUM
cpe-2383	169	7	,	,	PUNCT
cpe-2383	169	8	60	60	NUM
cpe-2383	169	9	-	-	SYM
cpe-2383	169	10	68	68	NUM
cpe-2383	169	11	.	.	PUNCT
cpe-2383	170	1	https://doi.org/10.1016/j.janxdis.2017.02.007	https://doi.org/10.1016/j.janxdis.2017.02.007	VERB
cpe-2383	170	2	fischer	fischer	PROPN
cpe-2383	170	3	,	,	PUNCT
cpe-2383	170	4	s.	s.	PROPN
cpe-2383	170	5	,	,	PUNCT
cpe-2383	170	6	&	&	CCONJ
cpe-2383	170	7	nater	nater	NOUN
cpe-2383	170	8	,	,	PUNCT
cpe-2383	170	9	u.	u.	PROPN
cpe-2383	170	10	m.	m.	NOUN
cpe-2383	170	11	(	(	PUNCT
cpe-2383	170	12	2015	2015	NUM
cpe-2383	170	13	)	)	PUNCT
cpe-2383	170	14	.	.	PUNCT
cpe-2383	171	1	autonomes	autonome	NOUN
cpe-2383	171	2	nervensystem	nervensystem	PROPN
cpe-2383	171	3	.	.	PUNCT
cpe-2383	172	1	in	in	ADP
cpe-2383	172	2	w.	w.	PROPN
cpe-2383	172	3	rief	rief	PROPN
cpe-2383	172	4	&	&	CCONJ
cpe-2383	172	5	p.	p.	PROPN
cpe-2383	172	6	henningsen	henningsen	PROPN
cpe-2383	172	7	(	(	PUNCT
cpe-2383	172	8	eds	ed	NOUN
cpe-2383	172	9	.	.	PUNCT
cpe-2383	172	10	)	)	PUNCT
cpe-2383	172	11	,	,	PUNCT
cpe-2383	172	12	psychosomatik	psychosomatik	NOUN
cpe-2383	172	13	und	und	VERB
cpe-2383	172	14	verhaltensmedizin	verhaltensmedizin	NOUN
cpe-2383	172	15	(	(	PUNCT
cpe-2383	172	16	pp	pp	ADJ
cpe-2383	172	17	.	.	PUNCT
cpe-2383	173	1	193	193	NUM
cpe-2383	173	2	-	-	NUM
cpe-2383	173	3	201	201	NUM
cpe-2383	173	4	)	)	PUNCT
cpe-2383	173	5	.	.	PUNCT
cpe-2383	174	1	stuttgart	stuttgart	PROPN
cpe-2383	174	2	,	,	PUNCT
cpe-2383	174	3	germany	germany	PROPN
cpe-2383	174	4	:	:	PUNCT
cpe-2383	174	5	schattauer	schattauer	PROPN
cpe-2383	174	6	.	.	PUNCT
cpe-2383	175	1	fischer	fischer	PROPN
cpe-2383	175	2	,	,	PUNCT
cpe-2383	175	3	s.	s.	PROPN
cpe-2383	175	4	,	,	PUNCT
cpe-2383	175	5	strawbridge	strawbridge	VERB
cpe-2383	175	6	,	,	PUNCT
cpe-2383	175	7	r.	r.	PROPN
cpe-2383	175	8	,	,	PUNCT
cpe-2383	175	9	herane	herane	NOUN
cpe-2383	175	10	vives	vive	NOUN
cpe-2383	175	11	,	,	PUNCT
cpe-2383	175	12	a.	a.	NOUN
cpe-2383	175	13	,	,	PUNCT
cpe-2383	175	14	&	&	CCONJ
cpe-2383	175	15	cleare	cleare	PROPN
cpe-2383	175	16	,	,	PUNCT
cpe-2383	175	17	a.	a.	PROPN
cpe-2383	175	18	j.	j.	PROPN
cpe-2383	175	19	(	(	PUNCT
cpe-2383	175	20	2017	2017	NUM
cpe-2383	175	21	)	)	PUNCT
cpe-2383	175	22	.	.	PUNCT
cpe-2383	176	1	cortisol	cortisol	NOUN
cpe-2383	176	2	as	as	ADP
cpe-2383	176	3	a	a	DET
cpe-2383	176	4	predictor	predictor	NOUN
cpe-2383	176	5	of	of	ADP
cpe-2383	176	6	psychological	psychological	ADJ
cpe-2383	176	7	therapy	therapy	NOUN
cpe-2383	176	8	response	response	NOUN
cpe-2383	176	9	in	in	ADP
cpe-2383	176	10	depressive	depressive	ADJ
cpe-2383	176	11	disorders	disorder	NOUN
cpe-2383	176	12	:	:	PUNCT
cpe-2383	176	13	systematic	systematic	ADJ
cpe-2383	176	14	review	review	NOUN
cpe-2383	176	15	and	and	CCONJ
cpe-2383	176	16	meta	meta	ADJ
cpe-2383	176	17	-	-	PUNCT
cpe-2383	176	18	analysis	analysis	NOUN
cpe-2383	176	19	.	.	PUNCT
cpe-2383	177	1	the	the	DET
cpe-2383	177	2	british	british	PROPN
cpe-2383	177	3	journal	journal	PROPN
cpe-2383	177	4	of	of	ADP
cpe-2383	177	5	psychiatry	psychiatry	NOUN
cpe-2383	177	6	,	,	PUNCT
cpe-2383	177	7	210(2	210(2	NUM
cpe-2383	177	8	)	)	PUNCT
cpe-2383	177	9	,	,	PUNCT
cpe-2383	177	10	105	105	NUM
cpe-2383	177	11	-	-	SYM
cpe-2383	177	12	109	109	NUM
cpe-2383	177	13	.	.	PUNCT
cpe-2383	178	1	https://doi.org/10.1192/bjp.bp.115.180653	https://doi.org/10.1192/bjp.bp.115.180653	PRON
cpe-2383	178	2	gordon	gordon	PROPN
cpe-2383	178	3	,	,	PUNCT
cpe-2383	178	4	j.	j.	PROPN
cpe-2383	178	5	l.	l.	PROPN
cpe-2383	178	6	,	,	PUNCT
cpe-2383	178	7	rubinow	rubinow	PROPN
cpe-2383	178	8	,	,	PUNCT
cpe-2383	178	9	d.	d.	PROPN
cpe-2383	178	10	r.	r.	PROPN
cpe-2383	178	11	,	,	PUNCT
cpe-2383	178	12	eisenlohr	eisenlohr	NOUN
cpe-2383	178	13	-	-	PUNCT
cpe-2383	178	14	moul	moul	NOUN
cpe-2383	178	15	,	,	PUNCT
cpe-2383	178	16	t.	t.	PROPN
cpe-2383	178	17	a.	a.	PROPN
cpe-2383	178	18	,	,	PUNCT
cpe-2383	178	19	leserman	leserman	PROPN
cpe-2383	178	20	,	,	PUNCT
cpe-2383	178	21	j.	j.	PROPN
cpe-2383	178	22	,	,	PUNCT
cpe-2383	178	23	&	&	CCONJ
cpe-2383	178	24	girdler	girdler	PROPN
cpe-2383	178	25	,	,	PUNCT
cpe-2383	178	26	s.	s.	PROPN
cpe-2383	178	27	s.	s.	PROPN
cpe-2383	178	28	(	(	PUNCT
cpe-2383	178	29	2016	2016	NUM
cpe-2383	178	30	)	)	PUNCT
cpe-2383	178	31	.	.	PUNCT
cpe-2383	179	1	estradiol	estradiol	PROPN
cpe-2383	179	2	variability	variability	NOUN
cpe-2383	179	3	,	,	PUNCT
cpe-2383	179	4	stressful	stressful	ADJ
cpe-2383	179	5	life	life	NOUN
cpe-2383	179	6	events	event	NOUN
cpe-2383	179	7	,	,	PUNCT
cpe-2383	179	8	and	and	CCONJ
cpe-2383	179	9	the	the	DET
cpe-2383	179	10	emergence	emergence	NOUN
cpe-2383	179	11	of	of	ADP
cpe-2383	179	12	depressive	depressive	ADJ
cpe-2383	179	13	symptomatology	symptomatology	NOUN
cpe-2383	179	14	during	during	ADP
cpe-2383	179	15	the	the	DET
cpe-2383	179	16	menopausal	menopausal	ADJ
cpe-2383	179	17	transition	transition	NOUN
cpe-2383	179	18	.	.	PUNCT
cpe-2383	180	1	menopause	menopause	NOUN
cpe-2383	180	2	,	,	PUNCT
cpe-2383	180	3	23(3	23(3	NUM
cpe-2383	180	4	)	)	PUNCT
cpe-2383	180	5	,	,	PUNCT
cpe-2383	180	6	257	257	NUM
cpe-2383	180	7	-	-	SYM
cpe-2383	180	8	266	266	NUM
cpe-2383	180	9	.	.	PUNCT
cpe-2383	180	10	https://doi.org/10.1097/gme.0000000000000528	https://doi.org/10.1097/gme.0000000000000528	PROPN
cpe-2383	180	11	greenhalgh	greenhalgh	PROPN
cpe-2383	180	12	,	,	PUNCT
cpe-2383	180	13	a.	a.	NOUN
cpe-2383	180	14	m.	m.	NOUN
cpe-2383	180	15	,	,	PUNCT
cpe-2383	180	16	gonzalez	gonzalez	PROPN
cpe-2383	180	17	-	-	PUNCT
cpe-2383	180	18	blanco	blanco	PROPN
cpe-2383	180	19	,	,	PUNCT
cpe-2383	180	20	l.	l.	PROPN
cpe-2383	180	21	,	,	PUNCT
cpe-2383	180	22	garcia	garcia	PROPN
cpe-2383	180	23	-	-	PUNCT
cpe-2383	180	24	rizo	rizo	PROPN
cpe-2383	180	25	,	,	PUNCT
cpe-2383	180	26	c.	c.	NOUN
cpe-2383	180	27	,	,	PUNCT
cpe-2383	180	28	fernandez	fernandez	NOUN
cpe-2383	180	29	-	-	PUNCT
cpe-2383	180	30	egea	egea	NOUN
cpe-2383	180	31	,	,	PUNCT
cpe-2383	180	32	e.	e.	PROPN
cpe-2383	180	33	,	,	PUNCT
cpe-2383	180	34	miller	miller	PROPN
cpe-2383	180	35	,	,	PUNCT
cpe-2383	180	36	b.	b.	PROPN
cpe-2383	180	37	,	,	PUNCT
cpe-2383	180	38	arroyo	arroyo	PROPN
cpe-2383	180	39	,	,	PUNCT
cpe-2383	180	40	m.	m.	PROPN
cpe-2383	180	41	b.	b.	PROPN
cpe-2383	180	42	,	,	PUNCT
cpe-2383	180	43	&	&	CCONJ
cpe-2383	180	44	kirkpatrick	kirkpatrick	PROPN
cpe-2383	180	45	,	,	PUNCT
cpe-2383	180	46	b.	b.	PROPN
cpe-2383	180	47	(	(	PUNCT
cpe-2383	180	48	2017	2017	NUM
cpe-2383	180	49	)	)	PUNCT
cpe-2383	180	50	.	.	PUNCT
cpe-2383	181	1	meta	meta	ADJ
cpe-2383	181	2	-	-	PUNCT
cpe-2383	181	3	analysis	analysis	NOUN
cpe-2383	181	4	of	of	ADP
cpe-2383	181	5	glucose	glucose	NOUN
cpe-2383	181	6	tolerance	tolerance	NOUN
cpe-2383	181	7	,	,	PUNCT
cpe-2383	181	8	insulin	insulin	NOUN
cpe-2383	181	9	,	,	PUNCT
cpe-2383	181	10	and	and	CCONJ
cpe-2383	181	11	insulin	insulin	NOUN
cpe-2383	181	12	resistance	resistance	NOUN
cpe-2383	181	13	in	in	ADP
cpe-2383	181	14	antipsychotic	antipsychotic	ADJ
cpe-2383	181	15	-	-	PUNCT
cpe-2383	181	16	naive	naive	ADJ
cpe-2383	181	17	patients	patient	NOUN
cpe-2383	181	18	with	with	ADP
cpe-2383	181	19	nonaffective	nonaffective	ADJ
cpe-2383	181	20	psychosis	psychosis	NOUN
cpe-2383	181	21	.	.	PUNCT
cpe-2383	182	1	schizophrenia	schizophrenia	PROPN
cpe-2383	182	2	research	research	PROPN
cpe-2383	182	3	,	,	PUNCT
cpe-2383	182	4	179	179	NUM
cpe-2383	182	5	,	,	PUNCT
cpe-2383	182	6	57	57	NUM
cpe-2383	182	7	-	-	SYM
cpe-2383	182	8	63	63	NUM
cpe-2383	182	9	.	.	PUNCT
cpe-2383	183	1	https://doi.org/10.1016/j.schres.2016.09.026	https://doi.org/10.1016/j.schres.2016.09.026	PROPN
cpe-2383	183	2	heim	heim	PROPN
cpe-2383	183	3	,	,	PUNCT
cpe-2383	183	4	c.	c.	PROPN
cpe-2383	183	5	,	,	PUNCT
cpe-2383	183	6	ehlert	ehlert	NOUN
cpe-2383	183	7	,	,	PUNCT
cpe-2383	183	8	u.	u.	PROPN
cpe-2383	183	9	,	,	PUNCT
cpe-2383	183	10	&	&	CCONJ
cpe-2383	183	11	hellhammer	hellhammer	PROPN
cpe-2383	183	12	,	,	PUNCT
cpe-2383	183	13	d.	d.	PROPN
cpe-2383	183	14	h.	h.	PROPN
cpe-2383	183	15	(	(	PUNCT
cpe-2383	183	16	2000	2000	NUM
cpe-2383	183	17	)	)	PUNCT
cpe-2383	183	18	.	.	PUNCT
cpe-2383	184	1	the	the	DET
cpe-2383	184	2	potential	potential	ADJ
cpe-2383	184	3	role	role	NOUN
cpe-2383	184	4	of	of	ADP
cpe-2383	184	5	hypocortisolism	hypocortisolism	NOUN
cpe-2383	184	6	in	in	ADP
cpe-2383	184	7	the	the	DET
cpe-2383	184	8	pathophysiology	pathophysiology	NOUN
cpe-2383	184	9	of	of	ADP
cpe-2383	184	10	stress	stress	NOUN
cpe-2383	184	11	-	-	PUNCT
cpe-2383	184	12	related	relate	VERB
cpe-2383	184	13	bodily	bodily	ADJ
cpe-2383	184	14	disorders	disorder	NOUN
cpe-2383	184	15	.	.	PUNCT
cpe-2383	185	1	psychoneuroendocrinology	psychoneuroendocrinology	NOUN
cpe-2383	185	2	,	,	PUNCT
cpe-2383	185	3	25(1	25(1	NUM
cpe-2383	185	4	)	)	PUNCT
cpe-2383	185	5	,	,	PUNCT
cpe-2383	185	6	1	1	NUM
cpe-2383	185	7	-	-	SYM
cpe-2383	185	8	35	35	NUM
cpe-2383	185	9	.	.	PUNCT
cpe-2383	186	1	https://doi.org/10.1016/s0306-4530(99)00035-9	https://doi.org/10.1016/s0306-4530(99)00035-9	NOUN
cpe-2383	186	2	heinrichs	heinrich	NOUN
cpe-2383	186	3	,	,	PUNCT
cpe-2383	186	4	m.	m.	NOUN
cpe-2383	186	5	,	,	PUNCT
cpe-2383	186	6	baumgartner	baumgartner	PROPN
cpe-2383	186	7	,	,	PUNCT
cpe-2383	186	8	t.	t.	PROPN
cpe-2383	186	9	,	,	PUNCT
cpe-2383	186	10	kirschbaum	kirschbaum	PROPN
cpe-2383	186	11	,	,	PUNCT
cpe-2383	186	12	c.	c.	PROPN
cpe-2383	186	13	,	,	PUNCT
cpe-2383	186	14	&	&	CCONJ
cpe-2383	186	15	ehlert	ehlert	PROPN
cpe-2383	186	16	,	,	PUNCT
cpe-2383	186	17	u.	u.	PROPN
cpe-2383	186	18	(	(	PUNCT
cpe-2383	186	19	2003	2003	NUM
cpe-2383	186	20	)	)	PUNCT
cpe-2383	186	21	.	.	PUNCT
cpe-2383	187	1	social	social	ADJ
cpe-2383	187	2	support	support	NOUN
cpe-2383	187	3	and	and	CCONJ
cpe-2383	187	4	oxytocin	oxytocin	NOUN
cpe-2383	187	5	interact	interact	VERB
cpe-2383	187	6	to	to	PART
cpe-2383	187	7	suppress	suppress	VERB
cpe-2383	187	8	cortisol	cortisol	NOUN
cpe-2383	187	9	and	and	CCONJ
cpe-2383	187	10	subjective	subjective	ADJ
cpe-2383	187	11	responses	response	NOUN
cpe-2383	187	12	to	to	ADP
cpe-2383	187	13	psychosocial	psychosocial	ADJ
cpe-2383	187	14	stress	stress	NOUN
cpe-2383	187	15	.	.	PUNCT
cpe-2383	188	1	biological	biological	ADJ
cpe-2383	188	2	psychiatry	psychiatry	NOUN
cpe-2383	188	3	,	,	PUNCT
cpe-2383	188	4	54(12	54(12	NUM
cpe-2383	188	5	)	)	PUNCT
cpe-2383	188	6	,	,	PUNCT
cpe-2383	188	7	1389	1389	NUM
cpe-2383	188	8	-	-	SYM
cpe-2383	188	9	1398	1398	NUM
cpe-2383	188	10	.	.	PUNCT
cpe-2383	189	1	https://doi.org/10.1016/s0006-3223(03)00465-7	https://doi.org/10.1016/s0006-3223(03)00465-7	PROPN
cpe-2383	189	2	ilyas	ilyas	PROPN
cpe-2383	189	3	,	,	PUNCT
cpe-2383	189	4	a.	a.	PROPN
cpe-2383	189	5	,	,	PUNCT
cpe-2383	189	6	hubel	hubel	PROPN
cpe-2383	189	7	,	,	PUNCT
cpe-2383	189	8	c.	c.	PROPN
cpe-2383	189	9	,	,	PUNCT
cpe-2383	189	10	stahl	stahl	PROPN
cpe-2383	189	11	,	,	PUNCT
cpe-2383	189	12	d.	d.	PROPN
cpe-2383	189	13	,	,	PUNCT
cpe-2383	189	14	stadler	stadler	NOUN
cpe-2383	189	15	,	,	PUNCT
cpe-2383	189	16	m.	m.	NOUN
cpe-2383	189	17	,	,	PUNCT
cpe-2383	189	18	ismail	ismail	PROPN
cpe-2383	189	19	,	,	PUNCT
cpe-2383	189	20	k.	k.	PROPN
cpe-2383	189	21	,	,	PUNCT
cpe-2383	189	22	breen	breen	PROPN
cpe-2383	189	23	,	,	PUNCT
cpe-2383	189	24	g.	g.	PROPN
cpe-2383	189	25	,	,	PUNCT
cpe-2383	189	26	.	.	PUNCT
cpe-2383	189	27	.	.	PUNCT
cpe-2383	189	28	.	.	PUNCT
cpe-2383	190	1	kan	kan	PROPN
cpe-2383	190	2	,	,	PUNCT
cpe-2383	190	3	c.	c.	PROPN
cpe-2383	190	4	(	(	PUNCT
cpe-2383	190	5	2018	2018	NUM
cpe-2383	190	6	)	)	PUNCT
cpe-2383	190	7	.	.	PUNCT
cpe-2383	191	1	the	the	DET
cpe-2383	191	2	metabolic	metabolic	NOUN
cpe-2383	191	3	underpinning	underpinning	NOUN
cpe-2383	191	4	of	of	ADP
cpe-2383	191	5	eating	eat	VERB
cpe-2383	191	6	disorders	disorder	NOUN
cpe-2383	191	7	:	:	PUNCT
cpe-2383	191	8	a	a	DET
cpe-2383	191	9	systematic	systematic	ADJ
cpe-2383	191	10	review	review	NOUN
cpe-2383	191	11	and	and	CCONJ
cpe-2383	191	12	meta	meta	ADJ
cpe-2383	191	13	-	-	PUNCT
cpe-2383	191	14	analysis	analysis	NOUN
cpe-2383	191	15	of	of	ADP
cpe-2383	191	16	insulin	insulin	NOUN
cpe-2383	191	17	sensitivity	sensitivity	NOUN
cpe-2383	191	18	.	.	PUNCT
cpe-2383	192	1	molecular	molecular	ADJ
cpe-2383	192	2	and	and	CCONJ
cpe-2383	192	3	cellular	cellular	ADJ
cpe-2383	192	4	endocrinology	endocrinology	NOUN
cpe-2383	192	5	.	.	PUNCT
cpe-2383	193	1	advance	advance	VERB
cpe-2383	193	2	online	online	ADJ
cpe-2383	193	3	publication	publication	NOUN
cpe-2383	193	4	.	.	PUNCT
cpe-2383	194	1	https://doi.org/10.1016/j.mce.2018.10.005	https://doi.org/10.1016/j.mce.2018.10.005	PROPN
cpe-2383	194	2	insel	insel	PROPN
cpe-2383	194	3	,	,	PUNCT
cpe-2383	194	4	t.	t.	PROPN
cpe-2383	194	5	,	,	PUNCT
cpe-2383	194	6	cuthbert	cuthbert	PROPN
cpe-2383	194	7	,	,	PUNCT
cpe-2383	194	8	b.	b.	PROPN
cpe-2383	194	9	,	,	PUNCT
cpe-2383	194	10	garvey	garvey	PROPN
cpe-2383	194	11	,	,	PUNCT
cpe-2383	194	12	m.	m.	NOUN
cpe-2383	194	13	,	,	PUNCT
cpe-2383	194	14	heinssen	heinssen	PROPN
cpe-2383	194	15	,	,	PUNCT
cpe-2383	194	16	r.	r.	PROPN
cpe-2383	194	17	,	,	PUNCT
cpe-2383	194	18	pine	pine	PROPN
cpe-2383	194	19	,	,	PUNCT
cpe-2383	194	20	d.	d.	PROPN
cpe-2383	194	21	s.	s.	PROPN
cpe-2383	194	22	,	,	PUNCT
cpe-2383	194	23	quinn	quinn	PROPN
cpe-2383	194	24	,	,	PUNCT
cpe-2383	194	25	k.	k.	PROPN
cpe-2383	194	26	,	,	PUNCT
cpe-2383	194	27	.	.	PUNCT
cpe-2383	194	28	.	.	PUNCT
cpe-2383	194	29	.	.	PUNCT
cpe-2383	195	1	wang	wang	PROPN
cpe-2383	195	2	,	,	PUNCT
cpe-2383	195	3	p.	p.	PROPN
cpe-2383	195	4	(	(	PUNCT
cpe-2383	195	5	2010	2010	NUM
cpe-2383	195	6	)	)	PUNCT
cpe-2383	195	7	.	.	PUNCT
cpe-2383	196	1	research	research	NOUN
cpe-2383	196	2	domain	domain	NOUN
cpe-2383	196	3	criteria	criterion	NOUN
cpe-2383	196	4	(	(	PUNCT
cpe-2383	196	5	rdoc	rdoc	PROPN
cpe-2383	196	6	):	):	PUNCT
cpe-2383	196	7	toward	toward	ADP
cpe-2383	196	8	a	a	DET
cpe-2383	196	9	new	new	ADJ
cpe-2383	196	10	classification	classification	NOUN
cpe-2383	196	11	framework	framework	NOUN
cpe-2383	196	12	for	for	ADP
cpe-2383	196	13	research	research	NOUN
cpe-2383	196	14	on	on	ADP
cpe-2383	196	15	mental	mental	ADJ
cpe-2383	196	16	disorders	disorder	NOUN
cpe-2383	196	17	.	.	PUNCT
cpe-2383	197	1	the	the	DET
cpe-2383	197	2	american	american	PROPN
cpe-2383	197	3	journal	journal	PROPN
cpe-2383	197	4	of	of	ADP
cpe-2383	197	5	psychiatry	psychiatry	NOUN
cpe-2383	197	6	,	,	PUNCT
cpe-2383	197	7	167(7	167(7	NUM
cpe-2383	197	8	)	)	PUNCT
cpe-2383	197	9	,	,	PUNCT
cpe-2383	197	10	748	748	NUM
cpe-2383	197	11	-	-	SYM
cpe-2383	197	12	751	751	NUM
cpe-2383	197	13	.	.	PUNCT
cpe-2383	198	1	https://doi.org/10.1176/appi.ajp.2010.09091379	https://doi.org/10.1176/appi.ajp.2010.09091379	PROPN
cpe-2383	198	2	isidori	isidori	NOUN
cpe-2383	198	3	,	,	PUNCT
cpe-2383	198	4	a.	a.	NOUN
cpe-2383	198	5	m.	m.	NOUN
cpe-2383	198	6	,	,	PUNCT
cpe-2383	198	7	buvat	buvat	PROPN
cpe-2383	198	8	,	,	PUNCT
cpe-2383	198	9	j.	j.	PROPN
cpe-2383	198	10	,	,	PUNCT
cpe-2383	198	11	corona	corona	PROPN
cpe-2383	198	12	,	,	PUNCT
cpe-2383	198	13	g.	g.	PROPN
cpe-2383	198	14	,	,	PUNCT
cpe-2383	198	15	goldstein	goldstein	PROPN
cpe-2383	198	16	,	,	PUNCT
cpe-2383	198	17	i.	i.	PROPN
cpe-2383	198	18	,	,	PUNCT
cpe-2383	198	19	jannini	jannini	PROPN
cpe-2383	198	20	,	,	PUNCT
cpe-2383	198	21	e.	e.	PROPN
cpe-2383	198	22	a.	a.	PROPN
cpe-2383	198	23	,	,	PUNCT
cpe-2383	198	24	lenzi	lenzi	PROPN
cpe-2383	198	25	,	,	PUNCT
cpe-2383	198	26	a.	a.	NOUN
cpe-2383	198	27	,	,	PUNCT
cpe-2383	198	28	.	.	PUNCT
cpe-2383	198	29	.	.	PUNCT
cpe-2383	198	30	.	.	PUNCT
cpe-2383	199	1	maggi	maggi	PROPN
cpe-2383	199	2	,	,	PUNCT
cpe-2383	199	3	m.	m.	NOUN
cpe-2383	199	4	(	(	PUNCT
cpe-2383	199	5	2014	2014	NUM
cpe-2383	199	6	)	)	PUNCT
cpe-2383	199	7	.	.	PUNCT
cpe-2383	200	1	a	a	DET
cpe-2383	200	2	critical	critical	ADJ
cpe-2383	200	3	analysis	analysis	NOUN
cpe-2383	200	4	of	of	ADP
cpe-2383	200	5	the	the	DET
cpe-2383	200	6	role	role	NOUN
cpe-2383	200	7	of	of	ADP
cpe-2383	200	8	testosterone	testosterone	NOUN
cpe-2383	200	9	in	in	ADP
cpe-2383	200	10	erectile	erectile	ADJ
cpe-2383	200	11	function	function	NOUN
cpe-2383	200	12	:	:	PUNCT
cpe-2383	200	13	from	from	ADP
cpe-2383	200	14	pathophysiology	pathophysiology	NOUN
cpe-2383	200	15	to	to	ADP
cpe-2383	200	16	treatment	treatment	NOUN
cpe-2383	200	17	-	-	PUNCT
cpe-2383	200	18	a	a	DET
cpe-2383	200	19	systematic	systematic	ADJ
cpe-2383	200	20	review	review	NOUN
cpe-2383	200	21	.	.	PUNCT
cpe-2383	201	1	european	european	ADJ
cpe-2383	201	2	urology	urology	NOUN
cpe-2383	201	3	,	,	PUNCT
cpe-2383	201	4	65(1	65(1	NOUN
cpe-2383	201	5	)	)	PUNCT
cpe-2383	201	6	,	,	PUNCT
cpe-2383	201	7	99	99	NUM
cpe-2383	201	8	-	-	SYM
cpe-2383	201	9	112	112	NUM
cpe-2383	201	10	.	.	PUNCT
cpe-2383	202	1	https://doi.org/10.1016/j.eururo.2013.08.048	https://doi.org/10.1016/j.eururo.2013.08.048	PROPN
cpe-2383	202	2	jobst	jobst	PROPN
cpe-2383	202	3	,	,	PUNCT
cpe-2383	202	4	a.	a.	PROPN
cpe-2383	202	5	,	,	PUNCT
cpe-2383	202	6	sabass	sabass	PROPN
cpe-2383	202	7	,	,	PUNCT
cpe-2383	202	8	l.	l.	PROPN
cpe-2383	202	9	,	,	PUNCT
cpe-2383	202	10	hall	hall	PROPN
cpe-2383	202	11	,	,	PUNCT
cpe-2383	202	12	d.	d.	PROPN
cpe-2383	202	13	,	,	PUNCT
cpe-2383	202	14	brucklmeier	brucklmeier	PROPN
cpe-2383	202	15	,	,	PUNCT
cpe-2383	202	16	b.	b.	PROPN
cpe-2383	202	17	,	,	PUNCT
cpe-2383	202	18	buchheim	buchheim	PROPN
cpe-2383	202	19	,	,	PUNCT
cpe-2383	202	20	a.	a.	NOUN
cpe-2383	202	21	,	,	PUNCT
cpe-2383	202	22	hall	hall	PROPN
cpe-2383	202	23	,	,	PUNCT
cpe-2383	202	24	j.	j.	PROPN
cpe-2383	202	25	,	,	PUNCT
cpe-2383	202	26	.	.	PUNCT
cpe-2383	202	27	.	.	PUNCT
cpe-2383	202	28	.	.	PUNCT
cpe-2383	203	1	padberg	padberg	PROPN
cpe-2383	203	2	,	,	PUNCT
cpe-2383	203	3	f.	f.	PROPN
cpe-2383	203	4	(	(	PUNCT
cpe-2383	203	5	2018	2018	NUM
cpe-2383	203	6	)	)	PUNCT
cpe-2383	203	7	.	.	PUNCT
cpe-2383	204	1	oxytocin	oxytocin	PROPN
cpe-2383	204	2	plasma	plasma	NOUN
cpe-2383	204	3	levels	level	NOUN
cpe-2383	204	4	predict	predict	VERB
cpe-2383	204	5	the	the	DET
cpe-2383	204	6	outcome	outcome	NOUN
cpe-2383	204	7	of	of	ADP
cpe-2383	204	8	psychotherapy	psychotherapy	NOUN
cpe-2383	204	9	:	:	PUNCT
cpe-2383	204	10	a	a	DET
cpe-2383	204	11	pilot	pilot	NOUN
cpe-2383	204	12	study	study	NOUN
cpe-2383	204	13	in	in	ADP
cpe-2383	204	14	chronic	chronic	ADJ
cpe-2383	204	15	depression	depression	NOUN
cpe-2383	204	16	.	.	PUNCT
cpe-2383	205	1	journal	journal	NOUN
cpe-2383	205	2	of	of	ADP
cpe-2383	205	3	affective	affective	ADJ
cpe-2383	205	4	disorders	disorder	NOUN
cpe-2383	205	5	,	,	PUNCT
cpe-2383	205	6	227	227	NUM
cpe-2383	205	7	,	,	PUNCT
cpe-2383	205	8	206	206	NUM
cpe-2383	205	9	-	-	SYM
cpe-2383	205	10	213	213	NUM
cpe-2383	205	11	.	.	PUNCT
cpe-2383	206	1	https://doi.org/10.1016/j.jad.2017.10.037	https://doi.org/10.1016/j.jad.2017.10.037	VERB
cpe-2383	206	2	kan	kan	PROPN
cpe-2383	206	3	,	,	PUNCT
cpe-2383	206	4	c.	c.	PROPN
cpe-2383	206	5	,	,	PUNCT
cpe-2383	206	6	silva	silva	PROPN
cpe-2383	206	7	,	,	PUNCT
cpe-2383	206	8	n.	n.	NOUN
cpe-2383	206	9	,	,	PUNCT
cpe-2383	206	10	golden	golden	ADJ
cpe-2383	206	11	,	,	PUNCT
cpe-2383	206	12	s.	s.	PROPN
cpe-2383	206	13	h.	h.	PROPN
cpe-2383	206	14	,	,	PUNCT
cpe-2383	206	15	rajala	rajala	PROPN
cpe-2383	206	16	,	,	PUNCT
cpe-2383	206	17	u.	u.	PROPN
cpe-2383	206	18	,	,	PUNCT
cpe-2383	206	19	timonen	timonen	NOUN
cpe-2383	206	20	,	,	PUNCT
cpe-2383	206	21	m.	m.	NOUN
cpe-2383	206	22	,	,	PUNCT
cpe-2383	206	23	stahl	stahl	PROPN
cpe-2383	206	24	,	,	PUNCT
cpe-2383	206	25	d.	d.	PROPN
cpe-2383	206	26	,	,	PUNCT
cpe-2383	206	27	&	&	CCONJ
cpe-2383	206	28	ismail	ismail	PROPN
cpe-2383	206	29	,	,	PUNCT
cpe-2383	206	30	k.	k.	PROPN
cpe-2383	206	31	(	(	PUNCT
cpe-2383	206	32	2013	2013	NUM
cpe-2383	206	33	)	)	PUNCT
cpe-2383	206	34	.	.	PUNCT
cpe-2383	207	1	a	a	DET
cpe-2383	207	2	systematic	systematic	ADJ
cpe-2383	207	3	review	review	NOUN
cpe-2383	207	4	and	and	CCONJ
cpe-2383	207	5	meta	meta	NOUN
cpe-2383	207	6	-	-	PUNCT
cpe-2383	207	7	analysis	analysis	NOUN
cpe-2383	207	8	of	of	ADP
cpe-2383	207	9	the	the	DET
cpe-2383	207	10	association	association	NOUN
cpe-2383	207	11	between	between	ADP
cpe-2383	207	12	depression	depression	NOUN
cpe-2383	207	13	and	and	CCONJ
cpe-2383	207	14	insulin	insulin	NOUN
cpe-2383	207	15	resistance	resistance	NOUN
cpe-2383	207	16	.	.	PUNCT
cpe-2383	208	1	diabetes	diabetes	NOUN
cpe-2383	208	2	care	care	NOUN
cpe-2383	208	3	,	,	PUNCT
cpe-2383	208	4	36(2	36(2	NUM
cpe-2383	208	5	)	)	PUNCT
cpe-2383	208	6	,	,	PUNCT
cpe-2383	208	7	480	480	NUM
cpe-2383	208	8	-	-	SYM
cpe-2383	208	9	489	489	NUM
cpe-2383	208	10	.	.	PUNCT
cpe-2383	209	1	https://doi.org/10.2337/dc12-1442	https://doi.org/10.2337/dc12-1442	PROPN
cpe-2383	209	2	psychoneuroendocrinology	psychoneuroendocrinology	NOUN
cpe-2383	209	3	and	and	CCONJ
cpe-2383	209	4	clinical	clinical	ADJ
cpe-2383	209	5	psychology	psychology	NOUN
cpe-2383	209	6	10	10	NUM
cpe-2383	209	7	clinical	clinical	ADJ
cpe-2383	209	8	psychology	psychology	NOUN
cpe-2383	209	9	in	in	ADP
cpe-2383	209	10	europe	europe	PROPN
cpe-2383	209	11	2019	2019	NUM
cpe-2383	209	12	,	,	PUNCT
cpe-2383	209	13	vol.1(2	vol.1(2	PROPN
cpe-2383	209	14	)	)	PUNCT
cpe-2383	209	15	,	,	PUNCT
cpe-2383	209	16	article	article	NOUN
cpe-2383	209	17	33030	33030	NUM
cpe-2383	209	18	https://doi.org/10.32872/cpe.v1i2.33030	https://doi.org/10.32872/cpe.v1i2.33030	PROPN
cpe-2383	209	19	https://doi.org/10.1016/j.janxdis.2017.02.007	https://doi.org/10.1016/j.janxdis.2017.02.007	VERB
cpe-2383	209	20	https://doi.org/10.1192/bjp.bp.115.180653	https://doi.org/10.1192/bjp.bp.115.180653	PRON
cpe-2383	209	21	https://doi.org/10.1097/gme.0000000000000528	https://doi.org/10.1097/gme.0000000000000528	NOUN
cpe-2383	209	22	https://doi.org/10.1016/j.schres.2016.09.026	https://doi.org/10.1016/j.schres.2016.09.026	PROPN
cpe-2383	209	23	https://doi.org/10.1016/s0306-4530(99)00035-9	https://doi.org/10.1016/s0306-4530(99)00035-9	NOUN
cpe-2383	209	24	https://doi.org/10.1016/s0006-3223(03)00465-7	https://doi.org/10.1016/s0006-3223(03)00465-7	PROPN
cpe-2383	209	25	https://doi.org/10.1016/j.mce.2018.10.005	https://doi.org/10.1016/j.mce.2018.10.005	PROPN
cpe-2383	209	26	https://doi.org/10.1176/appi.ajp.2010.09091379	https://doi.org/10.1176/appi.ajp.2010.09091379	PROPN
cpe-2383	209	27	https://doi.org/10.1016/j.eururo.2013.08.048	https://doi.org/10.1016/j.eururo.2013.08.048	PROPN
cpe-2383	209	28	https://doi.org/10.1016/j.jad.2017.10.037	https://doi.org/10.1016/j.jad.2017.10.037	PROPN
cpe-2383	209	29	https://doi.org/10.2337/dc12-1442	https://doi.org/10.2337/dc12-1442	PROPN
cpe-2383	209	30	https://www.psychopen.eu/	https://www.psychopen.eu/	PROPN
cpe-2383	209	31	keech	keech	NOUN
cpe-2383	209	32	,	,	PUNCT
cpe-2383	209	33	b.	b.	PROPN
cpe-2383	209	34	,	,	PUNCT
cpe-2383	209	35	crowe	crowe	PROPN
cpe-2383	209	36	,	,	PUNCT
cpe-2383	209	37	s.	s.	PROPN
cpe-2383	209	38	,	,	PUNCT
cpe-2383	209	39	&	&	CCONJ
cpe-2383	209	40	hocking	hocking	PROPN
cpe-2383	209	41	,	,	PUNCT
cpe-2383	209	42	d.	d.	PROPN
cpe-2383	209	43	r.	r.	PROPN
cpe-2383	209	44	(	(	PUNCT
cpe-2383	209	45	2018	2018	NUM
cpe-2383	209	46	)	)	PUNCT
cpe-2383	209	47	.	.	PUNCT
cpe-2383	210	1	intranasal	intranasal	ADJ
cpe-2383	210	2	oxytocin	oxytocin	PROPN
cpe-2383	210	3	,	,	PUNCT
cpe-2383	210	4	social	social	ADJ
cpe-2383	210	5	cognition	cognition	NOUN
cpe-2383	210	6	and	and	CCONJ
cpe-2383	210	7	neurodevelopmental	neurodevelopmental	ADJ
cpe-2383	210	8	disorders	disorder	NOUN
cpe-2383	210	9	:	:	PUNCT
cpe-2383	210	10	a	a	DET
cpe-2383	210	11	meta	meta	ADJ
cpe-2383	210	12	-	-	PUNCT
cpe-2383	210	13	analysis	analysis	NOUN
cpe-2383	210	14	.	.	PUNCT
cpe-2383	211	1	psychoneuroendocrinology	psychoneuroendocrinology	NOUN
cpe-2383	211	2	,	,	PUNCT
cpe-2383	211	3	87	87	NUM
cpe-2383	211	4	,	,	PUNCT
cpe-2383	211	5	9	9	NUM
cpe-2383	211	6	-	-	SYM
cpe-2383	211	7	19	19	NUM
cpe-2383	211	8	.	.	PUNCT
cpe-2383	212	1	https://doi.org/10.1016/j.psyneuen.2017.09.022	https://doi.org/10.1016/j.psyneuen.2017.09.022	PROPN
cpe-2383	212	2	kranz	kranz	PROPN
cpe-2383	212	3	,	,	PUNCT
cpe-2383	212	4	t.	t.	NOUN
cpe-2383	212	5	m.	m.	NOUN
cpe-2383	212	6	,	,	PUNCT
cpe-2383	212	7	kopp	kopp	PROPN
cpe-2383	212	8	,	,	PUNCT
cpe-2383	212	9	m.	m.	NOUN
cpe-2383	212	10	,	,	PUNCT
cpe-2383	212	11	waltes	walte	NOUN
cpe-2383	212	12	,	,	PUNCT
cpe-2383	212	13	r.	r.	PROPN
cpe-2383	212	14	,	,	PUNCT
cpe-2383	212	15	sachse	sachse	PROPN
cpe-2383	212	16	,	,	PUNCT
cpe-2383	212	17	m.	m.	NOUN
cpe-2383	212	18	,	,	PUNCT
cpe-2383	212	19	duketis	duketis	PROPN
cpe-2383	212	20	,	,	PUNCT
cpe-2383	212	21	e.	e.	PROPN
cpe-2383	212	22	,	,	PUNCT
cpe-2383	212	23	jarczok	jarczok	PROPN
cpe-2383	212	24	,	,	PUNCT
cpe-2383	212	25	t.	t.	PROPN
cpe-2383	212	26	a.	a.	PROPN
cpe-2383	212	27	,	,	PUNCT
cpe-2383	212	28	.	.	PUNCT
cpe-2383	212	29	.	.	PUNCT
cpe-2383	212	30	.	.	PUNCT
cpe-2383	213	1	chiocchetti	chiocchetti	PROPN
cpe-2383	213	2	,	,	PUNCT
cpe-2383	213	3	a.	a.	NOUN
cpe-2383	213	4	g.	g.	PROPN
cpe-2383	213	5	(	(	PUNCT
cpe-2383	213	6	2016	2016	NUM
cpe-2383	213	7	)	)	PUNCT
cpe-2383	213	8	.	.	PUNCT
cpe-2383	214	1	meta	meta	ADJ
cpe-2383	214	2	-	-	PUNCT
cpe-2383	214	3	analysis	analysis	NOUN
cpe-2383	214	4	and	and	CCONJ
cpe-2383	214	5	association	association	NOUN
cpe-2383	214	6	of	of	ADP
cpe-2383	214	7	two	two	NUM
cpe-2383	214	8	common	common	ADJ
cpe-2383	214	9	polymorphisms	polymorphism	NOUN
cpe-2383	214	10	of	of	ADP
cpe-2383	214	11	the	the	DET
cpe-2383	214	12	human	human	ADJ
cpe-2383	214	13	oxytocin	oxytocin	PROPN
cpe-2383	214	14	receptor	receptor	NOUN
cpe-2383	214	15	gene	gene	NOUN
cpe-2383	214	16	in	in	ADP
cpe-2383	214	17	autism	autism	NOUN
cpe-2383	214	18	spectrum	spectrum	NOUN
cpe-2383	214	19	disorder	disorder	NOUN
cpe-2383	214	20	.	.	PUNCT
cpe-2383	215	1	autism	autism	NOUN
cpe-2383	215	2	research	research	NOUN
cpe-2383	215	3	,	,	PUNCT
cpe-2383	215	4	9(10	9(10	NUM
cpe-2383	215	5	)	)	PUNCT
cpe-2383	215	6	,	,	PUNCT
cpe-2383	215	7	1036	1036	NUM
cpe-2383	215	8	-	-	SYM
cpe-2383	215	9	1045	1045	NUM
cpe-2383	215	10	.	.	PUNCT
cpe-2383	216	1	https://doi.org/10.1002/aur.1597	https://doi.org/10.1002/aur.1597	ADJ
cpe-2383	216	2	loparo	loparo	NOUN
cpe-2383	216	3	,	,	PUNCT
cpe-2383	216	4	d.	d.	PROPN
cpe-2383	216	5	,	,	PUNCT
cpe-2383	216	6	&	&	CCONJ
cpe-2383	216	7	waldman	waldman	PROPN
cpe-2383	216	8	,	,	PUNCT
cpe-2383	216	9	i.	i.	PROPN
cpe-2383	216	10	d.	d.	PROPN
cpe-2383	216	11	(	(	PUNCT
cpe-2383	216	12	2015	2015	NUM
cpe-2383	216	13	)	)	PUNCT
cpe-2383	216	14	.	.	PUNCT
cpe-2383	217	1	the	the	DET
cpe-2383	217	2	oxytocin	oxytocin	PROPN
cpe-2383	217	3	receptor	receptor	NOUN
cpe-2383	217	4	gene	gene	NOUN
cpe-2383	217	5	(	(	PUNCT
cpe-2383	217	6	oxtr	oxtr	NOUN
cpe-2383	217	7	)	)	PUNCT
cpe-2383	217	8	is	be	AUX
cpe-2383	217	9	associated	associate	VERB
cpe-2383	217	10	with	with	ADP
cpe-2383	217	11	autism	autism	NOUN
cpe-2383	217	12	spectrum	spectrum	NOUN
cpe-2383	217	13	disorder	disorder	NOUN
cpe-2383	217	14	:	:	PUNCT
cpe-2383	217	15	a	a	DET
cpe-2383	217	16	meta	meta	ADJ
cpe-2383	217	17	-	-	PUNCT
cpe-2383	217	18	analysis	analysis	NOUN
cpe-2383	217	19	.	.	PUNCT
cpe-2383	218	1	molecular	molecular	ADJ
cpe-2383	218	2	psychiatry	psychiatry	NOUN
cpe-2383	218	3	,	,	PUNCT
cpe-2383	218	4	20(5	20(5	NUM
cpe-2383	218	5	)	)	PUNCT
cpe-2383	218	6	,	,	PUNCT
cpe-2383	218	7	640	640	NUM
cpe-2383	218	8	-	-	SYM
cpe-2383	218	9	646	646	NUM
cpe-2383	218	10	.	.	PUNCT
cpe-2383	219	1	https://doi.org/10.1038/mp.2014.77	https://doi.org/10.1038/mp.2014.77	NUM
cpe-2383	219	2	maletic	maletic	ADJ
cpe-2383	219	3	,	,	PUNCT
cpe-2383	219	4	v.	v.	ADJ
cpe-2383	219	5	,	,	PUNCT
cpe-2383	219	6	eramo	eramo	PROPN
cpe-2383	219	7	,	,	PUNCT
cpe-2383	219	8	a.	a.	NOUN
cpe-2383	219	9	,	,	PUNCT
cpe-2383	219	10	gwin	gwin	PROPN
cpe-2383	219	11	,	,	PUNCT
cpe-2383	219	12	k.	k.	PROPN
cpe-2383	219	13	,	,	PUNCT
cpe-2383	219	14	offord	offord	PROPN
cpe-2383	219	15	,	,	PUNCT
cpe-2383	219	16	s.	s.	PROPN
cpe-2383	219	17	j.	j.	PROPN
cpe-2383	219	18	,	,	PUNCT
cpe-2383	219	19	&	&	CCONJ
cpe-2383	219	20	duffy	duffy	PROPN
cpe-2383	219	21	,	,	PUNCT
cpe-2383	219	22	r.	r.	PROPN
cpe-2383	219	23	a.	a.	PROPN
cpe-2383	219	24	(	(	PUNCT
cpe-2383	219	25	2017	2017	NUM
cpe-2383	219	26	)	)	PUNCT
cpe-2383	219	27	.	.	PUNCT
cpe-2383	220	1	the	the	DET
cpe-2383	220	2	role	role	NOUN
cpe-2383	220	3	of	of	ADP
cpe-2383	220	4	norepinephrine	norepinephrine	NOUN
cpe-2383	220	5	and	and	CCONJ
cpe-2383	220	6	its	its	PRON
cpe-2383	220	7	alpha	alpha	ADJ
cpe-2383	220	8	-	-	PUNCT
cpe-2383	220	9	adrenergic	adrenergic	ADJ
cpe-2383	220	10	receptors	receptor	NOUN
cpe-2383	220	11	in	in	ADP
cpe-2383	220	12	the	the	DET
cpe-2383	220	13	pathophysiology	pathophysiology	NOUN
cpe-2383	220	14	and	and	CCONJ
cpe-2383	220	15	treatment	treatment	NOUN
cpe-2383	220	16	of	of	ADP
cpe-2383	220	17	major	major	ADJ
cpe-2383	220	18	depressive	depressive	ADJ
cpe-2383	220	19	disorder	disorder	NOUN
cpe-2383	220	20	and	and	CCONJ
cpe-2383	220	21	schizophrenia	schizophrenia	NOUN
cpe-2383	220	22	:	:	PUNCT
cpe-2383	220	23	a	a	DET
cpe-2383	220	24	systematic	systematic	ADJ
cpe-2383	220	25	review	review	NOUN
cpe-2383	220	26	.	.	PUNCT
cpe-2383	221	1	frontiers	frontier	NOUN
cpe-2383	221	2	in	in	ADP
cpe-2383	221	3	psychiatry	psychiatry	NOUN
cpe-2383	221	4	,	,	PUNCT
cpe-2383	221	5	8	8	NUM
cpe-2383	221	6	,	,	PUNCT
cpe-2383	221	7	article	article	NOUN
cpe-2383	221	8	42	42	NUM
cpe-2383	221	9	.	.	PUNCT
cpe-2383	222	1	https://doi.org/10.3389/fpsyt.2017.00042	https://doi.org/10.3389/fpsyt.2017.00042	PROPN
cpe-2383	222	2	marsh	marsh	PROPN
cpe-2383	222	3	,	,	PUNCT
cpe-2383	222	4	w.	w.	PROPN
cpe-2383	222	5	k.	k.	PROPN
cpe-2383	222	6	,	,	PUNCT
cpe-2383	222	7	bromberger	bromberger	NOUN
cpe-2383	222	8	,	,	PUNCT
cpe-2383	222	9	j.	j.	PROPN
cpe-2383	222	10	t.	t.	PROPN
cpe-2383	222	11	,	,	PUNCT
cpe-2383	222	12	crawford	crawford	PROPN
cpe-2383	222	13	,	,	PUNCT
cpe-2383	222	14	s.	s.	PROPN
cpe-2383	222	15	l.	l.	PROPN
cpe-2383	222	16	,	,	PUNCT
cpe-2383	222	17	leung	leung	PROPN
cpe-2383	222	18	,	,	PUNCT
cpe-2383	222	19	k.	k.	PROPN
cpe-2383	222	20	,	,	PUNCT
cpe-2383	222	21	kravitz	kravitz	PROPN
cpe-2383	222	22	,	,	PUNCT
cpe-2383	222	23	h.	h.	PROPN
cpe-2383	222	24	m.	m.	PROPN
cpe-2383	222	25	,	,	PUNCT
cpe-2383	222	26	randolph	randolph	PROPN
cpe-2383	222	27	,	,	PUNCT
cpe-2383	222	28	j.	j.	PROPN
cpe-2383	222	29	f.	f.	PROPN
cpe-2383	222	30	,	,	PUNCT
cpe-2383	222	31	.	.	PUNCT
cpe-2383	222	32	.	.	PUNCT
cpe-2383	222	33	.	.	PUNCT
cpe-2383	223	1	soares	soare	NOUN
cpe-2383	223	2	,	,	PUNCT
cpe-2383	223	3	c.	c.	PROPN
cpe-2383	223	4	n.	n.	PROPN
cpe-2383	223	5	(	(	PUNCT
cpe-2383	223	6	2017	2017	NUM
cpe-2383	223	7	)	)	PUNCT
cpe-2383	223	8	.	.	PUNCT
cpe-2383	224	1	lifelong	lifelong	ADJ
cpe-2383	224	2	estradiol	estradiol	PROPN
cpe-2383	224	3	exposure	exposure	NOUN
cpe-2383	224	4	and	and	CCONJ
cpe-2383	224	5	risk	risk	NOUN
cpe-2383	224	6	of	of	ADP
cpe-2383	224	7	depressive	depressive	ADJ
cpe-2383	224	8	symptoms	symptom	NOUN
cpe-2383	224	9	during	during	ADP
cpe-2383	224	10	the	the	DET
cpe-2383	224	11	transition	transition	NOUN
cpe-2383	224	12	to	to	ADP
cpe-2383	224	13	menopause	menopause	NOUN
cpe-2383	224	14	and	and	CCONJ
cpe-2383	224	15	postmenopause	postmenopause	NOUN
cpe-2383	224	16	.	.	PROPN
cpe-2383	224	17	menopause	menopause	NOUN
cpe-2383	224	18	,	,	PUNCT
cpe-2383	224	19	24(12	24(12	NUM
cpe-2383	224	20	)	)	PUNCT
cpe-2383	224	21	,	,	PUNCT
cpe-2383	224	22	1351	1351	NUM
cpe-2383	224	23	-	-	SYM
cpe-2383	224	24	1359	1359	NUM
cpe-2383	224	25	.	.	PUNCT
cpe-2383	225	1	https://doi.org/10.1097/gme.0000000000000929	https://doi.org/10.1097/gme.0000000000000929	PROPN
cpe-2383	225	2	melcangi	melcangi	PROPN
cpe-2383	225	3	,	,	PUNCT
cpe-2383	225	4	r.	r.	PROPN
cpe-2383	225	5	c.	c.	PROPN
cpe-2383	225	6	,	,	PUNCT
cpe-2383	225	7	giatti	giatti	PROPN
cpe-2383	225	8	,	,	PUNCT
cpe-2383	225	9	s.	s.	PROPN
cpe-2383	225	10	,	,	PUNCT
cpe-2383	225	11	&	&	CCONJ
cpe-2383	225	12	garcia	garcia	PROPN
cpe-2383	225	13	-	-	PUNCT
cpe-2383	225	14	segura	segura	PROPN
cpe-2383	225	15	,	,	PUNCT
cpe-2383	225	16	l.	l.	PROPN
cpe-2383	225	17	m.	m.	PROPN
cpe-2383	225	18	(	(	PUNCT
cpe-2383	225	19	2016	2016	NUM
cpe-2383	225	20	)	)	PUNCT
cpe-2383	225	21	.	.	PUNCT
cpe-2383	226	1	levels	level	NOUN
cpe-2383	226	2	and	and	CCONJ
cpe-2383	226	3	actions	action	NOUN
cpe-2383	226	4	of	of	ADP
cpe-2383	226	5	neuroactive	neuroactive	ADJ
cpe-2383	226	6	steroids	steroid	NOUN
cpe-2383	226	7	in	in	ADP
cpe-2383	226	8	the	the	DET
cpe-2383	226	9	nervous	nervous	ADJ
cpe-2383	226	10	system	system	NOUN
cpe-2383	226	11	under	under	ADP
cpe-2383	226	12	physiological	physiological	ADJ
cpe-2383	226	13	and	and	CCONJ
cpe-2383	226	14	pathological	pathological	ADJ
cpe-2383	226	15	conditions	condition	NOUN
cpe-2383	226	16	:	:	PUNCT
cpe-2383	226	17	sex	sex	NOUN
cpe-2383	226	18	-	-	PUNCT
cpe-2383	226	19	specific	specific	ADJ
cpe-2383	226	20	features	feature	NOUN
cpe-2383	226	21	.	.	PUNCT
cpe-2383	227	1	neuroscience	neuroscience	NOUN
cpe-2383	227	2	&	&	CCONJ
cpe-2383	227	3	biobehavioral	biobehavioral	ADJ
cpe-2383	227	4	reviews	review	NOUN
cpe-2383	227	5	,	,	PUNCT
cpe-2383	227	6	67	67	NUM
cpe-2383	227	7	,	,	PUNCT
cpe-2383	227	8	25	25	NUM
cpe-2383	227	9	-	-	SYM
cpe-2383	227	10	40	40	NUM
cpe-2383	227	11	.	.	PUNCT
cpe-2383	228	1	https://doi.org/10.1016/j.neubiorev.2015.09.023	https://doi.org/10.1016/j.neubiorev.2015.09.023	PROPN
cpe-2383	228	2	meuret	meuret	PROPN
cpe-2383	228	3	,	,	PUNCT
cpe-2383	228	4	a.	a.	PROPN
cpe-2383	228	5	e.	e.	PROPN
cpe-2383	228	6	,	,	PUNCT
cpe-2383	228	7	rosenfield	rosenfield	VERB
cpe-2383	228	8	,	,	PUNCT
cpe-2383	228	9	d.	d.	PROPN
cpe-2383	228	10	,	,	PUNCT
cpe-2383	228	11	bhaskara	bhaskara	PROPN
cpe-2383	228	12	,	,	PUNCT
cpe-2383	228	13	l.	l.	PROPN
cpe-2383	228	14	,	,	PUNCT
cpe-2383	228	15	auchus	auchus	PROPN
cpe-2383	228	16	,	,	PUNCT
cpe-2383	228	17	r.	r.	PROPN
cpe-2383	228	18	,	,	PUNCT
cpe-2383	228	19	liberzon	liberzon	PROPN
cpe-2383	228	20	,	,	PUNCT
cpe-2383	228	21	i.	i.	PROPN
cpe-2383	228	22	,	,	PUNCT
cpe-2383	228	23	ritz	ritz	PROPN
cpe-2383	228	24	,	,	PUNCT
cpe-2383	228	25	t.	t.	PROPN
cpe-2383	228	26	,	,	PUNCT
cpe-2383	228	27	&	&	CCONJ
cpe-2383	228	28	abelson	abelson	PROPN
cpe-2383	228	29	,	,	PUNCT
cpe-2383	228	30	j.	j.	PROPN
cpe-2383	228	31	l.	l.	PROPN
cpe-2383	228	32	(	(	PUNCT
cpe-2383	228	33	2016	2016	NUM
cpe-2383	228	34	)	)	PUNCT
cpe-2383	228	35	.	.	PUNCT
cpe-2383	229	1	timing	timing	NOUN
cpe-2383	229	2	matters	matter	NOUN
cpe-2383	229	3	:	:	PUNCT
cpe-2383	229	4	endogenous	endogenous	ADJ
cpe-2383	229	5	cortisol	cortisol	NOUN
cpe-2383	229	6	mediates	mediate	VERB
cpe-2383	229	7	benefits	benefit	NOUN
cpe-2383	229	8	from	from	ADP
cpe-2383	229	9	early	early	ADJ
cpe-2383	229	10	-	-	PUNCT
cpe-2383	229	11	day	day	NOUN
cpe-2383	229	12	psychotherapy	psychotherapy	NOUN
cpe-2383	229	13	.	.	PUNCT
cpe-2383	230	1	psychoneuroendocrinology	psychoneuroendocrinology	NOUN
cpe-2383	230	2	,	,	PUNCT
cpe-2383	230	3	74	74	NUM
cpe-2383	230	4	,	,	PUNCT
cpe-2383	230	5	197	197	NUM
cpe-2383	230	6	-	-	SYM
cpe-2383	230	7	202	202	NUM
cpe-2383	230	8	.	.	PUNCT
cpe-2383	231	1	https://doi.org/10.1016/j.psyneuen.2016.09.008	https://doi.org/10.1016/j.psyneuen.2016.09.008	PROPN
cpe-2383	231	2	meyer	meyer	PROPN
cpe-2383	231	3	-	-	PUNCT
cpe-2383	231	4	lindenberg	lindenberg	PROPN
cpe-2383	231	5	,	,	PUNCT
cpe-2383	231	6	a.	a.	NOUN
cpe-2383	231	7	,	,	PUNCT
cpe-2383	231	8	domes	dome	NOUN
cpe-2383	231	9	,	,	PUNCT
cpe-2383	231	10	g.	g.	PROPN
cpe-2383	231	11	,	,	PUNCT
cpe-2383	231	12	kirsch	kirsch	PROPN
cpe-2383	231	13	,	,	PUNCT
cpe-2383	231	14	p.	p.	NOUN
cpe-2383	231	15	,	,	PUNCT
cpe-2383	231	16	&	&	CCONJ
cpe-2383	231	17	heinrichs	heinrichs	PROPN
cpe-2383	231	18	,	,	PUNCT
cpe-2383	231	19	m.	m.	NOUN
cpe-2383	231	20	(	(	PUNCT
cpe-2383	231	21	2011	2011	NUM
cpe-2383	231	22	)	)	PUNCT
cpe-2383	231	23	.	.	PUNCT
cpe-2383	232	1	oxytocin	oxytocin	PROPN
cpe-2383	232	2	and	and	CCONJ
cpe-2383	232	3	vasopressin	vasopressin	NOUN
cpe-2383	232	4	in	in	ADP
cpe-2383	232	5	the	the	DET
cpe-2383	232	6	human	human	ADJ
cpe-2383	232	7	brain	brain	NOUN
cpe-2383	232	8	:	:	PUNCT
cpe-2383	232	9	social	social	ADJ
cpe-2383	232	10	neuropeptides	neuropeptide	NOUN
cpe-2383	232	11	for	for	ADP
cpe-2383	232	12	translational	translational	ADJ
cpe-2383	232	13	medicine	medicine	NOUN
cpe-2383	232	14	.	.	PUNCT
cpe-2383	233	1	nature	nature	NOUN
cpe-2383	233	2	reviews	review	VERB
cpe-2383	233	3	neuroscience	neuroscience	NOUN
cpe-2383	233	4	,	,	PUNCT
cpe-2383	233	5	12(9	12(9	NUM
cpe-2383	233	6	)	)	PUNCT
cpe-2383	233	7	,	,	PUNCT
cpe-2383	233	8	524	524	NUM
cpe-2383	233	9	-	-	SYM
cpe-2383	233	10	538	538	NUM
cpe-2383	233	11	.	.	PUNCT
cpe-2383	234	1	https://doi.org/10.1038/nrn3044	https://doi.org/10.1038/nrn3044	PROPN
cpe-2383	234	2	morris	morris	PROPN
cpe-2383	234	3	,	,	PUNCT
cpe-2383	234	4	m.	m.	PROPN
cpe-2383	234	5	c.	c.	PROPN
cpe-2383	234	6	,	,	PUNCT
cpe-2383	234	7	compas	compas	PROPN
cpe-2383	234	8	,	,	PUNCT
cpe-2383	234	9	b.	b.	PROPN
cpe-2383	234	10	e.	e.	PROPN
cpe-2383	234	11	,	,	PUNCT
cpe-2383	234	12	&	&	CCONJ
cpe-2383	234	13	garber	garber	PROPN
cpe-2383	234	14	,	,	PUNCT
cpe-2383	234	15	j.	j.	PROPN
cpe-2383	234	16	(	(	PUNCT
cpe-2383	234	17	2012	2012	NUM
cpe-2383	234	18	)	)	PUNCT
cpe-2383	234	19	.	.	PUNCT
cpe-2383	235	1	relations	relation	NOUN
cpe-2383	235	2	among	among	ADP
cpe-2383	235	3	posttraumatic	posttraumatic	ADJ
cpe-2383	235	4	stress	stress	NOUN
cpe-2383	235	5	disorder	disorder	NOUN
cpe-2383	235	6	,	,	PUNCT
cpe-2383	235	7	comorbid	comorbid	NOUN
cpe-2383	235	8	major	major	ADJ
cpe-2383	235	9	depression	depression	NOUN
cpe-2383	235	10	,	,	PUNCT
cpe-2383	235	11	and	and	CCONJ
cpe-2383	235	12	hpa	hpa	NOUN
cpe-2383	235	13	function	function	NOUN
cpe-2383	235	14	:	:	PUNCT
cpe-2383	235	15	a	a	DET
cpe-2383	235	16	systematic	systematic	ADJ
cpe-2383	235	17	review	review	NOUN
cpe-2383	235	18	and	and	CCONJ
cpe-2383	235	19	meta	meta	ADJ
cpe-2383	235	20	-	-	PUNCT
cpe-2383	235	21	analysis	analysis	NOUN
cpe-2383	235	22	.	.	PUNCT
cpe-2383	236	1	clinical	clinical	ADJ
cpe-2383	236	2	psychology	psychology	NOUN
cpe-2383	236	3	review	review	NOUN
cpe-2383	236	4	,	,	PUNCT
cpe-2383	236	5	32(4	32(4	NUM
cpe-2383	236	6	)	)	PUNCT
cpe-2383	236	7	,	,	PUNCT
cpe-2383	236	8	301	301	NUM
cpe-2383	236	9	-	-	SYM
cpe-2383	236	10	315	315	NUM
cpe-2383	236	11	.	.	PUNCT
cpe-2383	237	1	https://doi.org/10.1016/j.cpr.2012.02.002	https://doi.org/10.1016/j.cpr.2012.02.002	NOUN
cpe-2383	237	2	nastri	nastri	PROPN
cpe-2383	237	3	,	,	PUNCT
cpe-2383	237	4	c.	c.	PROPN
cpe-2383	237	5	o.	o.	PROPN
cpe-2383	237	6	,	,	PUNCT
cpe-2383	237	7	lara	lara	PROPN
cpe-2383	237	8	,	,	PUNCT
cpe-2383	237	9	l.	l.	PROPN
cpe-2383	237	10	a.	a.	PROPN
cpe-2383	237	11	,	,	PUNCT
cpe-2383	237	12	ferriani	ferriani	PROPN
cpe-2383	237	13	,	,	PUNCT
cpe-2383	237	14	r.	r.	PROPN
cpe-2383	237	15	a.	a.	PROPN
cpe-2383	237	16	,	,	PUNCT
cpe-2383	237	17	rosa	rosa	PROPN
cpe-2383	237	18	,	,	PUNCT
cpe-2383	237	19	e.	e.	PROPN
cpe-2383	237	20	s.	s.	PROPN
cpe-2383	237	21	a.	a.	PROPN
cpe-2383	237	22	c.	c.	PROPN
cpe-2383	237	23	,	,	PUNCT
cpe-2383	237	24	figueiredo	figueiredo	PROPN
cpe-2383	237	25	,	,	PUNCT
cpe-2383	237	26	j.	j.	PROPN
cpe-2383	237	27	b.	b.	PROPN
cpe-2383	237	28	,	,	PUNCT
cpe-2383	237	29	&	&	CCONJ
cpe-2383	237	30	martins	martins	PROPN
cpe-2383	237	31	,	,	PUNCT
cpe-2383	237	32	w.	w.	PROPN
cpe-2383	237	33	p.	p.	PROPN
cpe-2383	237	34	(	(	PUNCT
cpe-2383	237	35	2013	2013	NUM
cpe-2383	237	36	)	)	PUNCT
cpe-2383	237	37	.	.	PUNCT
cpe-2383	238	1	hormone	hormone	NOUN
cpe-2383	238	2	therapy	therapy	NOUN
cpe-2383	238	3	for	for	ADP
cpe-2383	238	4	sexual	sexual	ADJ
cpe-2383	238	5	function	function	NOUN
cpe-2383	238	6	in	in	ADP
cpe-2383	238	7	perimenopausal	perimenopausal	NOUN
cpe-2383	238	8	and	and	CCONJ
cpe-2383	238	9	postmenopausal	postmenopausal	ADJ
cpe-2383	238	10	women	woman	NOUN
cpe-2383	238	11	.	.	PUNCT
cpe-2383	239	1	cochrane	cochrane	NOUN
cpe-2383	239	2	database	database	NOUN
cpe-2383	239	3	of	of	ADP
cpe-2383	239	4	systematic	systematic	ADJ
cpe-2383	239	5	reviews	review	NOUN
cpe-2383	239	6	,	,	PUNCT
cpe-2383	239	7	6	6	NUM
cpe-2383	239	8	,	,	PUNCT
cpe-2383	239	9	article	article	NOUN
cpe-2383	239	10	cd009672	cd009672	PROPN
cpe-2383	239	11	.	.	PUNCT
cpe-2383	239	12	nater	nater	NOUN
cpe-2383	239	13	,	,	PUNCT
cpe-2383	239	14	u.	u.	PROPN
cpe-2383	239	15	m.	m.	PROPN
cpe-2383	239	16	,	,	PUNCT
cpe-2383	239	17	fischer	fischer	PROPN
cpe-2383	239	18	,	,	PUNCT
cpe-2383	239	19	s.	s.	PROPN
cpe-2383	239	20	,	,	PUNCT
cpe-2383	239	21	&	&	CCONJ
cpe-2383	239	22	ehlert	ehlert	PROPN
cpe-2383	239	23	,	,	PUNCT
cpe-2383	239	24	u.	u.	PROPN
cpe-2383	239	25	(	(	PUNCT
cpe-2383	239	26	2011	2011	NUM
cpe-2383	239	27	)	)	PUNCT
cpe-2383	239	28	.	.	PUNCT
cpe-2383	240	1	stress	stress	NOUN
cpe-2383	240	2	as	as	ADP
cpe-2383	240	3	a	a	DET
cpe-2383	240	4	pathophysiological	pathophysiological	ADJ
cpe-2383	240	5	factor	factor	NOUN
cpe-2383	240	6	in	in	ADP
cpe-2383	240	7	functional	functional	ADJ
cpe-2383	240	8	somatic	somatic	ADJ
cpe-2383	240	9	syndromes	syndrome	NOUN
cpe-2383	240	10	.	.	PUNCT
cpe-2383	241	1	current	current	ADJ
cpe-2383	241	2	psychiatry	psychiatry	NOUN
cpe-2383	241	3	reviews	review	NOUN
cpe-2383	241	4	,	,	PUNCT
cpe-2383	241	5	7(2	7(2	NUM
cpe-2383	241	6	)	)	PUNCT
cpe-2383	241	7	,	,	PUNCT
cpe-2383	241	8	152	152	NUM
cpe-2383	241	9	-	-	SYM
cpe-2383	241	10	169	169	NUM
cpe-2383	241	11	.	.	PUNCT
cpe-2383	242	1	https://doi.org/10.2174/157340011796391184	https://doi.org/10.2174/157340011796391184	NOUN
cpe-2383	242	2	nater	nater	NOUN
cpe-2383	242	3	,	,	PUNCT
cpe-2383	242	4	u.	u.	NOUN
cpe-2383	242	5	m.	m.	PROPN
cpe-2383	242	6	,	,	PUNCT
cpe-2383	242	7	&	&	CCONJ
cpe-2383	242	8	rohleder	rohleder	PROPN
cpe-2383	242	9	,	,	PUNCT
cpe-2383	242	10	n.	n.	NOUN
cpe-2383	242	11	(	(	PUNCT
cpe-2383	242	12	2009	2009	NUM
cpe-2383	242	13	)	)	PUNCT
cpe-2383	242	14	.	.	PUNCT
cpe-2383	243	1	salivary	salivary	VERB
cpe-2383	243	2	alpha	alpha	NOUN
cpe-2383	243	3	-	-	PUNCT
cpe-2383	243	4	amylase	amylase	NOUN
cpe-2383	243	5	as	as	ADP
cpe-2383	243	6	a	a	DET
cpe-2383	243	7	non	non	ADJ
cpe-2383	243	8	-	-	ADJ
cpe-2383	243	9	invasive	invasive	ADJ
cpe-2383	243	10	biomarker	biomarker	NOUN
cpe-2383	243	11	for	for	ADP
cpe-2383	243	12	the	the	DET
cpe-2383	243	13	sympathetic	sympathetic	ADJ
cpe-2383	243	14	nervous	nervous	ADJ
cpe-2383	243	15	system	system	NOUN
cpe-2383	243	16	:	:	PUNCT
cpe-2383	243	17	current	current	ADJ
cpe-2383	243	18	state	state	NOUN
cpe-2383	243	19	of	of	ADP
cpe-2383	243	20	research	research	NOUN
cpe-2383	243	21	.	.	PUNCT
cpe-2383	244	1	psychoneuroendocrinology	psychoneuroendocrinology	NOUN
cpe-2383	244	2	,	,	PUNCT
cpe-2383	244	3	34(4	34(4	NUM
cpe-2383	244	4	)	)	PUNCT
cpe-2383	244	5	,	,	PUNCT
cpe-2383	244	6	486	486	NUM
cpe-2383	244	7	-	-	SYM
cpe-2383	244	8	496	496	NUM
cpe-2383	244	9	.	.	PUNCT
cpe-2383	245	1	https://doi.org/10.1016/j.psyneuen.2009.01.014	https://doi.org/10.1016/j.psyneuen.2009.01.014	PROPN
cpe-2383	245	2	fischer	fischer	PROPN
cpe-2383	245	3	&	&	CCONJ
cpe-2383	245	4	ehlert	ehlert	VERB
cpe-2383	245	5	11	11	NUM
cpe-2383	245	6	clinical	clinical	ADJ
cpe-2383	245	7	psychology	psychology	NOUN
cpe-2383	245	8	in	in	ADP
cpe-2383	245	9	europe	europe	PROPN
cpe-2383	245	10	2019	2019	NUM
cpe-2383	245	11	,	,	PUNCT
cpe-2383	245	12	vol.1(2	vol.1(2	PROPN
cpe-2383	245	13	)	)	PUNCT
cpe-2383	245	14	,	,	PUNCT
cpe-2383	245	15	article	article	NOUN
cpe-2383	245	16	33030	33030	NUM
cpe-2383	245	17	https://doi.org/10.32872/cpe.v1i2.33030	https://doi.org/10.32872/cpe.v1i2.33030	PROPN
cpe-2383	245	18	https://doi.org/10.1016/j.psyneuen.2017.09.022	https://doi.org/10.1016/j.psyneuen.2017.09.022	NOUN
cpe-2383	245	19	https://doi.org/10.1002/aur.1597	https://doi.org/10.1002/aur.1597	ADJ
cpe-2383	245	20	https://doi.org/10.1038/mp.2014.77	https://doi.org/10.1038/mp.2014.77	NUM
cpe-2383	245	21	https://doi.org/10.3389/fpsyt.2017.00042	https://doi.org/10.3389/fpsyt.2017.00042	PROPN
cpe-2383	245	22	https://doi.org/10.1097/gme.0000000000000929	https://doi.org/10.1097/gme.0000000000000929	NOUN
cpe-2383	245	23	https://doi.org/10.1016/j.neubiorev.2015.09.023	https://doi.org/10.1016/j.neubiorev.2015.09.023	NOUN
cpe-2383	245	24	https://doi.org/10.1016/j.psyneuen.2016.09.008	https://doi.org/10.1016/j.psyneuen.2016.09.008	NOUN
cpe-2383	245	25	https://doi.org/10.1038/nrn3044	https://doi.org/10.1038/nrn3044	VERB
cpe-2383	245	26	https://doi.org/10.1016/j.cpr.2012.02.002	https://doi.org/10.1016/j.cpr.2012.02.002	NOUN
cpe-2383	245	27	https://doi.org/10.2174/157340011796391184	https://doi.org/10.2174/157340011796391184	X
cpe-2383	245	28	https://doi.org/10.1016/j.psyneuen.2009.01.014	https://doi.org/10.1016/j.psyneuen.2009.01.014	ADJ
cpe-2383	245	29	https://www.psychopen.eu/	https://www.psychopen.eu/	VERB
cpe-2383	245	30	pillinger	pillinger	NOUN
cpe-2383	245	31	,	,	PUNCT
cpe-2383	245	32	t.	t.	PROPN
cpe-2383	245	33	,	,	PUNCT
cpe-2383	245	34	beck	beck	PROPN
cpe-2383	245	35	,	,	PUNCT
cpe-2383	245	36	k.	k.	PROPN
cpe-2383	245	37	,	,	PUNCT
cpe-2383	245	38	gobjila	gobjila	PROPN
cpe-2383	245	39	,	,	PUNCT
cpe-2383	245	40	c.	c.	PROPN
cpe-2383	245	41	,	,	PUNCT
cpe-2383	245	42	donocik	donocik	PROPN
cpe-2383	245	43	,	,	PUNCT
cpe-2383	245	44	j.	j.	PROPN
cpe-2383	245	45	g.	g.	PROPN
cpe-2383	245	46	,	,	PUNCT
cpe-2383	245	47	jauhar	jauhar	PROPN
cpe-2383	245	48	,	,	PUNCT
cpe-2383	245	49	s.	s.	PROPN
cpe-2383	245	50	,	,	PUNCT
cpe-2383	245	51	&	&	CCONJ
cpe-2383	245	52	howes	howes	PROPN
cpe-2383	245	53	,	,	PUNCT
cpe-2383	245	54	o.	o.	PROPN
cpe-2383	245	55	d.	d.	PROPN
cpe-2383	245	56	(	(	PUNCT
cpe-2383	245	57	2017	2017	NUM
cpe-2383	245	58	)	)	PUNCT
cpe-2383	245	59	.	.	PUNCT
cpe-2383	246	1	impaired	impair	VERB
cpe-2383	246	2	glucose	glucose	NOUN
cpe-2383	246	3	homeostasis	homeostasis	NOUN
cpe-2383	246	4	in	in	ADP
cpe-2383	246	5	first	first	ADJ
cpe-2383	246	6	-	-	PUNCT
cpe-2383	246	7	episode	episode	NOUN
cpe-2383	246	8	schizophrenia	schizophrenia	NOUN
cpe-2383	246	9	:	:	PUNCT
cpe-2383	246	10	a	a	DET
cpe-2383	246	11	systematic	systematic	ADJ
cpe-2383	246	12	review	review	NOUN
cpe-2383	246	13	and	and	CCONJ
cpe-2383	246	14	meta	meta	ADJ
cpe-2383	246	15	-	-	PUNCT
cpe-2383	246	16	analysis	analysis	NOUN
cpe-2383	246	17	.	.	PUNCT
cpe-2383	247	1	jama	jama	PROPN
cpe-2383	247	2	psychiatry	psychiatry	PROPN
cpe-2383	247	3	,	,	PUNCT
cpe-2383	247	4	74(3	74(3	NOUN
cpe-2383	247	5	)	)	PUNCT
cpe-2383	247	6	,	,	PUNCT
cpe-2383	247	7	261	261	NUM
cpe-2383	247	8	-	-	SYM
cpe-2383	247	9	269	269	NUM
cpe-2383	247	10	.	.	PUNCT
cpe-2383	248	1	https://doi.org/10.1001/jamapsychiatry.2016.3803	https://doi.org/10.1001/jamapsychiatry.2016.3803	PROPN
cpe-2383	248	2	prince	prince	PROPN
cpe-2383	248	3	,	,	PUNCT
cpe-2383	248	4	a.	a.	PROPN
cpe-2383	248	5	c.	c.	PROPN
cpe-2383	248	6	,	,	PUNCT
cpe-2383	248	7	brooks	brooks	PROPN
cpe-2383	248	8	,	,	PUNCT
cpe-2383	248	9	s.	s.	PROPN
cpe-2383	248	10	j.	j.	PROPN
cpe-2383	248	11	,	,	PUNCT
cpe-2383	248	12	stahl	stahl	PROPN
cpe-2383	248	13	,	,	PUNCT
cpe-2383	248	14	d.	d.	PROPN
cpe-2383	248	15	,	,	PUNCT
cpe-2383	248	16	&	&	CCONJ
cpe-2383	248	17	treasure	treasure	NOUN
cpe-2383	248	18	,	,	PUNCT
cpe-2383	248	19	j.	j.	PROPN
cpe-2383	248	20	(	(	PUNCT
cpe-2383	248	21	2009	2009	NUM
cpe-2383	248	22	)	)	PUNCT
cpe-2383	248	23	.	.	PUNCT
cpe-2383	249	1	systematic	systematic	ADJ
cpe-2383	249	2	review	review	NOUN
cpe-2383	249	3	and	and	CCONJ
cpe-2383	249	4	meta	meta	NOUN
cpe-2383	249	5	-	-	PUNCT
cpe-2383	249	6	analysis	analysis	NOUN
cpe-2383	249	7	of	of	ADP
cpe-2383	249	8	the	the	DET
cpe-2383	249	9	baseline	baseline	ADJ
cpe-2383	249	10	concentrations	concentration	NOUN
cpe-2383	249	11	and	and	CCONJ
cpe-2383	249	12	physiologic	physiologic	ADJ
cpe-2383	249	13	responses	response	NOUN
cpe-2383	249	14	of	of	ADP
cpe-2383	249	15	gut	gut	NOUN
cpe-2383	249	16	hormones	hormone	NOUN
cpe-2383	249	17	to	to	ADP
cpe-2383	249	18	food	food	NOUN
cpe-2383	249	19	in	in	ADP
cpe-2383	249	20	eating	eat	VERB
cpe-2383	249	21	disorders	disorder	NOUN
cpe-2383	249	22	.	.	PUNCT
cpe-2383	250	1	the	the	DET
cpe-2383	250	2	american	american	PROPN
cpe-2383	250	3	journal	journal	PROPN
cpe-2383	250	4	of	of	ADP
cpe-2383	250	5	clinical	clinical	ADJ
cpe-2383	250	6	nutrition	nutrition	NOUN
cpe-2383	250	7	,	,	PUNCT
cpe-2383	250	8	89(3	89(3	NUM
cpe-2383	250	9	)	)	PUNCT
cpe-2383	250	10	,	,	PUNCT
cpe-2383	250	11	755	755	NUM
cpe-2383	250	12	-	-	SYM
cpe-2383	250	13	765	765	NUM
cpe-2383	250	14	.	.	PUNCT
cpe-2383	251	1	https://doi.org/10.3945/ajcn.2008.27056	https://doi.org/10.3945/ajcn.2008.27056	PROPN
cpe-2383	251	2	ricken	ricken	VERB
cpe-2383	251	3	,	,	PUNCT
cpe-2383	251	4	r.	r.	PROPN
cpe-2383	251	5	,	,	PUNCT
cpe-2383	251	6	bopp	bopp	PROPN
cpe-2383	251	7	,	,	PUNCT
cpe-2383	251	8	s.	s.	PROPN
cpe-2383	251	9	,	,	PUNCT
cpe-2383	251	10	schlattmann	schlattmann	PROPN
cpe-2383	251	11	,	,	PUNCT
cpe-2383	251	12	p.	p.	PROPN
cpe-2383	251	13	,	,	PUNCT
cpe-2383	251	14	himmerich	himmerich	PROPN
cpe-2383	251	15	,	,	PUNCT
cpe-2383	251	16	h.	h.	PROPN
cpe-2383	251	17	,	,	PUNCT
cpe-2383	251	18	bschor	bschor	NOUN
cpe-2383	251	19	,	,	PUNCT
cpe-2383	251	20	t.	t.	PROPN
cpe-2383	251	21	,	,	PUNCT
cpe-2383	251	22	richter	richter	PROPN
cpe-2383	251	23	,	,	PUNCT
cpe-2383	251	24	c.	c.	PROPN
cpe-2383	251	25	,	,	PUNCT
cpe-2383	251	26	.	.	PUNCT
cpe-2383	251	27	.	.	PUNCT
cpe-2383	251	28	.	.	PUNCT
cpe-2383	252	1	adli	adli	PROPN
cpe-2383	252	2	,	,	PUNCT
cpe-2383	252	3	m.	m.	NOUN
cpe-2383	252	4	(	(	PUNCT
cpe-2383	252	5	2017	2017	NUM
cpe-2383	252	6	)	)	PUNCT
cpe-2383	252	7	.	.	PUNCT
cpe-2383	253	1	ghrelin	ghrelin	NOUN
cpe-2383	253	2	serum	serum	NOUN
cpe-2383	253	3	concentrations	concentration	NOUN
cpe-2383	253	4	are	be	AUX
cpe-2383	253	5	associated	associate	VERB
cpe-2383	253	6	with	with	ADP
cpe-2383	253	7	treatment	treatment	NOUN
cpe-2383	253	8	response	response	NOUN
cpe-2383	253	9	during	during	ADP
cpe-2383	253	10	lithium	lithium	NOUN
cpe-2383	253	11	augmentation	augmentation	NOUN
cpe-2383	253	12	of	of	ADP
cpe-2383	253	13	antidepressants	antidepressant	NOUN
cpe-2383	253	14	.	.	PUNCT
cpe-2383	254	1	international	international	ADJ
cpe-2383	254	2	journal	journal	PROPN
cpe-2383	254	3	of	of	ADP
cpe-2383	254	4	neuropsychopharmacology	neuropsychopharmacology	PROPN
cpe-2383	254	5	,	,	PUNCT
cpe-2383	254	6	20(9	20(9	NUM
cpe-2383	254	7	)	)	PUNCT
cpe-2383	254	8	,	,	PUNCT
cpe-2383	254	9	692	692	NUM
cpe-2383	254	10	-	-	SYM
cpe-2383	254	11	697	697	NUM
cpe-2383	254	12	.	.	PUNCT
cpe-2383	255	1	https://doi.org/10.1093/ijnp/pyw082	https://doi.org/10.1093/ijnp/pyw082	PROPN
cpe-2383	255	2	ricken	ricken	PROPN
cpe-2383	255	3	,	,	PUNCT
cpe-2383	255	4	r.	r.	PROPN
cpe-2383	255	5	,	,	PUNCT
cpe-2383	255	6	bopp	bopp	PROPN
cpe-2383	255	7	,	,	PUNCT
cpe-2383	255	8	s.	s.	PROPN
cpe-2383	255	9	,	,	PUNCT
cpe-2383	255	10	schlattmann	schlattmann	PROPN
cpe-2383	255	11	,	,	PUNCT
cpe-2383	255	12	p.	p.	PROPN
cpe-2383	255	13	,	,	PUNCT
cpe-2383	255	14	himmerich	himmerich	PROPN
cpe-2383	255	15	,	,	PUNCT
cpe-2383	255	16	h.	h.	PROPN
cpe-2383	255	17	,	,	PUNCT
cpe-2383	255	18	bschor	bschor	NOUN
cpe-2383	255	19	,	,	PUNCT
cpe-2383	255	20	t.	t.	PROPN
cpe-2383	255	21	,	,	PUNCT
cpe-2383	255	22	richter	richter	PROPN
cpe-2383	255	23	,	,	PUNCT
cpe-2383	255	24	c.	c.	PROPN
cpe-2383	255	25	,	,	PUNCT
cpe-2383	255	26	.	.	PUNCT
cpe-2383	255	27	.	.	PUNCT
cpe-2383	255	28	.	.	PUNCT
cpe-2383	256	1	adli	adli	PROPN
cpe-2383	256	2	,	,	PUNCT
cpe-2383	256	3	m.	m.	NOUN
cpe-2383	256	4	(	(	PUNCT
cpe-2383	256	5	2016	2016	NUM
cpe-2383	256	6	)	)	PUNCT
cpe-2383	256	7	.	.	PUNCT
cpe-2383	257	1	leptin	leptin	NOUN
cpe-2383	257	2	serum	serum	NOUN
cpe-2383	257	3	concentrations	concentration	NOUN
cpe-2383	257	4	are	be	AUX
cpe-2383	257	5	associated	associate	VERB
cpe-2383	257	6	with	with	ADP
cpe-2383	257	7	weight	weight	NOUN
cpe-2383	257	8	gain	gain	NOUN
cpe-2383	257	9	during	during	ADP
cpe-2383	257	10	lithium	lithium	NOUN
cpe-2383	257	11	augmentation	augmentation	NOUN
cpe-2383	257	12	.	.	PUNCT
cpe-2383	258	1	psychoneuroendocrinology	psychoneuroendocrinology	NOUN
cpe-2383	258	2	,	,	PUNCT
cpe-2383	258	3	71	71	NUM
cpe-2383	258	4	,	,	PUNCT
cpe-2383	258	5	31	31	NUM
cpe-2383	258	6	-	-	SYM
cpe-2383	258	7	35	35	NUM
cpe-2383	258	8	.	.	PUNCT
cpe-2383	259	1	https://doi.org/10.1016/j.psyneuen.2016.04.013	https://doi.org/10.1016/j.psyneuen.2016.04.013	PROPN
cpe-2383	259	2	rutigliano	rutigliano	NOUN
cpe-2383	259	3	,	,	PUNCT
cpe-2383	259	4	g.	g.	PROPN
cpe-2383	259	5	,	,	PUNCT
cpe-2383	259	6	rocchetti	rocchetti	PROPN
cpe-2383	259	7	,	,	PUNCT
cpe-2383	259	8	m.	m.	NOUN
cpe-2383	259	9	,	,	PUNCT
cpe-2383	259	10	paloyelis	paloyelis	PROPN
cpe-2383	259	11	,	,	PUNCT
cpe-2383	259	12	y.	y.	PROPN
cpe-2383	259	13	,	,	PUNCT
cpe-2383	259	14	gilleen	gilleen	VERB
cpe-2383	259	15	,	,	PUNCT
cpe-2383	259	16	j.	j.	PROPN
cpe-2383	259	17	,	,	PUNCT
cpe-2383	259	18	sardella	sardella	NOUN
cpe-2383	259	19	,	,	PUNCT
cpe-2383	259	20	a.	a.	NOUN
cpe-2383	259	21	,	,	PUNCT
cpe-2383	259	22	cappucciati	cappucciati	NOUN
cpe-2383	259	23	,	,	PUNCT
cpe-2383	259	24	m.	m.	NOUN
cpe-2383	259	25	,	,	PUNCT
cpe-2383	259	26	.	.	PUNCT
cpe-2383	259	27	.	.	PUNCT
cpe-2383	259	28	.	.	PUNCT
cpe-2383	260	1	fusar	fusar	VERB
cpe-2383	260	2	-	-	PUNCT
cpe-2383	260	3	poli	poli	PROPN
cpe-2383	260	4	,	,	PUNCT
cpe-2383	260	5	p.	p.	NOUN
cpe-2383	260	6	(	(	PUNCT
cpe-2383	260	7	2016	2016	NUM
cpe-2383	260	8	)	)	PUNCT
cpe-2383	260	9	.	.	PUNCT
cpe-2383	261	1	peripheral	peripheral	ADJ
cpe-2383	261	2	oxytocin	oxytocin	PROPN
cpe-2383	261	3	and	and	CCONJ
cpe-2383	261	4	vasopressin	vasopressin	NOUN
cpe-2383	261	5	:	:	PUNCT
cpe-2383	261	6	biomarkers	biomarker	NOUN
cpe-2383	261	7	of	of	ADP
cpe-2383	261	8	psychiatric	psychiatric	ADJ
cpe-2383	261	9	disorders	disorder	NOUN
cpe-2383	261	10	?	?	PUNCT
cpe-2383	262	1	a	a	DET
cpe-2383	262	2	comprehensive	comprehensive	ADJ
cpe-2383	262	3	systematic	systematic	ADJ
cpe-2383	262	4	review	review	NOUN
cpe-2383	262	5	and	and	CCONJ
cpe-2383	262	6	preliminary	preliminary	ADJ
cpe-2383	262	7	meta	meta	ADJ
cpe-2383	262	8	-	-	PUNCT
cpe-2383	262	9	analysis	analysis	NOUN
cpe-2383	262	10	.	.	PUNCT
cpe-2383	263	1	psychiatry	psychiatry	NOUN
cpe-2383	263	2	research	research	PROPN
cpe-2383	263	3	,	,	PUNCT
cpe-2383	263	4	241	241	NUM
cpe-2383	263	5	,	,	PUNCT
cpe-2383	263	6	207	207	NUM
cpe-2383	263	7	-	-	SYM
cpe-2383	263	8	220	220	NUM
cpe-2383	263	9	.	.	PUNCT
cpe-2383	264	1	https://doi.org/10.1016/j.psychres.2016.04.117	https://doi.org/10.1016/j.psychres.2016.04.117	PROPN
cpe-2383	264	2	salzmann	salzmann	NOUN
cpe-2383	264	3	,	,	PUNCT
cpe-2383	264	4	s.	s.	PROPN
cpe-2383	264	5	,	,	PUNCT
cpe-2383	264	6	euteneuer	euteneuer	NOUN
cpe-2383	264	7	,	,	PUNCT
cpe-2383	264	8	f.	f.	PROPN
cpe-2383	264	9	,	,	PUNCT
cpe-2383	264	10	laferton	laferton	PROPN
cpe-2383	264	11	,	,	PUNCT
cpe-2383	264	12	j.	j.	PROPN
cpe-2383	264	13	a.	a.	PROPN
cpe-2383	264	14	c.	c.	PROPN
cpe-2383	264	15	,	,	PUNCT
cpe-2383	264	16	auer	auer	NOUN
cpe-2383	264	17	,	,	PUNCT
cpe-2383	264	18	c.	c.	PROPN
cpe-2383	264	19	j.	j.	PROPN
cpe-2383	264	20	,	,	PUNCT
cpe-2383	264	21	shedden	shedden	PROPN
cpe-2383	264	22	-	-	PUNCT
cpe-2383	264	23	mora	mora	PROPN
cpe-2383	264	24	,	,	PUNCT
cpe-2383	264	25	m.	m.	PROPN
cpe-2383	264	26	c.	c.	PROPN
cpe-2383	264	27	,	,	PUNCT
cpe-2383	264	28	schedlowski	schedlowski	NOUN
cpe-2383	264	29	,	,	PUNCT
cpe-2383	264	30	m.	m.	NOUN
cpe-2383	264	31	,	,	PUNCT
cpe-2383	264	32	.	.	PUNCT
cpe-2383	264	33	.	.	PUNCT
cpe-2383	264	34	.	.	PUNCT
cpe-2383	265	1	rief	rief	NOUN
cpe-2383	265	2	,	,	PUNCT
cpe-2383	265	3	w.	w.	PROPN
cpe-2383	265	4	(	(	PUNCT
cpe-2383	265	5	2017	2017	NUM
cpe-2383	265	6	)	)	PUNCT
cpe-2383	265	7	.	.	PUNCT
cpe-2383	266	1	effects	effect	NOUN
cpe-2383	266	2	of	of	ADP
cpe-2383	266	3	preoperative	preoperative	ADJ
cpe-2383	266	4	psychological	psychological	ADJ
cpe-2383	266	5	interventions	intervention	NOUN
cpe-2383	266	6	on	on	ADP
cpe-2383	266	7	catecholamine	catecholamine	NOUN
cpe-2383	266	8	and	and	CCONJ
cpe-2383	266	9	cortisol	cortisol	ADJ
cpe-2383	266	10	levels	level	NOUN
cpe-2383	266	11	after	after	ADP
cpe-2383	266	12	surgery	surgery	NOUN
cpe-2383	266	13	in	in	ADP
cpe-2383	266	14	coronary	coronary	ADJ
cpe-2383	266	15	artery	artery	NOUN
cpe-2383	266	16	bypass	bypass	NOUN
cpe-2383	266	17	graft	graft	NOUN
cpe-2383	266	18	patients	patient	NOUN
cpe-2383	266	19	:	:	PUNCT
cpe-2383	266	20	the	the	DET
cpe-2383	266	21	randomized	randomize	VERB
cpe-2383	266	22	controlled	control	VERB
cpe-2383	266	23	psy	psy	NOUN
cpe-2383	266	24	-	-	PUNCT
cpe-2383	266	25	heart	heart	NOUN
cpe-2383	266	26	trial	trial	NOUN
cpe-2383	266	27	.	.	PUNCT
cpe-2383	267	1	psychosomatic	psychosomatic	ADJ
cpe-2383	267	2	medicine	medicine	NOUN
cpe-2383	267	3	,	,	PUNCT
cpe-2383	267	4	79(7	79(7	NOUN
cpe-2383	267	5	)	)	PUNCT
cpe-2383	267	6	,	,	PUNCT
cpe-2383	267	7	806	806	NUM
cpe-2383	267	8	-	-	SYM
cpe-2383	267	9	814	814	NUM
cpe-2383	267	10	.	.	PUNCT
cpe-2383	268	1	https://doi.org/10.1097/psy.0000000000000483	https://doi.org/10.1097/psy.0000000000000483	PROPN
cpe-2383	268	2	soria	soria	PROPN
cpe-2383	268	3	,	,	PUNCT
cpe-2383	268	4	v.	v.	PROPN
cpe-2383	268	5	,	,	PUNCT
cpe-2383	268	6	gonzalez	gonzalez	PROPN
cpe-2383	268	7	-	-	PUNCT
cpe-2383	268	8	rodriguez	rodriguez	PROPN
cpe-2383	268	9	,	,	PUNCT
cpe-2383	268	10	a.	a.	PROPN
cpe-2383	268	11	,	,	PUNCT
cpe-2383	268	12	huerta	huerta	PROPN
cpe-2383	268	13	-	-	PUNCT
cpe-2383	268	14	ramos	ramos	PROPN
cpe-2383	268	15	,	,	PUNCT
cpe-2383	268	16	e.	e.	PROPN
cpe-2383	268	17	,	,	PUNCT
cpe-2383	268	18	usall	usall	PROPN
cpe-2383	268	19	,	,	PUNCT
cpe-2383	268	20	j.	j.	PROPN
cpe-2383	268	21	,	,	PUNCT
cpe-2383	268	22	cobo	cobo	PROPN
cpe-2383	268	23	,	,	PUNCT
cpe-2383	268	24	j.	j.	PROPN
cpe-2383	268	25	,	,	PUNCT
cpe-2383	268	26	bioque	bioque	NOUN
cpe-2383	268	27	,	,	PUNCT
cpe-2383	268	28	m.	m.	NOUN
cpe-2383	268	29	,	,	PUNCT
cpe-2383	268	30	.	.	PUNCT
cpe-2383	268	31	.	.	PUNCT
cpe-2383	268	32	.	.	PUNCT
cpe-2383	269	1	labad	labad	PROPN
cpe-2383	269	2	,	,	PUNCT
cpe-2383	269	3	j.	j.	PROPN
cpe-2383	269	4	(	(	PUNCT
cpe-2383	269	5	2018	2018	NUM
cpe-2383	269	6	)	)	PUNCT
cpe-2383	269	7	.	.	PUNCT
cpe-2383	270	1	targeting	target	VERB
cpe-2383	270	2	hypothalamic	hypothalamic	ADJ
cpe-2383	270	3	-	-	PUNCT
cpe-2383	270	4	pituitary	pituitary	ADJ
cpe-2383	270	5	-	-	PUNCT
cpe-2383	270	6	adrenal	adrenal	ADJ
cpe-2383	270	7	axis	axis	NOUN
cpe-2383	270	8	hormones	hormone	NOUN
cpe-2383	270	9	and	and	CCONJ
cpe-2383	270	10	sex	sex	NOUN
cpe-2383	270	11	steroids	steroid	NOUN
cpe-2383	270	12	for	for	ADP
cpe-2383	270	13	improving	improve	VERB
cpe-2383	270	14	cognition	cognition	NOUN
cpe-2383	270	15	in	in	ADP
cpe-2383	270	16	major	major	ADJ
cpe-2383	270	17	mood	mood	NOUN
cpe-2383	270	18	disorders	disorder	NOUN
cpe-2383	270	19	and	and	CCONJ
cpe-2383	270	20	schizophrenia	schizophrenia	NOUN
cpe-2383	270	21	:	:	PUNCT
cpe-2383	270	22	a	a	DET
cpe-2383	270	23	systematic	systematic	ADJ
cpe-2383	270	24	review	review	NOUN
cpe-2383	270	25	and	and	CCONJ
cpe-2383	270	26	narrative	narrative	NOUN
cpe-2383	270	27	synthesis	synthesis	NOUN
cpe-2383	270	28	.	.	PUNCT
cpe-2383	271	1	psychoneuroendocrinology	psychoneuroendocrinology	NOUN
cpe-2383	271	2	,	,	PUNCT
cpe-2383	271	3	93	93	NUM
cpe-2383	271	4	,	,	PUNCT
cpe-2383	271	5	8	8	NUM
cpe-2383	271	6	-	-	SYM
cpe-2383	271	7	19	19	NUM
cpe-2383	271	8	.	.	PUNCT
cpe-2383	271	9	https://doi.org/10.1016/j.psyneuen.2018.04.012	https://doi.org/10.1016/j.psyneuen.2018.04.012	NOUN
cpe-2383	271	10	stetler	stetler	NOUN
cpe-2383	271	11	,	,	PUNCT
cpe-2383	271	12	c.	c.	PROPN
cpe-2383	271	13	,	,	PUNCT
cpe-2383	271	14	&	&	CCONJ
cpe-2383	271	15	miller	miller	PROPN
cpe-2383	271	16	,	,	PUNCT
cpe-2383	271	17	g.	g.	PROPN
cpe-2383	271	18	e.	e.	PROPN
cpe-2383	271	19	(	(	PUNCT
cpe-2383	271	20	2011	2011	NUM
cpe-2383	271	21	)	)	PUNCT
cpe-2383	271	22	.	.	PUNCT
cpe-2383	272	1	depression	depression	NOUN
cpe-2383	272	2	and	and	CCONJ
cpe-2383	272	3	hypothalamic	hypothalamic	ADJ
cpe-2383	272	4	-	-	PUNCT
cpe-2383	272	5	pituitary	pituitary	ADJ
cpe-2383	272	6	-	-	PUNCT
cpe-2383	272	7	adrenal	adrenal	ADJ
cpe-2383	272	8	activation	activation	NOUN
cpe-2383	272	9	:	:	PUNCT
cpe-2383	272	10	a	a	DET
cpe-2383	272	11	quantitative	quantitative	ADJ
cpe-2383	272	12	summary	summary	NOUN
cpe-2383	272	13	of	of	ADP
cpe-2383	272	14	four	four	NUM
cpe-2383	272	15	decades	decade	NOUN
cpe-2383	272	16	of	of	ADP
cpe-2383	272	17	research	research	NOUN
cpe-2383	272	18	.	.	PUNCT
cpe-2383	273	1	psychosomatic	psychosomatic	ADJ
cpe-2383	273	2	medicine	medicine	NOUN
cpe-2383	273	3	,	,	PUNCT
cpe-2383	273	4	73(2	73(2	NUM
cpe-2383	273	5	)	)	PUNCT
cpe-2383	273	6	,	,	PUNCT
cpe-2383	273	7	114	114	NUM
cpe-2383	273	8	-	-	SYM
cpe-2383	273	9	126	126	NUM
cpe-2383	273	10	.	.	PUNCT
cpe-2383	274	1	https://doi.org/10.1097/psy.0b013e31820ad12b	https://doi.org/10.1097/psy.0b013e31820ad12b	NUM
cpe-2383	274	2	stubbs	stubbs	PROPN
cpe-2383	274	3	,	,	PUNCT
cpe-2383	274	4	b.	b.	PROPN
cpe-2383	274	5	,	,	PUNCT
cpe-2383	274	6	wang	wang	PROPN
cpe-2383	274	7	,	,	PUNCT
cpe-2383	274	8	a.	a.	PROPN
cpe-2383	274	9	k.	k.	PROPN
cpe-2383	274	10	,	,	PUNCT
cpe-2383	274	11	vancampfort	vancampfort	PROPN
cpe-2383	274	12	,	,	PUNCT
cpe-2383	274	13	d.	d.	PROPN
cpe-2383	274	14	,	,	PUNCT
cpe-2383	274	15	&	&	CCONJ
cpe-2383	274	16	miller	miller	PROPN
cpe-2383	274	17	,	,	PUNCT
cpe-2383	274	18	b.	b.	PROPN
cpe-2383	274	19	j.	j.	PROPN
cpe-2383	274	20	(	(	PUNCT
cpe-2383	274	21	2016	2016	NUM
cpe-2383	274	22	)	)	PUNCT
cpe-2383	274	23	.	.	PUNCT
cpe-2383	274	24	are	be	AUX
cpe-2383	274	25	leptin	leptin	NOUN
cpe-2383	274	26	levels	level	NOUN
cpe-2383	274	27	increased	increase	VERB
cpe-2383	274	28	among	among	ADP
cpe-2383	274	29	people	people	NOUN
cpe-2383	274	30	with	with	ADP
cpe-2383	274	31	schizophrenia	schizophrenia	NOUN
cpe-2383	274	32	versus	versus	ADP
cpe-2383	274	33	controls	control	NOUN
cpe-2383	274	34	?	?	PUNCT
cpe-2383	275	1	a	a	DET
cpe-2383	275	2	systematic	systematic	ADJ
cpe-2383	275	3	review	review	NOUN
cpe-2383	275	4	and	and	CCONJ
cpe-2383	275	5	comparative	comparative	ADJ
cpe-2383	275	6	metaanalysis	metaanalysis	NOUN
cpe-2383	275	7	.	.	PUNCT
cpe-2383	276	1	psychoneuroendocrinology	psychoneuroendocrinology	NOUN
cpe-2383	276	2	,	,	PUNCT
cpe-2383	276	3	63	63	NUM
cpe-2383	276	4	,	,	PUNCT
cpe-2383	276	5	144	144	NUM
cpe-2383	276	6	-	-	SYM
cpe-2383	276	7	154	154	NUM
cpe-2383	276	8	.	.	PUNCT
cpe-2383	277	1	https://doi.org/10.1016/j.psyneuen.2015.09.026	https://doi.org/10.1016/j.psyneuen.2015.09.026	PROPN
cpe-2383	277	2	tak	tak	PROPN
cpe-2383	277	3	,	,	PUNCT
cpe-2383	277	4	l.	l.	PROPN
cpe-2383	277	5	m.	m.	PROPN
cpe-2383	277	6	,	,	PUNCT
cpe-2383	277	7	cleare	cleare	PROPN
cpe-2383	277	8	,	,	PUNCT
cpe-2383	277	9	a.	a.	PROPN
cpe-2383	277	10	j.	j.	PROPN
cpe-2383	277	11	,	,	PUNCT
cpe-2383	277	12	ormel	ormel	PROPN
cpe-2383	277	13	,	,	PUNCT
cpe-2383	277	14	j.	j.	PROPN
cpe-2383	277	15	,	,	PUNCT
cpe-2383	277	16	manoharan	manoharan	NOUN
cpe-2383	277	17	,	,	PUNCT
cpe-2383	277	18	a.	a.	PROPN
cpe-2383	277	19	,	,	PUNCT
cpe-2383	277	20	kok	kok	PROPN
cpe-2383	277	21	,	,	PUNCT
cpe-2383	277	22	i.	i.	PROPN
cpe-2383	277	23	c.	c.	PROPN
cpe-2383	277	24	,	,	PUNCT
cpe-2383	277	25	wessely	wessely	ADV
cpe-2383	277	26	,	,	PUNCT
cpe-2383	277	27	s.	s.	PROPN
cpe-2383	277	28	,	,	PUNCT
cpe-2383	277	29	&	&	CCONJ
cpe-2383	277	30	rosmalen	rosmalen	PROPN
cpe-2383	277	31	,	,	PUNCT
cpe-2383	277	32	j.	j.	PROPN
cpe-2383	277	33	g.	g.	PROPN
cpe-2383	277	34	m.	m.	PROPN
cpe-2383	277	35	(	(	PUNCT
cpe-2383	277	36	2011	2011	NUM
cpe-2383	277	37	)	)	PUNCT
cpe-2383	277	38	.	.	PUNCT
cpe-2383	278	1	meta	meta	ADJ
cpe-2383	278	2	-	-	PUNCT
cpe-2383	278	3	analysis	analysis	NOUN
cpe-2383	278	4	and	and	CCONJ
cpe-2383	278	5	meta	meta	NOUN
cpe-2383	278	6	-	-	PUNCT
cpe-2383	278	7	regression	regression	NOUN
cpe-2383	278	8	of	of	ADP
cpe-2383	278	9	hypothalamic	hypothalamic	ADJ
cpe-2383	278	10	-	-	PUNCT
cpe-2383	278	11	pituitary	pituitary	ADJ
cpe-2383	278	12	-	-	PUNCT
cpe-2383	278	13	adrenal	adrenal	ADJ
cpe-2383	278	14	axis	axis	NOUN
cpe-2383	278	15	activity	activity	NOUN
cpe-2383	278	16	in	in	ADP
cpe-2383	278	17	functional	functional	ADJ
cpe-2383	278	18	somatic	somatic	ADJ
cpe-2383	278	19	disorders	disorder	NOUN
cpe-2383	278	20	.	.	PUNCT
cpe-2383	279	1	biological	biological	ADJ
cpe-2383	279	2	psychiatry	psychiatry	NOUN
cpe-2383	279	3	,	,	PUNCT
cpe-2383	279	4	87(2	87(2	NUM
cpe-2383	279	5	)	)	PUNCT
cpe-2383	279	6	,	,	PUNCT
cpe-2383	279	7	183	183	NUM
cpe-2383	279	8	-	-	SYM
cpe-2383	279	9	194	194	NUM
cpe-2383	279	10	.	.	PUNCT
cpe-2383	280	1	https://doi.org/10.1016/j.biopsycho.2011.02.002	https://doi.org/10.1016/j.biopsycho.2011.02.002	NOUN
cpe-2383	280	2	valstad	valstad	NOUN
cpe-2383	280	3	,	,	PUNCT
cpe-2383	280	4	m.	m.	NOUN
cpe-2383	280	5	,	,	PUNCT
cpe-2383	280	6	alvares	alvare	NOUN
cpe-2383	280	7	,	,	PUNCT
cpe-2383	280	8	g.	g.	PROPN
cpe-2383	280	9	a.	a.	PROPN
cpe-2383	280	10	,	,	PUNCT
cpe-2383	280	11	egknud	egknud	PROPN
cpe-2383	280	12	,	,	PUNCT
cpe-2383	280	13	m.	m.	NOUN
cpe-2383	280	14	,	,	PUNCT
cpe-2383	280	15	matziorinis	matziorinis	NOUN
cpe-2383	280	16	,	,	PUNCT
cpe-2383	280	17	a.	a.	NOUN
cpe-2383	280	18	m.	m.	NOUN
cpe-2383	280	19	,	,	PUNCT
cpe-2383	280	20	andreassen	andreassen	PROPN
cpe-2383	280	21	,	,	PUNCT
cpe-2383	280	22	o.	o.	NOUN
cpe-2383	280	23	a.	a.	PROPN
cpe-2383	280	24	,	,	PUNCT
cpe-2383	280	25	westlye	westlye	NOUN
cpe-2383	280	26	,	,	PUNCT
cpe-2383	280	27	l.	l.	PROPN
cpe-2383	280	28	t.	t.	PROPN
cpe-2383	280	29	,	,	PUNCT
cpe-2383	280	30	&	&	CCONJ
cpe-2383	280	31	quintana	quintana	PROPN
cpe-2383	280	32	,	,	PUNCT
cpe-2383	280	33	d.	d.	PROPN
cpe-2383	280	34	s.	s.	PROPN
cpe-2383	280	35	(	(	PUNCT
cpe-2383	280	36	2017	2017	NUM
cpe-2383	280	37	)	)	PUNCT
cpe-2383	280	38	.	.	PUNCT
cpe-2383	281	1	the	the	DET
cpe-2383	281	2	correlation	correlation	NOUN
cpe-2383	281	3	between	between	ADP
cpe-2383	281	4	central	central	ADJ
cpe-2383	281	5	and	and	CCONJ
cpe-2383	281	6	peripheral	peripheral	ADJ
cpe-2383	281	7	oxytocin	oxytocin	NOUN
cpe-2383	281	8	concentrations	concentration	NOUN
cpe-2383	281	9	:	:	PUNCT
cpe-2383	281	10	psychoneuroendocrinology	psychoneuroendocrinology	NOUN
cpe-2383	281	11	and	and	CCONJ
cpe-2383	281	12	clinical	clinical	ADJ
cpe-2383	281	13	psychology	psychology	NOUN
cpe-2383	281	14	12	12	NUM
cpe-2383	281	15	clinical	clinical	ADJ
cpe-2383	281	16	psychology	psychology	NOUN
cpe-2383	281	17	in	in	ADP
cpe-2383	281	18	europe	europe	PROPN
cpe-2383	281	19	2019	2019	NUM
cpe-2383	281	20	,	,	PUNCT
cpe-2383	281	21	vol.1(2	vol.1(2	PROPN
cpe-2383	281	22	)	)	PUNCT
cpe-2383	281	23	,	,	PUNCT
cpe-2383	281	24	article	article	NOUN
cpe-2383	281	25	33030	33030	NUM
cpe-2383	281	26	https://doi.org/10.32872/cpe.v1i2.33030	https://doi.org/10.32872/cpe.v1i2.33030	PROPN
cpe-2383	282	1	https://doi.org/10.1001/jamapsychiatry.2016.3803	https://doi.org/10.1001/jamapsychiatry.2016.3803	PROPN
cpe-2383	282	2	https://doi.org/10.3945/ajcn.2008.27056	https://doi.org/10.3945/ajcn.2008.27056	PROPN
cpe-2383	282	3	https://doi.org/10.1093/ijnp/pyw082	https://doi.org/10.1093/ijnp/pyw082	PROPN
cpe-2383	282	4	https://doi.org/10.1016/j.psyneuen.2016.04.013	https://doi.org/10.1016/j.psyneuen.2016.04.013	PROPN
cpe-2383	282	5	https://doi.org/10.1016/j.psychres.2016.04.117	https://doi.org/10.1016/j.psychres.2016.04.117	PROPN
cpe-2383	282	6	https://doi.org/10.1097/psy.0000000000000483	https://doi.org/10.1097/psy.0000000000000483	PROPN
cpe-2383	282	7	https://doi.org/10.1016/j.psyneuen.2018.04.012	https://doi.org/10.1016/j.psyneuen.2018.04.012	NOUN
cpe-2383	282	8	https://doi.org/10.1097/psy.0b013e31820ad12b	https://doi.org/10.1097/psy.0b013e31820ad12b	X
cpe-2383	282	9	https://doi.org/10.1016/j.psyneuen.2015.09.026	https://doi.org/10.1016/j.psyneuen.2015.09.026	PROPN
cpe-2383	282	10	https://doi.org/10.1016/j.biopsycho.2011.02.002	https://doi.org/10.1016/j.biopsycho.2011.02.002	NOUN
cpe-2383	282	11	https://www.psychopen.eu/	https://www.psychopen.eu/	VERB
cpe-2383	282	12	a	a	DET
cpe-2383	282	13	systematic	systematic	ADJ
cpe-2383	282	14	review	review	NOUN
cpe-2383	282	15	and	and	CCONJ
cpe-2383	282	16	meta	meta	ADJ
cpe-2383	282	17	-	-	PUNCT
cpe-2383	282	18	analysis	analysis	NOUN
cpe-2383	282	19	.	.	PUNCT
cpe-2383	283	1	neuroscience	neuroscience	NOUN
cpe-2383	283	2	&	&	CCONJ
cpe-2383	283	3	biobehavioral	biobehavioral	ADJ
cpe-2383	283	4	reviews	review	NOUN
cpe-2383	283	5	,	,	PUNCT
cpe-2383	283	6	78	78	NUM
cpe-2383	283	7	,	,	PUNCT
cpe-2383	283	8	117	117	NUM
cpe-2383	283	9	-	-	SYM
cpe-2383	283	10	124	124	NUM
cpe-2383	283	11	.	.	PUNCT
cpe-2383	284	1	https://doi.org/10.1016/j.neubiorev.2017.04.017	https://doi.org/10.1016/j.neubiorev.2017.04.017	PROPN
cpe-2383	284	2	wolf	wolf	PROPN
cpe-2383	284	3	,	,	PUNCT
cpe-2383	284	4	j.	j.	PROPN
cpe-2383	284	5	m.	m.	PROPN
cpe-2383	284	6	,	,	PUNCT
cpe-2383	284	7	&	&	CCONJ
cpe-2383	284	8	saucier	saucy	ADJ
cpe-2383	284	9	,	,	PUNCT
cpe-2383	284	10	e.	e.	PROPN
cpe-2383	284	11	(	(	PUNCT
cpe-2383	284	12	2013	2013	NUM
cpe-2383	284	13	)	)	PUNCT
cpe-2383	284	14	.	.	PUNCT
cpe-2383	285	1	psychoneuroendocrinology	psychoneuroendocrinology	NOUN
cpe-2383	285	2	.	.	PUNCT
cpe-2383	286	1	in	in	ADP
cpe-2383	286	2	m.	m.	PROPN
cpe-2383	286	3	d.	d.	PROPN
cpe-2383	286	4	gellman	gellman	PROPN
cpe-2383	286	5	&	&	CCONJ
cpe-2383	286	6	j.	j.	PROPN
cpe-2383	286	7	r.	r.	PROPN
cpe-2383	286	8	turner	turner	PROPN
cpe-2383	286	9	(	(	PUNCT
cpe-2383	286	10	eds	eds	PROPN
cpe-2383	286	11	.	.	PUNCT
cpe-2383	286	12	)	)	PUNCT
cpe-2383	286	13	,	,	PUNCT
cpe-2383	286	14	encyclopedia	encyclopedia	NOUN
cpe-2383	286	15	of	of	ADP
cpe-2383	286	16	behavioral	behavioral	ADJ
cpe-2383	286	17	medicine	medicine	NOUN
cpe-2383	286	18	.	.	PUNCT
cpe-2383	287	1	new	new	PROPN
cpe-2383	287	2	york	york	PROPN
cpe-2383	287	3	,	,	PUNCT
cpe-2383	287	4	ny	ny	PROPN
cpe-2383	287	5	,	,	PUNCT
cpe-2383	287	6	usa	usa	PROPN
cpe-2383	287	7	:	:	PUNCT
cpe-2383	287	8	springer	springer	NOUN
cpe-2383	287	9	.	.	PUNCT
cpe-2383	288	1	https://doi.org/10.1007/978-1-4419-1005-9	https://doi.org/10.1007/978-1-4419-1005-9	PROPN
cpe-2383	288	2	zilcha	zilcha	PROPN
cpe-2383	288	3	-	-	PUNCT
cpe-2383	288	4	mano	mano	PROPN
cpe-2383	288	5	,	,	PUNCT
cpe-2383	288	6	s.	s.	PROPN
cpe-2383	288	7	,	,	PUNCT
cpe-2383	288	8	porat	porat	NOUN
cpe-2383	288	9	,	,	PUNCT
cpe-2383	288	10	y.	y.	PROPN
cpe-2383	288	11	,	,	PUNCT
cpe-2383	288	12	dolev	dolev	ADV
cpe-2383	288	13	,	,	PUNCT
cpe-2383	288	14	t.	t.	PROPN
cpe-2383	288	15	,	,	PUNCT
cpe-2383	288	16	&	&	CCONJ
cpe-2383	288	17	shamay	shamay	NOUN
cpe-2383	288	18	-	-	PUNCT
cpe-2383	288	19	tsoory	tsoory	NOUN
cpe-2383	288	20	,	,	PUNCT
cpe-2383	288	21	s.	s.	PROPN
cpe-2383	288	22	(	(	PUNCT
cpe-2383	288	23	2018	2018	NUM
cpe-2383	288	24	)	)	PUNCT
cpe-2383	288	25	.	.	PUNCT
cpe-2383	289	1	oxytocin	oxytocin	PROPN
cpe-2383	289	2	as	as	ADP
cpe-2383	289	3	a	a	DET
cpe-2383	289	4	neurobiological	neurobiological	ADJ
cpe-2383	289	5	marker	marker	NOUN
cpe-2383	289	6	of	of	ADP
cpe-2383	289	7	ruptures	rupture	NOUN
cpe-2383	289	8	in	in	ADP
cpe-2383	289	9	the	the	DET
cpe-2383	289	10	working	working	NOUN
cpe-2383	289	11	alliance	alliance	NOUN
cpe-2383	289	12	.	.	PUNCT
cpe-2383	290	1	psychotherapy	psychotherapy	NOUN
cpe-2383	290	2	and	and	CCONJ
cpe-2383	290	3	psychosomatics	psychosomatic	NOUN
cpe-2383	290	4	,	,	PUNCT
cpe-2383	290	5	87(2	87(2	NUM
cpe-2383	290	6	)	)	PUNCT
cpe-2383	290	7	,	,	PUNCT
cpe-2383	290	8	126	126	NUM
cpe-2383	290	9	-	-	SYM
cpe-2383	290	10	127	127	NUM
cpe-2383	290	11	.	.	PUNCT
cpe-2383	291	1	https://doi.org/10.1159/000487190	https://doi.org/10.1159/000487190	NOUN
cpe-2383	291	2	clinical	clinical	ADJ
cpe-2383	291	3	psychology	psychology	NOUN
cpe-2383	291	4	in	in	ADP
cpe-2383	291	5	europe	europe	PROPN
cpe-2383	291	6	(	(	PUNCT
cpe-2383	291	7	cpe	cpe	PROPN
cpe-2383	291	8	)	)	PUNCT
cpe-2383	291	9	is	be	AUX
cpe-2383	291	10	the	the	DET
cpe-2383	291	11	official	official	ADJ
cpe-2383	291	12	journal	journal	NOUN
cpe-2383	291	13	of	of	ADP
cpe-2383	291	14	the	the	DET
cpe-2383	291	15	european	european	PROPN
cpe-2383	291	16	association	association	PROPN
cpe-2383	291	17	of	of	ADP
cpe-2383	291	18	clinical	clinical	ADJ
cpe-2383	291	19	psychology	psychology	NOUN
cpe-2383	291	20	and	and	CCONJ
cpe-2383	291	21	psychological	psychological	ADJ
cpe-2383	291	22	treatment	treatment	NOUN
cpe-2383	291	23	(	(	PUNCT
cpe-2383	291	24	eaclipt	eaclipt	ADJ
cpe-2383	291	25	)	)	PUNCT
cpe-2383	291	26	.	.	PUNCT
cpe-2383	292	1	psychopen	psychopen	ADJ
cpe-2383	292	2	gold	gold	NOUN
cpe-2383	292	3	is	be	AUX
cpe-2383	292	4	a	a	DET
cpe-2383	292	5	publishing	publishing	NOUN
cpe-2383	292	6	service	service	NOUN
cpe-2383	292	7	by	by	ADP
cpe-2383	292	8	leibniz	leibniz	PROPN
cpe-2383	292	9	institute	institute	PROPN
cpe-2383	292	10	for	for	ADP
cpe-2383	292	11	psychology	psychology	NOUN
cpe-2383	292	12	information	information	NOUN
cpe-2383	292	13	(	(	PUNCT
cpe-2383	292	14	zpid	zpid	NOUN
cpe-2383	292	15	)	)	PUNCT
cpe-2383	292	16	,	,	PUNCT
cpe-2383	292	17	germany	germany	PROPN
cpe-2383	292	18	.	.	PUNCT
cpe-2383	293	1	fischer	fischer	PROPN
cpe-2383	293	2	&	&	CCONJ
cpe-2383	293	3	ehlert	ehlert	PROPN
cpe-2383	293	4	13	13	NUM
cpe-2383	293	5	clinical	clinical	ADJ
cpe-2383	293	6	psychology	psychology	NOUN
cpe-2383	293	7	in	in	ADP
cpe-2383	293	8	europe	europe	PROPN
cpe-2383	293	9	2019	2019	NUM
cpe-2383	293	10	,	,	PUNCT
cpe-2383	293	11	vol.1(2	vol.1(2	PROPN
cpe-2383	293	12	)	)	PUNCT
cpe-2383	293	13	,	,	PUNCT
cpe-2383	293	14	article	article	NOUN
cpe-2383	293	15	33030	33030	NUM
cpe-2383	293	16	https://doi.org/10.32872/cpe.v1i2.33030	https://doi.org/10.32872/cpe.v1i2.33030	PROPN
cpe-2383	293	17	https://doi.org/10.1016/j.neubiorev.2017.04.017	https://doi.org/10.1016/j.neubiorev.2017.04.017	PROPN
cpe-2383	293	18	https://doi.org/10.1007/978-1-4419-1005-9	https://doi.org/10.1007/978-1-4419-1005-9	PROPN
cpe-2383	293	19	https://doi.org/10.1159/000487190	https://doi.org/10.1159/000487190	NOUN
cpe-2383	293	20	https://www.psychopen.eu/	https://www.psychopen.eu/	VERB
cpe-2383	293	21	psychoneuroendocrinology	psychoneuroendocrinology	NOUN
cpe-2383	293	22	and	and	CCONJ
cpe-2383	293	23	clinical	clinical	ADJ
cpe-2383	293	24	psychology	psychology	NOUN
cpe-2383	293	25	(	(	PUNCT
cpe-2383	293	26	introduction	introduction	NOUN
cpe-2383	293	27	)	)	PUNCT
cpe-2383	293	28	how	how	SCONJ
cpe-2383	293	29	hormones	hormone	NOUN
cpe-2383	293	30	affect	affect	VERB
cpe-2383	293	31	social	social	ADJ
cpe-2383	293	32	interaction	interaction	NOUN
cpe-2383	293	33	how	how	SCONJ
cpe-2383	293	34	hormones	hormone	NOUN
cpe-2383	293	35	affect	affect	VERB
cpe-2383	293	36	cognition	cognition	NOUN
cpe-2383	293	37	,	,	PUNCT
cpe-2383	293	38	mood	mood	NOUN
cpe-2383	293	39	,	,	PUNCT
cpe-2383	293	40	and	and	CCONJ
cpe-2383	293	41	sexual	sexual	ADJ
cpe-2383	293	42	function	function	NOUN
cpe-2383	293	43	how	how	SCONJ
cpe-2383	293	44	hormones	hormone	NOUN
cpe-2383	293	45	affect	affect	VERB
cpe-2383	293	46	hunger	hunger	NOUN
cpe-2383	293	47	and	and	CCONJ
cpe-2383	293	48	satiety	satiety	VERB
cpe-2383	293	49	summary	summary	NOUN
cpe-2383	293	50	and	and	CCONJ
cpe-2383	293	51	integration	integration	NOUN
cpe-2383	293	52	(	(	PUNCT
cpe-2383	293	53	additional	additional	ADJ
cpe-2383	293	54	information	information	NOUN
cpe-2383	293	55	)	)	PUNCT
cpe-2383	293	56	funding	fund	VERB
cpe-2383	293	57	competing	compete	VERB
cpe-2383	293	58	interests	interest	NOUN
cpe-2383	293	59	acknowledgments	acknowledgment	NOUN
cpe-2383	293	60	references	reference	NOUN